Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,28187,-0.126115803305082,0.00292615886644292,-0.13185107468331,-0.120380531926854,0
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,27562,-0.296301464255103,0.00838572543263633,-0.31273748610307,-0.279865442407136,1.65931378073789e-267
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,28500,0.284342242853428,0.00827046674792505,0.268132128027495,0.300552357679361,7.67887989684794e-254
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,28091,-0.200548082073802,0.00610348496144287,-0.21251091259823,-0.188585251549374,2.21913611659818e-232
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,28521,-0.112377551978914,0.0035267689848982,-0.119290019189314,-0.105465084768513,5.83793097430151e-219
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,23872,0.113035164436835,0.00361842085087087,0.105943059569128,0.120127269304542,5.35311553863281e-210
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,28452,-0.137248237910353,0.00441625926081476,-0.14590410606155,-0.128592369759156,1.47921559325246e-208
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,23862,-0.0850635793359636,0.00275253510149025,-0.0904585481348845,-0.0796686105370427,1.20394987691469e-205
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,28239,-0.169244487211339,0.00551899846529946,-0.180061724203326,-0.158427250219352,3.52104331829252e-203
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,28244,-0.107592348986244,0.0035638145309339,-0.114577425466875,-0.100607272505614,4.34179398398594e-197
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,23846,-0.166434024960252,0.00563799349346291,-0.17748449220744,-0.155383557713065,3.86320966108027e-188
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,28044,-0.136029785514844,0.00506394321793151,-0.145955114221989,-0.126104456807698,5.88045050743864e-157
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,28321,-0.0624060749894454,0.00233700033458616,-0.0669865956452342,-0.0578255543336565,3.59505923813309e-155
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,28182,0.321696723756228,0.0120961461407723,0.297988277320314,0.345405170192141,6.19178954643508e-154
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,28336,0.0686998249912656,0.00259789061024463,0.0636079593951861,0.0737916905873451,2.98913180638163e-152
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,23071,-0.173886962760835,0.00662174557493815,-0.186865584087714,-0.160908341433956,8.75113732137463e-150
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,28224,0.0833578497225232,0.0032025881044295,0.0770807770378414,0.0896349224072051,1.31425462635279e-147
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,28307,-0.0593422058553953,0.00228187334311986,-0.0638146776079102,-0.0548697341028803,2.29489954546381e-147
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,28320,0.0494063285478681,0.00190798689893767,0.0456666742259502,0.0531459828697859,3.87700591673948e-146
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,23198,-0.088885200442372,0.0034857233099426,-0.0957172181298594,-0.0820531827548845,1.76573623704984e-141
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,28494,0.106353165238345,0.00426013960394646,0.0980032916146099,0.11470303886208,4.30490193000318e-136
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,23872,0.0866809717310211,0.00351344100681769,0.0797946273576585,0.0935673161043838,1.00287913824487e-132
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,23872,0.04129292929925,0.00169406970665596,0.0379725526742043,0.0446133059242957,1.21339319824155e-129
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,28367,0.0450584935881464,0.00190197286273943,0.0413306267771771,0.0487863603991157,7.09141103071487e-123
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,23872,0.0780528955813065,0.00329826994274957,0.0715882864935173,0.0845175046690957,2.13804733068799e-122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,27529,-0.0956381536153923,0.0040811779257642,-0.10363726234989,-0.0876390448808945,2.90718785047984e-120
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,28224,-0.0989236518560711,0.00423897888679115,-0.107232050474182,-0.0906152532379605,2.54595936748075e-119
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,28187,-0.0649353924180777,0.00280869086631573,-0.0704404265160565,-0.0594303583200988,3.64227220998185e-117
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,23337,-0.0450651301264572,0.00195032811106608,-0.0488877732241467,-0.0412424870287676,8.18261919727281e-117
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,27682,-0.131542981170874,0.00572389320443501,-0.142761811851566,-0.120324150490181,8.70363094727492e-116
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,28452,-0.0572987661345754,0.00252757921169668,-0.0622528213895009,-0.0523447108796499,8.9799975859273e-113
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,28344,-0.0920190614324873,0.00410097099613061,-0.100056964584903,-0.0839811582800713,1.53025530397345e-110
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,23163,-0.123475521345239,0.00553061535076158,-0.134315527432732,-0.112635515257746,2.95344226590096e-109
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,28176,-0.0809191265201916,0.00364671236209246,-0.0880666827498928,-0.0737715702904904,3.6634639412191e-108
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,28148,-0.153886494841071,0.00696489010908944,-0.167537679454886,-0.140235310227255,2.91455567670371e-107
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,23198,-0.0900343552635421,0.00410339969635394,-0.0980770186683958,-0.0819916918586884,1.2436077983884e-105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,27910,-0.108225371655599,0.00496895654601338,-0.117964526485786,-0.0984862168254132,2.64267694110737e-104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,28404,-0.177062834794086,0.00813589395848246,-0.193009186952711,-0.16111648263546,3.68761078884111e-104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,27791,0.079899841823589,0.00368750277864223,0.0726723363774503,0.0871273472697278,2.96612305343707e-103
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,23337,0.044567235427063,0.00208759946172056,0.0404755404820907,0.0486589303720352,3.65731567783666e-100
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,28187,0.0392420191674812,0.00184635365393084,0.0356231660057768,0.0428608723291857,1.83872656599668e-99
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,28187,-0.077581717457773,0.00365354005988114,-0.08474265597514,-0.0704207789404059,2.7450868134102e-99
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,23893,0.0977183006947763,0.00460723337282231,0.0886881232840445,0.106748478105508,6.34921993530287e-99
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),23428,0.255475295659173,0.0122336116828174,0.231497416760851,0.279453174557495,5.72593386383288e-96
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,27785,-0.209631164015224,0.0100615067756821,-0.229351717295561,-0.189910610734887,1.12702307542911e-95
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,23862,0.0840340752373481,0.00404334246334539,0.0761091240091911,0.0919590264655051,4.27053406337077e-95
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,23738,-0.102354663371109,0.0049333645020469,-0.112024057795121,-0.0926852689470968,8.98248299938261e-95
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,28307,-0.0350623244270626,0.0017011473801882,-0.0383965732922315,-0.0317280755618938,1.06861698438131e-93
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,28091,-0.12200134731486,0.0059318819656033,-0.133627835967442,-0.110374858662277,2.64206714170459e-93
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,28091,-0.0507632100596616,0.00247038428729802,-0.0556051632627657,-0.0459212568565575,3.834336364055e-93
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,28224,-0.0858708050551382,0.00418800778697115,-0.0940793003176017,-0.0776623097926748,9.42628015931598e-93
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,27562,-0.107623047939665,0.0052657956424091,-0.117944007398787,-0.0973020884805428,3.7014663418909e-92
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,23846,-0.127928050835258,0.00625954227828306,-0.140196753700693,-0.115659347969824,4.80013257202835e-92
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,28182,-0.159671827735121,0.00786794773098837,-0.175093005287858,-0.144250650182384,6.50396703744031e-91
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,26272,-0.0564716422028347,0.0027979282683389,-0.0619555816087789,-0.0509877027968905,6.59774757699578e-90
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,27840,-0.0526705316887359,0.00261030115478913,-0.0577867219521226,-0.0475543414253492,6.7341800157845e-90
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,27418,-0.0762975502013532,0.00378289284418639,-0.0837120201759585,-0.0688830802267479,8.21663869474161e-90
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,28176,-0.0543358130928048,0.00269512208841425,-0.0596182523860967,-0.0490533737995128,9.3144501173229e-90
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,27682,-0.0757448504529559,0.00376222261242251,-0.083118806773304,-0.0683708941326077,1.66193348933902e-89
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,27562,-0.0805638353659517,0.00407206701985004,-0.0885450867248578,-0.0725825840070456,1.61638785630318e-86
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23198,-0.0774564995870558,0.00391867956048889,-0.0851371115256141,-0.0697758876484976,3.00210603621205e-86
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,28091,-0.0588588057202696,0.00298360745757799,-0.0647066763371224,-0.0530109351034167,4.80657198455172e-86
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,28091,-0.107376734783099,0.00545486778270873,-0.118068275637208,-0.0966851939289895,1.10729222903945e-85
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,28091,-0.0554314847048298,0.00281878250808418,-0.0609562984206748,-0.0499066709889848,1.61906319902886e-85
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,28174,-0.113061204970575,0.00579135735022318,-0.124412265377012,-0.101710144564137,2.55960379189612e-84
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,23737,-0.114105174110903,0.00584338974866729,-0.125558218018291,-0.102652130203515,2.95861892656719e-84
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,28396,-0.0417584289806085,0.00215408351439483,-0.0459804326688224,-0.0375364252923947,3.5201508030477e-83
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,27965,-0.0480356419297916,0.00248529405557365,-0.0529068182787159,-0.0431644655808672,1.08431834315786e-82
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,23775,-0.100695405089275,0.00521142874930127,-0.110909805437905,-0.0904810047406443,1.50816249134717e-82
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,23071,-0.082262627830685,0.00426288623977656,-0.0906178848606471,-0.073907370800723,2.52010029876511e-82
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,27682,-0.0865074504078087,0.00453749487819158,-0.0954009403690642,-0.0776139604465532,1.62054160812116e-80
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,28428,-0.0314135015389145,0.00164970194006864,-0.0346469173414491,-0.02818008573638,2.42913132856199e-80
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,27702,-0.0715636454540429,0.00377339988844268,-0.0789595092353905,-0.0641677816726952,1.05799861320259e-79
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,28097,-0.0398214999347047,0.00212034630136548,-0.043977378685381,-0.0356656211840283,3.28107181075213e-78
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,27562,-0.105889922477865,0.00565986288876718,-0.116983253739849,-0.0947965912158813,1.26921617086933e-77
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,23893,-0.0249265819537335,0.00133561821997289,-0.0275443936648804,-0.0223087702425867,3.51159649286085e-77
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,28452,-0.041743364385962,0.00223814833815915,-0.0461301351287539,-0.03735659364317,3.59183781169634e-77
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,28553,-0.0639089630975613,0.00345222480658195,-0.0706753237184619,-0.0571426024766607,4.5792089127078e-76
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,28336,-0.0539762564503306,0.0029179812711735,-0.0596954997418307,-0.0482570131588305,6.03087429120473e-76
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,27554,-0.0622146945349368,0.00340146291495282,-0.0688815618482444,-0.0555478272216293,2.71159546113924e-74
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,23521,-0.0327829807389463,0.00179316138991969,-0.0362975770631889,-0.0292683844147037,3.74621194568257e-74
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,28176,-0.0346036814666537,0.00189735588646622,-0.0383224990041275,-0.0308848639291799,6.88860318135553e-74
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,23337,-0.0616294410797265,0.00339158819324895,-0.0682769539384945,-0.0549819282209586,2.79395649819049e-73
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,28224,-0.079376300285915,0.00437214979386195,-0.0879457138818844,-0.0708068866899456,3.06611325095148e-73
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,28236,-0.039371867167871,0.00217216544549725,-0.0436293114410456,-0.0351144228946964,5.19610902000907e-73
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,28176,-0.0498104818100561,0.00275706167948174,-0.0552143227018403,-0.0444066409182719,1.50395648991084e-72
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,28253,0.024369563025478,0.00135767289197463,0.0217085241572078,0.0270306018937483,1.21210313481527e-71
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,28176,0.0429183818733463,0.00240078138771262,0.0382128503534296,0.047623913393263,4.41910900563326e-71
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,27965,-0.0903162942071266,0.00506022439432827,-0.10023433402001,-0.0803982543942432,7.37942205091863e-71
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,28452,-0.0562220359276465,0.00316165018781131,-0.0624188702957566,-0.0500252015595363,2.32405225718003e-70
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,23322,-0.0577542488625342,0.00325028290717137,-0.0641248033605901,-0.0513836943644783,3.56964341120114e-70
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,28091,-0.0682982573012292,0.00386825676976019,-0.0758800405699591,-0.0607164740324992,2.16878682804765e-69
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,27682,-0.0627904452712956,0.00357232038858424,-0.0697921932329207,-0.0557886973096705,8.75896707151865e-69
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,23846,-0.0422716780778876,0.00240634233924681,-0.0469881090628113,-0.0375552470929638,1.19936680363682e-68
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,23337,-0.0908414914246444,0.00519033544948152,-0.101014548905628,-0.0806684339436606,3.77053718660699e-68
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,27940,-0.0439871270871409,0.0025435013242748,-0.0489723896827195,-0.0390018644915623,1.16369941000183e-66
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,23846,-0.0332885896438709,0.00194101351076876,-0.0370929761249776,-0.0294842031627641,1.55270975930197e-65
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,23846,-0.0345989917668704,0.00204554363769761,-0.0386082572967577,-0.0305897262369831,8.31930268691759e-64
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",27544,-0.0609477960349449,0.00361344921992125,-0.0680301565059905,-0.0538654355638992,1.64321179786521e-63
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,27850,-0.0548903238748435,0.0032613544129317,-0.0612825785241896,-0.0484980692254973,2.99772585461926e-63
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,23893,0.0299701122914096,0.00178655327176269,0.0264684678787547,0.0334717567040645,8.46068072886945e-63
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,28127,-0.0340764566173683,0.00203328147594032,-0.0380616883102113,-0.0300912249245253,9.7641196248579e-63
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,28307,-0.0254554591249085,0.00152077917050929,-0.0284361862991067,-0.0224747319507103,1.37667687479642e-62
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,28176,-0.0578101992659234,0.00346075777676473,-0.0645932845083823,-0.0510271140234645,2.42742937552897e-62
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,27910,-0.026982732227006,0.00161949223341108,-0.0301569370044918,-0.0238085274495203,5.00548767230789e-62
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,28439,0.0410790415574404,0.00247330849014783,0.0362313569167507,0.0459267261981302,1.17311236370688e-61
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,28470,-0.0571582023881158,0.0034477617914492,-0.0639158154993562,-0.0504005892768754,1.94165628320785e-61
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,23725,-0.0431502925385224,0.00260302975401442,-0.0482522308563906,-0.0380483542206541,2.26705480649323e-61
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",28091,-0.0928463946699297,0.00560819328434376,-0.103838453507243,-0.0818543358326159,2.85434529791657e-61
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,23795,-0.0500793612043861,0.00302661544347499,-0.056011527473597,-0.0441471949351751,3.74112853273379e-61
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,23862,-0.0373509052184071,0.0022595349800081,-0.041779593779223,-0.0329222166575912,4.85168603095573e-61
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,28176,-0.0543170303490506,0.00329828300619213,-0.0607816650411872,-0.047852395656914,1.19213397993581e-60
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,28187,-0.0362584313579506,0.00221134792758965,-0.0405926732960263,-0.0319241894198749,3.84794018249891e-60
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,28326,-0.0768358758142818,0.00468743401926703,-0.0860232464920451,-0.0676485051365184,4.13762543612778e-60
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,28286,-0.0344590383370235,0.00210622272715479,-0.0385872348822469,-0.0303308417918001,6.89383522707106e-60
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,23287,-0.0422317249706716,0.00258494840211154,-0.0472982238388103,-0.037165226102533,1.14679328653519e-59
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,28091,-0.0761681180722828,0.00467403774515551,-0.0853292320527876,-0.067007004091778,1.97580116613169e-59
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,28091,-0.0898112728900219,0.0055238191838557,-0.100637958490379,-0.0789845872896647,3.6013740122162e-59
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,23846,-0.0734942089423229,0.0045230021490575,-0.0823592931544756,-0.0646291247301702,4.71882605815579e-59
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,28452,-0.0318117658565822,0.00196107086007091,-0.0356554647423212,-0.0279680669708433,6.52452835969679e-59
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,28187,-0.0355476524476509,0.00219189609812063,-0.0398437687999673,-0.0312515360953344,6.98409340363519e-59
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,28091,-0.0776971855757979,0.0047934643540167,-0.0870923757096706,-0.0683019954419252,8.06299894601853e-59
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,28521,-0.085507786719603,0.00527630021166541,-0.0958493351344672,-0.0751662383047388,8.38090608584678e-59
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,28452,-0.0381095993670648,0.00235366631458117,-0.0427227853436439,-0.0334964133904857,1.05886889542577e-58
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,27544,-0.0572901537551447,0.00353839105543985,-0.0642254002238068,-0.0503549072864826,1.09006397616754e-58
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,27965,-0.0465719911372272,0.00287946744941659,-0.0522157473380837,-0.0409282349363707,1.42423643076347e-58
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,28521,-0.0315710455859142,0.00195364931487832,-0.0354001982430757,-0.0277418929287527,1.75665230073639e-58
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,28404,-0.0468287914840903,0.00289821533217304,-0.0525092935351495,-0.0411482894330312,1.8253606101363e-58
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,23846,-0.0621259897460929,0.0038790748867645,-0.0697289765241513,-0.0545230029680345,1.98152530322485e-57
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,28307,-0.059154254967129,0.0036952969190417,-0.0663970369284507,-0.0519114730058073,2.00990148989404e-57
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,23862,-0.123955560355458,0.00774626923117813,-0.139138248048567,-0.108772872662349,2.46274796414578e-57
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,27918,-0.0575235492214337,0.00360362757622021,-0.0645866592708253,-0.0504604391720421,4.16442758818886e-57
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,28182,-0.0408018094953648,0.00256300550712097,-0.0458253002893219,-0.0357783187014077,8.21291146044542e-57
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,28428,-0.0475295077651864,0.00299140125476929,-0.0533926542245343,-0.0416663613058386,1.33074833862524e-56
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,23198,-0.0695546848144074,0.00438751002089553,-0.0781542044553627,-0.0609551651734522,2.65457144258968e-56
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,28135,-0.0549199798419488,0.0034687061201419,-0.061718643837427,-0.0481213158464707,3.22519321965004e-56
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,28292,-0.0355650776599974,0.00224769980954849,-0.0399705692867124,-0.0311595860332824,3.77028376040907e-56
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,23337,-0.0566581052734759,0.0035813130273494,-0.0636774788070808,-0.0496387317398711,4.40129733336243e-56
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,27562,-0.0683622906456054,0.00437612138041385,-0.0769394885512165,-0.0597850927399943,8.91014660071814e-55
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,23337,-0.0291707866464541,0.00186862587977823,-0.0328332933708194,-0.0255082799220888,1.16214247375661e-54
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,23725,-0.0591219020323321,0.0038002548425246,-0.0665704015236803,-0.0516734025409839,2.63297337903838e-54
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,28521,-0.0400508884433054,0.00258161962215995,-0.0451108629027389,-0.0349909139838719,4.65234677215389e-54
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,23738,-0.118238942705637,0.0076190922586876,-0.133172363532665,-0.103305521878609,4.7762676325989e-54
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,28091,-0.112099802200967,0.00726616518555603,-0.126341485964656,-0.0978581184372768,1.76934556639803e-53
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,28086,0.066911971042997,0.00434322959307314,0.0583992410405737,0.0754247010454204,2.46532287653528e-53
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,28428,-0.0550394972330481,0.00358839319681588,-0.0620727478988072,-0.048006246567289,6.92316058344065e-53
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,28091,-0.0763597319734759,0.00498047777172878,-0.0861214684060643,-0.0665979955408875,7.67777703330319e-53
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,28277,-0.0348100602542556,0.0022812868106068,-0.0392813824030449,-0.0303387381054662,2.32175986078978e-52
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,23725,-0.0548520975785977,0.00359464090777853,-0.0618975937578436,-0.0478066013993518,2.52748246317837e-52
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,23502,-0.0249985315611168,0.00164117016134279,-0.0282152250773487,-0.0217818380448849,3.84230630634968e-52
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,28187,0.0391345237225226,0.00257432489810254,0.0340888469222416,0.0441802005228036,5.52943816786116e-52
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,23795,-0.0602315040751495,0.00397335374225982,-0.0680192774099787,-0.0524437307403202,1.15491627290849e-51
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,28428,0.0475580753977263,0.00315534827094416,0.0413735927866757,0.0537425580087769,3.89111743441207e-51
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,28521,-0.0427762639617896,0.00284322891034948,-0.0483489926260746,-0.0372035352975046,5.84817423647464e-51
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,23846,-0.0705893936751314,0.00469231109858051,-0.0797863234283492,-0.0613924639219136,6.51378629859996e-51
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,27373,-0.0203232819522528,0.00135337369888149,-0.0229758944020605,-0.0176706695024451,9.0906799934059e-51
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,27702,-0.081407251953934,0.00548255324246567,-0.0921530563091667,-0.0706614475987013,1.10656347475746e-49
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,28428,-0.141697323714359,0.00956588039011619,-0.160446449278987,-0.122948198149731,1.85309703521992e-49
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,23198,-0.0541632504538904,0.00368738898892741,-0.0613905328721882,-0.0469359680355927,1.25859578539228e-48
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,28363,-0.0489155729971922,0.00334119816788369,-0.0554643214062442,-0.0423668245881402,2.3398052869399e-48
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,28122,-0.0541411768419322,0.00370449327644483,-0.061401983663764,-0.0468803700201003,3.3871891453194e-48
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,23198,-0.0603240210213682,0.00414078156864365,-0.0684399528959098,-0.0522080891468267,7.27812730903926e-48
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,27562,-0.0589935178311154,0.00405960829150274,-0.0669503500824608,-0.05103668557977,1.14358265077571e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,23337,-0.0218173070589424,0.00150116785916676,-0.0247595960629092,-0.0188750180549755,1.19998695663611e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,28521,-0.0302165600004502,0.00208529370714203,-0.0343037356664486,-0.0261293843344518,2.05716960216068e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,28224,-0.0633132916675762,0.00436942685756303,-0.0718773683083997,-0.0547492150267527,2.07290913767715e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,23585,-0.0316302845224081,0.00218774957136989,-0.0359182736822931,-0.0273422953625231,3.55829812501866e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,28224,0.0372494772048202,0.00257878147494461,0.0321950655139288,0.0423038888957116,3.99458541970495e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,28367,-0.0469085298879528,0.00324823060005476,-0.0532750618640602,-0.0405419979118455,4.18381339850951e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,23071,-0.0676362055303194,0.00468163624329169,-0.0768122125671711,-0.0584601984934677,4.19844390932212e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,28091,-0.0392368551735635,0.00271805355414434,-0.0445642401396864,-0.0339094702074406,4.55305108805738e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,23467,-0.0276674691962332,0.00192257378809452,-0.0314357138208985,-0.0238992245715679,9.34617628998571e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,28224,-0.0260037681116201,0.00181362155392824,-0.0295584663573195,-0.0224490698659208,1.84436708508176e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,28313,-0.0642914331037873,0.00448869508936352,-0.0730892754789398,-0.0554935907286348,2.28497307575279e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,28428,-0.0639446254904976,0.00446808967182396,-0.0727020812472725,-0.0551871697337226,2.69136072886612e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,23846,-0.0290383717309638,0.00203102120274592,-0.0330191732883458,-0.0250575701735818,3.52594951007204e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,28044,-0.0253380326321393,0.00177862477920501,-0.0288241371993811,-0.0218519280648975,6.88096100053577e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,27544,-0.0598636901246752,0.00421489849457905,-0.0681248911740501,-0.0516024890753002,1.27467104994641e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,23725,-0.0678712332410335,0.00478171644740617,-0.0772433974779496,-0.0584990690041174,1.53588334649532e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,28176,-0.0624387156833079,0.00440969521490901,-0.0710817183045296,-0.0537957130620863,2.33814929185702e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,23198,-0.0821603578067153,0.00580196472854832,-0.09353220867467,-0.0707885069387606,2.47609938055901e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,23738,-0.0580040199320286,0.00409861953366131,-0.0660373142180048,-0.0499707256460524,2.77178716285069e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,28452,-0.06308020923037,0.0044694018094979,-0.0718402367769859,-0.0543201816837541,4.43510731278895e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,23188,-0.11934524758348,0.00845270194297427,-0.13591254339171,-0.102777951775251,4.4501327683242e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,28471,-0.0669212594514307,0.00474573429006577,-0.0762228986599596,-0.0576196202429018,5.28303629494092e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,28521,-0.0440055322136695,0.00312206549759744,-0.0501247805889605,-0.0378862838383785,5.77275629825545e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,28091,-0.0575430045751959,0.00409869395737132,-0.0655764447316437,-0.0495095644187481,1.26767535682934e-44
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,28553,-0.0538621200003544,0.00384291732389704,-0.0613942379551926,-0.0463300020455162,1.74944881066228e-44
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,23846,-0.025309202273541,0.00180754199738897,-0.0288519845884233,-0.0217664199586586,2.27237572964015e-44
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,23775,-0.0592848958682511,0.00424059260546153,-0.0675964573749557,-0.0509733343615465,3.07780522514183e-44
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,28320,0.0196349582692388,0.00141106844936483,0.0168692641084837,0.0224006524299938,7.16982136654693e-44
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,23337,-0.110581417088574,0.00796324593438432,-0.126189379119967,-0.0949734550571803,1.1419601485334e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,28553,0.0325745157328967,0.00234799268361957,0.0279724500730023,0.037176581392791,1.27354975128737e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,27562,-0.0611884099571851,0.00441802768164103,-0.0698477442132015,-0.0525290757011687,1.78695707676897e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,28496,-0.0501223374584036,0.0036232813833602,-0.0572239689697896,-0.0430207059470176,2.21408889763709e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,28176,-0.0545256983593308,0.00394693568772752,-0.0622616923072767,-0.0467897044113849,2.8773073687165e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,23872,0.0603207369112935,0.00437021819521572,0.0517551092486707,0.0688863645739163,3.59871135432035e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,28145,-0.0189166840952994,0.00137103807679896,-0.0216039187258254,-0.0162294494647734,3.65586221573126e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,28091,-0.0496545151451324,0.00360412483089883,-0.0567185998136941,-0.0425904304765707,4.83143684899823e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,28521,-0.046386025728409,0.00340236958035107,-0.0530546701058971,-0.0397173813509209,3.43636901731124e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,28336,0.0546020200099353,0.00401189485949423,0.0467387060853266,0.062465333934544,4.73488708329984e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,27965,-0.0500683830823208,0.00367967730485032,-0.0572805505998274,-0.0428562155648142,4.97211128824067e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,23775,-0.0621053053765665,0.00456773337826102,-0.0710580627979581,-0.0531525479551749,6.02824002877767e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,27544,-0.0478793886891746,0.00352710310910418,-0.0547925107830188,-0.0409662665953304,7.71533705359573e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,28176,-0.0509082444156202,0.00375454583114156,-0.0582671542446577,-0.0435493345865827,9.46712924503168e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,23872,-0.0206480993035585,0.00152684921455228,-0.023640723764081,-0.0176554748430361,1.62016550806002e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,28320,-0.0717116336216647,0.0053079991215665,-0.082115311899935,-0.0613079553433943,1.83317145483143e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,27562,-0.0531180169134106,0.0039451118105995,-0.0608504360621856,-0.0453855977646356,3.42727941107265e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,23071,-0.062678303546524,0.00465892365894532,-0.0718097939180568,-0.0535468131749912,4.20362427922976e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,28307,-0.0524881182081876,0.00391576821386569,-0.0601630239073644,-0.0448132125090109,7.60466446026775e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,28182,0.0415313783954407,0.00310485223988741,0.0354458680052613,0.04761688878562,1.10766585443307e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,23846,-0.0839837753725004,0.00627704274371281,-0.0962867791501775,-0.0716807715948233,1.11729006147989e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,28336,-0.0533081791552101,0.00399083060834901,-0.0611302071475741,-0.045486151162846,1.41816196229237e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,27965,-0.06539700486935,0.00490503796770714,-0.075010879286056,-0.0557831304526441,1.98787950001117e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,27544,-0.0471923708208704,0.00353959285919879,-0.0541299728249001,-0.0402547688168408,1.99406442311383e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,23337,-0.0209442003655418,0.0015724127735332,-0.0240261294016669,-0.0178622713294168,2.49413256702953e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,27562,-0.0578732221583052,0.00434725905340025,-0.0663938499029697,-0.0493525944136408,2.60647102344343e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,28452,-0.0309810383132566,0.00232842550214252,-0.0355447522974559,-0.0264173243290572,2.83543813800696e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,23862,-0.02564895351693,0.00193107062988132,-0.0294338519514974,-0.0218640550823626,4.07519431286538e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,28181,0.0538958094408504,0.00406265508435848,0.0459330054755078,0.061858613406193,4.79817809702833e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,27562,-0.0605265761503344,0.00459975303804069,-0.0695420921048941,-0.0515110601957746,1.99607937545123e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,23893,0.0247705858659927,0.00188481147729481,0.0210763553704948,0.0284648163614905,2.58332793864245e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",28091,-0.0877698818743936,0.0067093255418764,-0.100920159936471,-0.0746196038123158,5.44328397729857e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,27562,-0.0646499023376919,0.00494221196138408,-0.0743366377820047,-0.0549631668933791,5.514279196064e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,28521,-0.0295194922332927,0.00225825742722293,-0.0339456767906496,-0.0250933076759357,6.17692976397354e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,27562,-0.0608081359242921,0.00467992761031258,-0.0699807940405048,-0.0516354778080794,1.73100259384066e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,23337,-0.0570001877156219,0.00439244812116514,-0.0656093860331056,-0.0483909893981382,2.24806099013453e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,28113,-0.0611919125581749,0.00472389722049124,-0.0704507511103377,-0.0519330740060121,2.88232280217582e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,28276,0.0401111516373948,0.00310195014881988,0.0340313293457079,0.0461909739290818,3.86331226793722e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,23589,-0.0241020151619089,0.00186432879400537,-0.0277560995981594,-0.0204479307256584,4.21688949583405e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,28224,-0.0314458275743284,0.00243623472721817,-0.036220847639676,-0.0266708075089807,5.22899041114291e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,27544,-0.0309888047079945,0.00240480432131237,-0.0357022211777668,-0.0262753882382223,6.92812587256761e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,28187,-0.0498774672458211,0.00387141763565727,-0.0574654458117093,-0.0422894886799329,7.13156545319664e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,23893,-0.0639176722453826,0.0049601381706027,-0.0736395430597638,-0.0541958014310013,7.1936748727282e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,23337,0.0201259411416083,0.00156304176314957,0.0170623792858351,0.0231895029973815,8.25193433663417e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,23862,-0.0360102397114282,0.00280245000380836,-0.0415030417188926,-0.0305174377039638,1.15366322933637e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,23337,-0.061825789587416,0.0048167712155114,-0.0712666611698183,-0.0523849180050137,1.39012543344807e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,27544,-0.0246909274940704,0.00193090585279244,-0.0284755029655436,-0.0209063520225972,2.46850912162221e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,28174,-0.0858229248109289,0.00672384302407582,-0.0990016571381175,-0.0726441924837403,3.30468759340635e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,22802,-0.0281262812083767,0.00220990492268805,-0.0324576948568452,-0.0237948675599081,5.56816836803441e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,28144,-0.0803098356727746,0.00633058539608402,-0.0927177830490993,-0.0679018882964499,8.91764411126931e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,28237,-0.0231879462363349,0.00183384632526767,-0.0267822850338595,-0.0195936074388102,1.50900755430468e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,23775,-0.113636646044461,0.00898895880502075,-0.131255005302302,-0.0960182867866205,1.62804431844928e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,23337,-0.0398839249006377,0.00315615572487952,-0.0460699901214016,-0.0336978596798738,1.74154072863069e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,28091,0.0172049948643683,0.00136224793126032,0.014534988919098,0.0198750008096385,1.81654458836343e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,23775,-0.0412702359792444,0.00326925933900813,-0.0476779842837003,-0.0348624876747884,2.04544384204446e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,27338,-0.0874798367662517,0.00693925691857302,-0.101080780326655,-0.0738788932058486,2.4543338848264e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,28187,-0.0239054433339594,0.00189688174555341,-0.0276233315552441,-0.0201875551126748,2.56391409890238e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,27833,-0.0313177695529108,0.00248580003441877,-0.0361899376203716,-0.02644560148545,2.69836941761516e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,27562,-0.0958406759522287,0.00760974635616857,-0.110755778810319,-0.0809255730941383,2.8515659501605e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,27795,-0.0253418508792937,0.00201241965307926,-0.0292861933993291,-0.0213975083592584,2.90906555039025e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,28176,-0.0794458077566339,0.00631143081828836,-0.0918162121604791,-0.0670754033527887,3.09336268034085e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,28224,-0.0295054829515465,0.00234598063146845,-0.0341036049892246,-0.0249073609138683,3.53234424658223e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,28091,-0.107373834695819,0.00854636078269816,-0.124124701829908,-0.090622967561731,4.18235851468659e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,27562,-0.0249590323388027,0.00198783105594752,-0.0288551812084598,-0.0210628834691455,4.63161781179007e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,28176,-0.063764510350811,0.00507920958044901,-0.073719761128491,-0.0538092595731309,4.71952391653408e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,28091,-0.0296866040693338,0.00236596711509026,-0.0343238996149108,-0.0250493085237569,5.13585831424647e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,23893,-0.019904462207108,0.001588884082157,-0.0230186750081357,-0.0167902494060803,6.86321195649597e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,28091,-0.030570560690547,0.00244433847483717,-0.0353614641012279,-0.0257796572798662,8.55057193126585e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,28553,-0.0449079697932893,0.00359447781192598,-0.0519531463046642,-0.0378627932819143,1.00351473809558e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,23337,-0.0333891023542966,0.00267205564425335,-0.0386263314170332,-0.0281518732915601,1.02605565519154e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,23530,-0.0458303999809949,0.00367443676224604,-0.0530322960349971,-0.0386285039269926,1.36244646130197e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,28336,-0.0513633143727995,0.0041328732234465,-0.0594637458907547,-0.0432628828548444,2.27823952409539e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",28176,-0.0834924288746932,0.00672336905088224,-0.0966702322144224,-0.070314625534964,2.57494943420199e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,28091,-0.0271821970979589,0.00218948979953729,-0.031473597105052,-0.0228907970908658,2.68742125700408e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,28307,-0.0708088341657767,0.00570798136141227,-0.0819964776341447,-0.0596211906974086,3.02371194311225e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,28553,0.0202982781788851,0.00164005087840658,0.0170837784572082,0.023512777900562,4.30439313780967e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,27641,-0.0508715095425788,0.0041129711652657,-0.0589329330264995,-0.042810086058658,4.78877208845182e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,27544,-0.0570895904425828,0.00462146927030423,-0.0661476702123791,-0.0480315106727865,5.80033575041636e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,23071,-0.0335177195795406,0.00271861218513928,-0.0388461994624136,-0.0281892396966677,8.14226444785494e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,23337,-0.0349279952578868,0.00283818263035577,-0.0404908332133841,-0.0293651573023895,1.071400478469e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,23188,-0.0707085049041175,0.00575056833422063,-0.0819796188391899,-0.0594373909690451,1.2217933962209e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,28224,-0.0566102304865363,0.00462098684845682,-0.0656673647095117,-0.047553096263561,2.0379280169e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,28044,-0.0469548270427828,0.0038649102522753,-0.0545300511372424,-0.0393796029483232,7.06553904606792e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,23337,-0.0447705094438367,0.00368474689019566,-0.0519926133486202,-0.0375484055390532,7.24175298331889e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,23795,-0.0505714265090858,0.00416399864476041,-0.0587328638528162,-0.0424099891653554,7.68941709292253e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,28452,0.0297301308005276,0.00245504427004525,0.0249182440312389,0.0345420175698163,1.13423905165723e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,27562,-0.0413484522729656,0.00342048366894125,-0.0480526002640905,-0.0346443042818408,1.477856031631e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,28521,-0.0285916677648622,0.00236548994935673,-0.0332280280656013,-0.023955307464123,1.4948254881157e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,27965,-0.0247703376666284,0.00205149645959623,-0.028791270727437,-0.0207494046058198,1.75004426625255e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,28307,-0.0298557025248102,0.00247317148501081,-0.0347031186354314,-0.025008286414189,1.79847742179323e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,23738,-0.0249082473347417,0.00206557173697036,-0.0289567679392036,-0.0208597267302798,2.18365699374239e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,28320,-0.0343910425905463,0.00285772997785301,-0.0399921933471382,-0.0287898918339544,2.8259028776757e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,23188,-0.0706521764175535,0.0058810284086517,-0.0821789920985108,-0.0591253607365962,3.78313067802849e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,23775,-0.0458873199390862,0.00382486131938599,-0.0533840481250827,-0.0383905917530896,4.5844607524413e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,27562,-0.0504662643747376,0.00420942864394204,-0.058716744516864,-0.0422157842326112,4.91211238394535e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,27965,-0.0729650822117482,0.00610070239154002,-0.0849224588991666,-0.0610077055243297,6.91619818723431e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,28521,-0.0345966934810846,0.00289480468580323,-0.040270510665259,-0.0289228762969103,7.65807390459558e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,28428,-0.0476159980229587,0.0039855006906257,-0.0554275793765851,-0.0398044166693323,8.03831141733335e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,27702,-0.0578933349273363,0.00484766008784311,-0.0673947486995088,-0.0483919211551638,8.55131438857566e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,23644,-0.0207532239850945,0.00173760214771968,-0.0241589241946251,-0.017347523775564,8.7152108857208e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23188,-0.0367113811653443,0.0030740179165972,-0.0427364562818748,-0.0306863060488138,8.87087531448352e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,27682,-0.0432574007540447,0.00362626806972754,-0.0503648861707106,-0.0361499153373787,1.00661021362444e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,28224,-0.0229318601592544,0.00193446487542914,-0.0267234113150955,-0.0191403090034133,2.43784193609761e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,28384,-0.0249604115935969,0.00210728764973996,-0.0290906953870872,-0.0208301278001065,2.72829977139074e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,28224,0.0251944224991938,0.00212896893029522,0.0210216433958152,0.0293672016025725,3.10099204219621e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,28176,0.0355742397491841,0.00300973935286248,0.0296751506175736,0.0414733288807945,3.67862788364659e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,28176,-0.0572302887022335,0.00484317661741485,-0.0667229148723666,-0.0477376625321004,3.81273955120648e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,28187,0.0233315578408582,0.00197673779360229,0.0194571517653977,0.0272059639163187,4.47945413070299e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,27544,-0.0421102913691383,0.00356937212992771,-0.0491062607437966,-0.03511432199448,4.79344157800584e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,28452,-0.0349378860469673,0.00296486491813878,-0.0407490212865193,-0.0291267508074153,5.60414199213555e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,27702,-0.0486166728404027,0.0041304878047644,-0.0567124289377409,-0.0405209167430645,6.62370180613749e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,27965,-0.0466058512594752,0.00397183738231183,-0.0543906525288064,-0.038821049990144,1.01194627749545e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,28091,-0.0442670804704352,0.00377433492613698,-0.0516647769256637,-0.0368693840152067,1.08041100165547e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,28176,-0.0857309194390777,0.00731864052183655,-0.100075454861877,-0.0713863840162781,1.27883221697946e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,28176,-0.0493800687950397,0.00421879594992592,-0.0576489088568945,-0.0411112287331849,1.42585088248034e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,23775,-0.0508523165882628,0.00434990649190212,-0.0593781333123909,-0.0423264998641346,1.73990201023582e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,28091,-0.0915025022803271,0.00783497002967046,-0.106859043538481,-0.076145961022173,1.93581146677864e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,23393,-0.0435391071307627,0.00373014432438737,-0.0508501900065619,-0.0362280242549635,2.15986605848345e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,23337,-0.0447098433604445,0.00383805854283159,-0.0522324381043944,-0.0371872486164946,2.83173328480461e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,28091,-0.0544101989637934,0.00467413919259994,-0.0635715117812893,-0.0452488861462975,3.01966307419805e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,27544,-0.0455461612965692,0.00392160492112117,-0.0532325069419667,-0.0378598156511717,4.12707122424694e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,28428,-0.0533855695090591,0.00459677915979307,-0.0623952566622535,-0.0443758823558647,4.12842615278307e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,23846,-0.035903122108059,0.00309193727780121,-0.0419633191725494,-0.0298429250435687,4.35044355387808e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,23747,-0.0871832281712051,0.00751035120522863,-0.101903516533453,-0.0724629398089569,4.53186426691113e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,22885,-0.0426568193842554,0.00367682155744344,-0.0498633896368445,-0.0354502491316662,4.94380633937109e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,23775,-0.0704482921901865,0.00608108784317518,-0.0823672243628098,-0.0585293600175631,5.95923802342813e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,27969,-0.057764690512276,0.00498961668714415,-0.0675443392190786,-0.0479850418054735,6.34259002107523e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,27544,-0.0516382925715932,0.00446512932313258,-0.0603899460449331,-0.0428866390982534,7.32400868584103e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,23337,-0.0430219174971524,0.00372175652099534,-0.0503165602783033,-0.0357272747160015,8.01348687814759e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,28091,0.061054114088401,0.00529482991779033,0.050676247449532,0.0714319807272701,1.08099193250775e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,28307,-0.0725274094882941,0.00629345504725401,-0.084862581380912,-0.0601922375956763,1.16571480682158e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,27682,-0.0459380715248263,0.00398831108231176,-0.0537551612461573,-0.0381209818034953,1.25501976415839e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,23872,-0.0577261189431944,0.00501257582141239,-0.0675507675531627,-0.0479014703332262,1.31638117536048e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,23725,-0.0786851482071972,0.00683306538059033,-0.0920779563531542,-0.0652923400612401,1.3317637862684e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,23775,-0.056001612207187,0.00486417119604813,-0.0655353877514413,-0.0464678366629326,1.3665150631279e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,23893,-0.0156943116381064,0.00136525686231774,-0.0183702150882491,-0.0130184081879636,1.67197816141053e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,23725,-0.0628611960429584,0.00547359202806316,-0.0735894364179622,-0.0521329556679546,1.9012727527524e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,28553,-0.0529438945238075,0.00461483550705501,-0.0619889721176353,-0.0438988169299797,2.11343990199776e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,28224,-0.0240819487186314,0.00210053443939666,-0.0281989962198489,-0.019964901217414,2.31766171997911e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,23775,-0.0322591152560677,0.00281331560897817,-0.0377732138496649,-0.0267450166624705,2.33397873421908e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,23736,-0.0639924175600361,0.00558080384864691,-0.0749307931033841,-0.0530540420166882,2.33626707819019e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,23198,-0.037103578451556,0.00323679239969704,-0.0434476915549622,-0.0307594653481498,2.44116654176807e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23188,-0.0386150366525023,0.00336973374923509,-0.0452197148010031,-0.0320103585040016,2.54722873093024e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,23846,-0.0570408364731917,0.00498242145188808,-0.0668063825188923,-0.047275290427491,2.87363078839016e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,23862,-0.0589874819045376,0.00515303146285926,-0.0690874235717418,-0.0488875402373335,2.91560507937251e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,28232,-0.0312482980304534,0.00273992983305221,-0.0366185605032357,-0.025878035557671,4.6061547818597e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,28187,-0.0351716097795053,0.0030848972933151,-0.0412180084744029,-0.0291252110846077,4.79843845112654e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,28091,-0.0256643641389325,0.00225133747354337,-0.0300769855870775,-0.0212517426907875,4.89055250784821e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,28091,-0.0425230643306391,0.0037304807402091,-0.0498348065814489,-0.0352113220798292,4.93501091828175e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,28266,-0.0277936524318902,0.00244350830744577,-0.0325829287144839,-0.0230043761492965,6.50959940254977e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,28373,-0.0456128885870628,0.00401520264501888,-0.0534826857712998,-0.0377430914028258,7.67032967370307e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,27918,-0.069750986677316,0.00614889919763496,-0.0818028291046805,-0.0576991442499515,9.26661127223402e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,27702,-0.0411871911785748,0.00363383364100869,-0.0483095051149518,-0.0340648772421977,1.03114094560778e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,23862,-0.0423322423705434,0.00373722109476602,-0.0496571957162848,-0.035007289024802,1.14596739186977e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",23893,-0.0129498303602563,0.00114455480792151,-0.0151931577837824,-0.0107065029367301,1.32635228672803e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",27682,-0.0715853323419578,0.00633298391944845,-0.0839979808240768,-0.0591726838598388,1.46283395249417e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,28340,-0.0802398481839463,0.00710847469084256,-0.0941724585779978,-0.0663072377898949,1.74079600513135e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,28291,-0.0141622642160085,0.00125547535148737,-0.0166229959049238,-0.0117015325270933,1.89581732018462e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,28428,-0.0469860719421749,0.00416869383602203,-0.0551567118607781,-0.0388154320235717,2.10292097839169e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,27544,-0.0475480215728581,0.00422849366287174,-0.0558358691520868,-0.0392601739936295,2.84974987981197e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,28277,-0.0394981433091414,0.0035164895269445,-0.0463904627819526,-0.0326058238363301,3.26518466617682e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,23393,-0.0412461942262818,0.00367861676239977,-0.0484562830805853,-0.0340361053719782,4.20491753882389e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,23337,-0.0639848003548472,0.00571797481542007,-0.0751920309930706,-0.0527775697166239,5.40382234779602e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,23377,-0.0338397406330291,0.0030259012101053,-0.0397705070048355,-0.0279089742612227,5.82749699892963e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,27910,-0.0491098182914729,0.00439876708666494,-0.0577314017813362,-0.0404882348016096,7.00858661231975e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,23337,-0.0287441309140848,0.0025755275725349,-0.0337921649562532,-0.0236960968719164,7.53153029505083e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",28224,0.0603930285754352,0.00541344192192208,0.0497826824084679,0.0710033747424025,7.6815667497257e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,23775,-0.0244773034756545,0.00219549818251019,-0.0287804799133745,-0.0201741270379346,8.55049984292782e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,23198,-0.0554883438734991,0.0049844888847492,-0.0652579420876076,-0.0457187456593907,1.0341029957936e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,28496,-0.029330057117966,0.00263754891922989,-0.0344996529996566,-0.0241604612362754,1.1462856085014e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,27562,-0.042746876781315,0.0038440315539005,-0.05028117862696,-0.03521257493567,1.14990355305335e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,28187,-0.0498821623014774,0.00448591149726516,-0.0586745488361171,-0.0410897757668377,1.15385039651299e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,28304,0.0240363805710723,0.00216171934770112,0.0197994106495781,0.0282733504925665,1.16139936404246e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,23188,-0.0610692383210156,0.00549688824776307,-0.0718431392866313,-0.0502953373554,1.32788564668309e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,28176,-0.0621581355587234,0.00560224043448118,-0.0731385268103065,-0.0511777443071403,1.51646308552087e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,27544,0.0565309054461809,0.00509999454327919,0.0465349161413537,0.0665268947510081,1.71404851160391e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,27965,-0.0402571479387943,0.00363531505513996,-0.0473823654468687,-0.03313193043072,1.92431669732533e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,28176,-0.0724401388894581,0.00656180750746539,-0.0853012816040903,-0.059578996174826,2.81119401440658e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,28176,-0.0785085599918419,0.00715295927394604,-0.0925283601687761,-0.0644887598149076,5.70094978252985e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,23337,-0.0589526220160518,0.00537507486510384,-0.0694877687516554,-0.0484174752804483,6.38885333655305e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,28224,-0.0475974494929521,0.00434160107025921,-0.0561069875906601,-0.039087911395244,6.54555253633553e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,28363,-0.0448929510528157,0.00409897583322948,-0.0529269436859455,-0.0368589584196859,7.37261340317456e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,23775,-0.0476066533689386,0.00434620393156323,-0.0561252130748025,-0.0390880936630747,7.44359648403562e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,23738,-0.0207289765050034,0.0018939327296452,-0.0244410846551079,-0.0170168683548988,8.19003923511663e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,28134,-0.0488211426329596,0.00446801681879385,-0.0575784555977955,-0.0400638296681236,9.75845183838498e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,28176,-0.0688961132160456,0.0063149399353914,-0.0812733954894128,-0.0565188309426785,1.17275507161934e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,28224,-0.0320020515600157,0.00293664947601938,-0.0377578845330137,-0.0262462185870177,1.34516099433016e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,23725,-0.0362264036307678,0.00332431559858457,-0.0427420622039936,-0.0297107450575421,1.37882134348447e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,23775,-0.0349934276511151,0.00321222136595444,-0.0412893815283858,-0.0286974737738444,1.4331056827485e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,28176,-0.0424351892096169,0.00389642834630451,-0.0500721887683738,-0.0347981896508601,1.44742598993988e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,23493,-0.0461620470695713,0.00424437569118606,-0.054481023424296,-0.0378430707148467,1.74352104598815e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,23725,-0.0159448000311963,0.00146828544092875,-0.0188226394954167,-0.013066960566976,2.08599628586491e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,28233,-0.0483238497269753,0.00445372510564262,-0.0570531509340348,-0.0395945485199157,2.25353236273241e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,23071,-0.0556239909005885,0.00513400279853054,-0.0656866363857084,-0.0455613454154687,2.75090411484572e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,27965,-0.0353554960347294,0.00326565464746914,-0.0417561791437689,-0.0289548129256899,2.92152706092469e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,28137,-0.0619795030712227,0.00572611065772251,-0.0732026799603588,-0.0507563261820866,2.99813213530146e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,27562,-0.041810449710274,0.00386647999720694,-0.0493887505047996,-0.0342321489157484,3.36703659204873e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,27544,-0.0267507940290347,0.00247608034282685,-0.0316039115009753,-0.0218976765570941,3.74861770906425e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,27376,-0.0645746668967348,0.00597755003800752,-0.0762906649712295,-0.05285866882224,3.78504563371712e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,23846,-0.0279101337700412,0.00259358807853212,-0.0329935664039641,-0.0228267011361182,6.05248747127318e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23198,-0.0512879457689568,0.00476774695066195,-0.0606327297922542,-0.0419431617456594,6.34026763674899e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,23846,-0.0570896137680135,0.00530851467419113,-0.0674943025294281,-0.0466849250065989,6.51760327220718e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,28404,-0.0209552748391201,0.0019496165727037,-0.0247765233216194,-0.0171340263566209,6.79282967137347e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,27965,-0.0385652236503802,0.00359254920080772,-0.0456066200839634,-0.0315238272167971,7.88348314413118e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,23846,-0.043884503907551,0.00409294051351691,-0.0519066673140441,-0.0358623405010579,9.23638749253547e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",27544,-0.0377017135932259,0.00351942744863251,-0.0445997913925456,-0.0308036357939062,1.00445801599548e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,23738,-0.0788712041952712,0.00736460213803227,-0.0933058243858145,-0.064436584004728,1.0572160187956e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,23872,-0.0203904033346417,0.00190424802746751,-0.024122729468478,-0.0166580772008054,1.07527654754531e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,23775,-0.0511291179618104,0.00477830822113624,-0.0604946020752374,-0.0417636338483833,1.16736669856703e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,23198,-0.0400149835439814,0.00374000402495502,-0.0473453914328932,-0.0326845756550695,1.18500497590728e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,27562,-0.047317110348607,0.00442361960243612,-0.0559874047693818,-0.0386468159278322,1.19274761720125e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,23163,-0.036170625431253,0.00338205224415571,-0.0427994478297981,-0.0295418030327078,1.24135499871288e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,28096,-0.0318077370891381,0.00297510216637014,-0.0376389373352236,-0.0259765368430527,1.25784749410236e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,22764,0.0318916556078567,0.00298337266006343,0.0260442451941324,0.037739066021581,1.31412115235401e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,23163,-0.089277181902899,0.00835316626980389,-0.105649387791715,-0.0729049760140834,1.33889835296048e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,23738,-0.0376836019120152,0.00352799787990352,-0.0445984777566261,-0.0307687260674043,1.43101489213681e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,27705,-0.0580212505774564,0.00543553620743736,-0.0686749015440336,-0.0473675996108792,1.510120043869e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,28144,-0.0620561272509797,0.00581385394123431,-0.073451280975799,-0.0506609735261605,1.51694738875851e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,23071,-0.0317150003522032,0.0029728300576201,-0.0375417472651386,-0.0258882534392678,1.65173147154465e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,28411,-0.0253139267458189,0.00237420465894056,-0.0299673678773424,-0.0206604856142954,1.7190128782082e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],27601,-0.0353901180327748,0.00332257200996798,-0.0419023591723121,-0.0288778768932376,1.93299282988438e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,23846,-0.0548356489019415,0.0051503032756511,-0.0649302433222177,-0.0447410544816654,2.06302261326904e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,28266,-0.0332309898334203,0.00312263896826811,-0.0393513622112258,-0.0271106174556148,2.13300807768263e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,27607,-0.0323549626888528,0.00304027539695003,-0.0383139024668749,-0.0263960229108307,2.13524260755613e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,23725,-0.0417464315512521,0.00392535033000069,-0.0494401181980535,-0.0340527449044508,2.34649832178082e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,28336,-0.0218107607651349,0.00205499366640364,-0.025838548351286,-0.0177829731789837,2.88827630206807e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,23846,-0.0401690353857359,0.00378532301531109,-0.0475882684957457,-0.0327498022757262,3.00634484010747e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,27702,-0.0347472175280921,0.00327775334348242,-0.0411716140813176,-0.0283228209748665,3.31250792957656e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,28187,-0.0172039808841196,0.00162302598863314,-0.0203851118218406,-0.0140228499463986,3.34073730373884e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,23775,-0.0276145502841873,0.00260642451903112,-0.0327231423414883,-0.0225059582268863,3.60359237919418e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,28237,-0.0216705300731084,0.00204774007946873,-0.0256841006288671,-0.0176569595173497,4.01459043621807e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,23846,-0.0463425209670157,0.00438085018628956,-0.0549289873321432,-0.0377560546018882,4.28680641278765e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,23725,-0.0827365210103678,0.0078438552206537,-0.0981104772428491,-0.0673625647778866,5.92752522893587e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,28553,-0.0429043824321756,0.00406973883401535,-0.0508810705468456,-0.0349276943175055,6.15399670396801e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",28044,-0.0548630252691287,0.00520955314776198,-0.0650737494387422,-0.0446523010995153,6.93228391134401e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,28176,-0.0311393665036578,0.00295773619448681,-0.0369365294448519,-0.0253422035624636,7.16170814668658e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,23795,-0.0401346261086858,0.00381330462131438,-0.047608703166462,-0.0326605490509096,7.56144968521566e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,23337,-0.0500401777824259,0.00476217470414023,-0.0593740402025408,-0.0407063153623111,9.07652472898397e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,27544,-0.0571189537747369,0.00544438618378894,-0.0677899506949632,-0.0464479568545106,1.05856048169689e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,28452,-0.0925462990535155,0.00882926710268833,-0.109851662574785,-0.0752409355322464,1.16691547341341e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,23893,-0.0148606530556693,0.00141877320139214,-0.0176414485303979,-0.0120798575809407,1.28846435059846e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,27682,-0.0272304771799498,0.00260067653424363,-0.0323278031870673,-0.0221331511728323,1.3172835877098e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,27544,-0.032139808102307,0.003073986252775,-0.038164821157746,-0.026114795046868,1.54511753718272e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,28091,-0.0501285788204122,0.00480133214494996,-0.0595391898245141,-0.0407179678163103,1.8022085296956e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,23738,-0.0748740175269156,0.0071798771942461,-0.088946576827638,-0.0608014582261933,2.08959416035549e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",23777,-0.0287830135942517,0.00276456021791429,-0.0342015516213637,-0.0233644755671397,2.49309632028014e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,23845,-0.0201851638185628,0.00194031339689428,-0.0239881780764756,-0.01638214956065,2.72046404591508e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,28176,-0.0584649140153647,0.00562251458504791,-0.0694850426020586,-0.0474447854286708,2.80290968887353e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,28195,0.0245119133410301,0.00235785309304427,0.0198905212786633,0.0291333054033969,2.8767835493027e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,27651,-0.0294975919691851,0.0028394542288795,-0.0350629222577889,-0.0239322616805813,3.11403960878891e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,23775,-0.0273239754316489,0.00263140303619617,-0.0324815253825934,-0.0221664254807044,3.32684829461641e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,28176,-0.0550545872744787,0.00530709696363018,-0.0654564973231939,-0.0446526772257635,3.62333092543211e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,27562,-0.0324550186941776,0.00312961222007347,-0.0385890586455216,-0.0263209787428336,3.76541786199277e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,28553,-0.0434174654544521,0.00418811551031075,-0.0516261718546612,-0.0352087590542431,3.88988859436343e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,23393,-0.0806266000033427,0.00777969243078805,-0.0958747971676873,-0.0653784028389981,4.10941250965243e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,28187,-0.0268144705873317,0.00259127728829303,-0.0318933740723861,-0.0217355671022774,4.7398703972958e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,23188,-0.0322996275900126,0.00312462857118794,-0.0384238995895409,-0.0261753555904842,5.42556559738074e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",28091,-0.0314684479417697,0.00304542070712524,-0.0374374725277352,-0.0254994233558043,5.53802254844708e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,28336,-0.0380726089213477,0.00369135635770226,-0.0453076673824441,-0.0308375504602512,6.74275154725908e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,23198,-0.0421981972183768,0.00409264990607201,-0.0502197910342779,-0.0341766034024756,7.13267931759473e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,23725,-0.0256439371739845,0.0024889219478659,-0.0305222241918017,-0.0207656501561674,7.68735881774593e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,28224,0.0743601449631483,0.00722214345837719,0.060204743784729,0.0885155461415675,8.11641864903014e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,28307,-0.0188698600258741,0.00183359531210079,-0.0224637068375916,-0.0152760132141565,8.54073974547873e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,28307,-0.0284218813825654,0.00276288864879886,-0.0338371431342112,-0.0230066196309196,8.91669129699625e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,23813,-0.0314379237280336,0.0030601756684564,-0.0374358680382081,-0.025439979417859,1.04766810296631e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,23198,-0.0524582937283398,0.00511888311303529,-0.062491304629889,-0.0424252828267906,1.36339598907223e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,23738,-0.0765348590712617,0.00746960791195854,-0.0911752905787005,-0.061894427563823,1.38549571775662e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",23795,-0.0440790659558101,0.00430893723031721,-0.0525245829272318,-0.0356335489843883,1.64111164580896e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,23056,-0.0281264321027296,0.00275010754637141,-0.0335166428936176,-0.0227362213118417,1.68649863143634e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,23738,-0.0563949216187037,0.00552101353669259,-0.0672161081506211,-0.0455737350867862,1.91679289882587e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,27965,-0.0309448170074563,0.00303176239497099,-0.0368870713015995,-0.0250025627133132,2.03879571356349e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,28091,-0.0419726928667572,0.00411563478193274,-0.0500393370393454,-0.0339060486941691,2.22411497052884e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",23675,-0.0765759750336922,0.00751275518747508,-0.0913009752011433,-0.061850974866241,2.39773099557339e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,23163,-0.0318738402962336,0.00312800065429297,-0.0380047215786479,-0.0257429590138194,2.47762045125302e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,23738,-0.097678123753395,0.00961817542479981,-0.116529747586003,-0.0788264999207874,3.50716430531503e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,28187,-0.0164057990170032,0.00161797046942592,-0.019577021137078,-0.0132345768969284,4.04919455806319e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,22663,-0.0163078887336119,0.00160982812059324,-0.0194631518499747,-0.0131526256172492,4.56687004181524e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,23725,-0.0503361457819201,0.00497371588455511,-0.0600846289156481,-0.0405876626481921,5.01803372296521e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,23100,-0.034974623748943,0.00345636251130127,-0.0417490942710935,-0.0282001532267925,5.11169521551282e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,28091,0.028541927740603,0.00282389490000641,0.0230070937365904,0.0340767617446155,5.63656150005338e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,27562,-0.0356157357470907,0.00352673848232889,-0.0425281431724553,-0.028703328321726,6.15729131093821e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,28091,-0.0384116882306083,0.00380542782878357,-0.0458703267750241,-0.0309530496861926,6.45673910049426e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,23198,-0.0219565317592488,0.00217798258642208,-0.0262253776286361,-0.0176876858898615,7.4976148006959e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,28176,-0.0584290297249223,0.00580076576573971,-0.0697985306257721,-0.0470595288240725,8.01013985201326e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,27532,-0.0274829810319363,0.00273254174986723,-0.0328387628616761,-0.0221271992021966,9.34222590172044e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,22706,-0.0342284854496641,0.0034068098540334,-0.0409058327635695,-0.0275511381357586,1.06073036203675e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,23738,-0.0277792311101505,0.00276523478104785,-0.0331990912810043,-0.0223593709392967,1.06828952579928e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,28091,-0.0139794470499819,0.00139202864828057,-0.0167078232006118,-0.0112510708993519,1.08696864882281e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,28440,-0.0563960923138965,0.00563074238649955,-0.0674323473914356,-0.0453598372363574,1.42223294294682e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,27702,-0.0479447853589526,0.00479175262363547,-0.0573366205012781,-0.0385529502166271,1.57764574531092e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,28428,-0.0322851511504871,0.00322764483512717,-0.0386113350273363,-0.0259589672736378,1.62208226925187e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,28521,0.0174992607130605,0.00175025739541389,0.0140687562180493,0.0209297652080718,1.69825671614976e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,28452,0.0317757991315107,0.00317895002086323,0.0255450570906188,0.0380065411724026,1.74042906476796e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,28182,-0.0266401903066494,0.00266693193369678,-0.0318673768966951,-0.0214130037166037,1.86166690712147e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,23188,-0.0479892011403514,0.00481061043553201,-0.0574179975939941,-0.0385604046867087,2.17077450672637e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,23198,-0.0358874560691383,0.00360331943114873,-0.0429499621541898,-0.0288249499840868,2.55194034499049e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,28521,-0.0646959762219338,0.0065019466155004,-0.0774397915883146,-0.051952160855553,2.74558402669947e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,28553,-0.0279824812351077,0.00281315397411777,-0.0334962630243785,-0.0224686994458369,2.83564964802018e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",28050,-0.0718087894503705,0.00723371898452292,-0.0859868786600354,-0.0576307002407055,3.47101910227335e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,27965,-0.0417588988915381,0.00421557708239745,-0.0500214299730371,-0.0334963678100391,4.28564220222672e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,23337,-0.0522514316819284,0.00527474790898283,-0.0625899375835348,-0.0419129257803221,4.35619402816924e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,28485,0.0368564244996168,0.00373172342796639,0.0295422465808026,0.0441706024184309,5.73041377132106e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,23188,-0.0356565868361073,0.00361134198689266,-0.0427348171304169,-0.0285783565417977,6.02022202306758e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,23337,-0.022531189757733,0.00228554793417656,-0.0270108637087191,-0.018051515806747,7.00876380779812e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,28336,-0.0386617133791712,0.00392308446028717,-0.0463509589213341,-0.0309724678370084,7.10375367429857e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",27562,-0.0561953843465271,0.00570392233347911,-0.0673750721201462,-0.0450156965729081,7.32608963346033e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,28428,-0.0442659920368972,0.0045017552121434,-0.0530894322526983,-0.0354425518210961,8.82099090633523e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,28224,-0.0263668702276491,0.00268412221984148,-0.0316277497785384,-0.0211059906767598,9.72278218274797e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,23738,-0.0576488918582134,0.00588322184036988,-0.0691800066653383,-0.0461177770510884,1.25695119039452e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,28091,-0.0569854300237833,0.00583145896456082,-0.0684150895943225,-0.0455557704532441,1.61181235127483e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,27324,-0.0515818435770836,0.00528880638248105,-0.0619479040867465,-0.0412157830674207,1.94819439452667e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,28320,-0.0231664278634582,0.00237820784734613,-0.0278277152442567,-0.0185051404826598,2.18293582214516e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,28204,-0.0389611055507876,0.00400440155132054,-0.0468097325913758,-0.0311124785101993,2.44564608053123e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,23775,-0.0445024021190019,0.00457421850001674,-0.0534678703790347,-0.035536933858969,2.49753912454574e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",28187,-0.0308475941003698,0.00318302659962794,-0.0370863262356406,-0.0246088619650991,3.55660220423739e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,22829,-0.0218635694247824,0.00225570170610269,-0.0262847447687437,-0.0174423940808212,3.57792097105931e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",28091,0.0282893345750576,0.00291998801751558,0.022566158060727,0.0340125110893881,3.66717139151484e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,28176,-0.0592348990747391,0.00612885582998829,-0.0712474565015161,-0.047222341647962,4.59856527308384e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,27682,-0.04863281896879,0.00503340225487209,-0.0584982873883393,-0.0387673505492407,4.73696883938165e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,23507,-0.0373176223379461,0.00386426996055147,-0.044891591460627,-0.0297436532152652,5.04034803764203e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,27965,-0.0443707229696931,0.00461260900178599,-0.0534114366131937,-0.0353300093261926,7.15632847004372e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,23337,-0.0382810052809295,0.00397991602123912,-0.0460816406825582,-0.0304803698793008,7.33104308505065e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,23795,-0.0318284844794127,0.00331704341734239,-0.0383298895774038,-0.0253270793814217,9.15050134330674e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,27918,-0.0338549786800114,0.00353249116803146,-0.0407786613693531,-0.0269312959906698,1.00950967814972e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,23198,-0.020041001200003,0.00209093271445977,-0.0241392293203441,-0.0159427730796618,1.01718817866212e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',23775,-0.0275628422477106,0.00287807146592197,-0.0332038623209177,-0.0219218221745036,1.09499232006635e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,28176,0.0258795476092109,0.00270502618777123,0.0205776962811793,0.0311813989372425,1.18483901859094e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,23795,-0.0289671977906643,0.00302790905823112,-0.0349018995447973,-0.0230324960365313,1.20696962774657e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,23893,-0.0167312855778531,0.00175387456717684,-0.0201688797295197,-0.0132936914261864,1.56612699525e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,28452,-0.0174512661820472,0.00182991575342496,-0.0210379010587601,-0.0138646313053342,1.588748553613e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,28176,-0.05653677859046,0.00593111447136278,-0.0681617629543311,-0.044911794226589,1.65877724399817e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,28336,0.0218705915613036,0.00229555071745733,0.0173713121550873,0.02636987096752,1.73715189685781e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,28428,-0.0389240040995156,0.00408655269716143,-0.046933647385952,-0.0309143608130792,1.77863564696915e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,23795,-0.0512330081818321,0.00537874128269623,-0.0617753410959167,-0.0406906752677475,1.80101009164696e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,28224,0.033863818339467,0.0035562136365938,0.0268936396117432,0.0408339970671909,1.82214587052263e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,23216,-0.0183141915958601,0.00192315532163446,-0.0220835760262636,-0.0145448071654565,1.8417039841552e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,28452,-0.0163444082096928,0.00171822600213259,-0.0197121311738726,-0.0129766852455129,2.00554769447097e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,27562,-0.0391546696160852,0.00411793549765898,-0.0472258231914968,-0.0310835160406736,2.0898206775317e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,28307,0.018061018475251,0.00190340470993135,0.0143303452437855,0.0217916917067164,2.51433552240583e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,28187,-0.037473596955865,0.00395108140644161,-0.0452177165124905,-0.0297294773992394,2.62330387416386e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,27597,-0.0253447430920837,0.00267329788022609,-0.0305844069373268,-0.0201050792468405,2.72161658925447e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,27562,-0.0486155842471601,0.00513730773088387,-0.0586847073996925,-0.0385464610946277,3.21547696306812e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,28224,-0.0706597790530957,0.00747348362576652,-0.0853078069595981,-0.0560117511465933,3.48114069338889e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,28521,-0.064341434659782,0.00680803778789627,-0.0776851887240587,-0.0509976805955053,3.61111304845007e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23170,-0.0518434912326394,0.00548915527616077,-0.0626022355739145,-0.0410847468913643,3.89010058427675e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,23846,-0.0475120024088841,0.00503546239661435,-0.0573815087062482,-0.03764249611152,4.23651698871787e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,28174,-0.0398910584082035,0.00423251819660644,-0.0481867940735521,-0.0315953227428548,4.62413471056219e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,23893,-0.0230765827254685,0.00244852204941781,-0.0278756859423274,-0.0182774795086096,4.6925497659819e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,23893,-0.0173439134413,0.00184115057855094,-0.0209525685752598,-0.0137352583073401,4.89960425516895e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,23862,-0.0241969926927658,0.00257415460023354,-0.0292423357092236,-0.0191516496763081,5.93269895055363e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,23872,0.0171103560404822,0.00182034241574509,0.0135424849056218,0.0206782271753425,5.9578454000963e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,28422,-0.0367085033133185,0.00390641221276244,-0.0443650712503329,-0.0290519353763042,6.02206053296231e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,27562,-0.0505480060852654,0.00537927891468677,-0.0610913927580515,-0.0400046194124793,6.04590895358558e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,23396,-0.0162448381180275,0.00173037182292185,-0.0196363668909544,-0.0128533093451007,6.65173896868351e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,23188,-0.0214481207633418,0.0022866035191275,-0.0259298636608317,-0.0169663778658519,7.19044307329652e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,27544,-0.0247515455127426,0.00263955330953274,-0.0299250699994268,-0.0195780210260584,7.27995145491635e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,28404,-0.0370583553818131,0.00395444408292487,-0.0448090657843458,-0.0293076449792803,7.67731247391182e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,23862,0.0244180385302481,0.00260577672414245,0.0193107161509289,0.0295253609095673,7.82219236284453e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,28187,-0.0194530983941887,0.002077209198594,-0.0235244284234329,-0.0153817683649445,8.15241591129043e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,23738,-0.0491512145686865,0.00525004084635635,-0.0594412946275449,-0.038861134509828,8.49267610405815e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,23738,-0.066010966938276,0.0070736885679096,-0.0798753965313788,-0.0521465373451731,1.12822844785455e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,23775,-0.0201648109436619,0.00216201108793041,-0.0244023526760055,-0.0159272692113183,1.18264838033153e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,23337,-0.0430825063962739,0.00462097500603467,-0.0521396174081019,-0.034025395384446,1.22550001712173e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,23795,-0.0627175374384563,0.00672729223562182,-0.075903030220275,-0.0495320446566375,1.22816312137716e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,28307,-0.0360682755470547,0.00386942934434795,-0.0436523570619767,-0.0284841940321327,1.22972842717272e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,28428,-0.0615889404579977,0.00660946667418499,-0.0745434951394003,-0.0486343857765951,1.26511746915715e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,28091,-0.0881705892904376,0.00946269797296784,-0.106717477317455,-0.0696237012634206,1.27319442512408e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,23775,-0.0509862207960033,0.00547730629592828,-0.0617217411360227,-0.0402507004559838,1.40362641076633e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,23256,-0.0420845515856883,0.00452283212648585,-0.0509493025536006,-0.0332198006177761,1.45605474565191e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,23188,-0.035938156356879,0.00386874283591402,-0.0435208923152705,-0.0283554203984875,1.68475230841809e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,23188,-0.0622586182330829,0.00671918357131895,-0.0754282180328681,-0.0490890184332978,2.09988260366293e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,23735,-0.0374164461067225,0.00404070899453241,-0.0453362357360061,-0.029496656477439,2.21524831940855e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,28428,-0.0236543133883213,0.00255977718041527,-0.0286714766619352,-0.0186371501147073,2.61300300445993e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,28091,-0.0284970125328431,0.00308450295595737,-0.0345426383265195,-0.0224513867391666,2.66426030012203e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,28111,-0.0172155777683695,0.00186675468361822,-0.0208744169482612,-0.0135567385884778,3.10852918914323e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,28064,-0.0245947451027901,0.00267550693178514,-0.0298387386890889,-0.0193507515164912,4.0938674877419e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,23738,-0.0375004962493496,0.00407940961961518,-0.0454961391037953,-0.0295048533949038,4.13976695542792e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,27562,-0.0537763286411517,0.00586435263442356,-0.0652704598046219,-0.0422821974776816,5.04895374619014e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,23198,-0.0274481749945753,0.00299760697906501,-0.0333234846735427,-0.0215728653156078,5.78180460153979e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,28224,-0.0336145090241688,0.00367508681707941,-0.0408176791856445,-0.0264113388626932,6.26040047638732e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,28173,-0.046504806929752,0.00509828612818413,-0.0564974477409929,-0.0365121661185112,7.87818313724513e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,28176,-0.0490608011796756,0.00538999141870058,-0.0596251843603287,-0.0384964179990224,9.42047651002212e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",28553,-0.0313781774842171,0.00344750996307138,-0.038135297011837,-0.0246210579565972,9.4570071297328e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,23775,-0.043748244349393,0.00483063114323202,-0.0532162813901277,-0.0342802073086582,1.44908236137929e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,23725,-0.042596462082579,0.0047036692657289,-0.0518156538434076,-0.0333772703217503,1.45483336933959e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,28091,-0.0638427026961013,0.00705672014300119,-0.0776738741763836,-0.050011531215819,1.56077898494257e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,28151,-0.0220682926950806,0.00244137445945089,-0.0268533866356043,-0.0172831987545568,1.67551631257671e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,27928,0.0300309945209947,0.00332601464564647,0.0235120058155276,0.0365499832264617,1.83912482107199e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,23170,-0.0353180815150629,0.0039135989853615,-0.0429887355263714,-0.0276474275037543,1.94311907973933e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,28187,-0.0155350547004836,0.00172578931839975,-0.0189176017645471,-0.0121525076364201,2.35872349163214e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,27702,-0.0528926181171018,0.00587722827600032,-0.0644119855380625,-0.0413732506961412,2.40718296436924e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,28521,-0.0215314209997013,0.00239364348524014,-0.026222962230772,-0.0168398797686306,2.49949626308505e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,28129,-0.0253511117080984,0.00282108462854613,-0.0308804375800488,-0.019821785836148,2.71315957111749e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,27481,-0.0432255823100784,0.00481020758265907,-0.0526535891720902,-0.0337975754480667,2.71891941711953e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,27562,-0.0609626195131747,0.00679257453188541,-0.0742760655956701,-0.0476491734306793,3.01235272950285e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,23198,-0.0454466714586122,0.0050749484187147,-0.055393570359293,-0.0354997725579313,3.64368209237062e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,23198,-0.0328858069721785,0.00367236942902911,-0.0400836510530756,-0.0256879628912815,3.64932491228642e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,27969,-0.0319334633815064,0.0035688353452154,-0.0389283806581286,-0.0249385461048842,3.84305410085159e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,23795,-0.0406128287015366,0.00453883577655125,-0.049508946823577,-0.0317167105794961,3.88325893848604e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,28187,-0.0342042859398619,0.00382648703651939,-0.0417042005314399,-0.0267043713482839,4.16810892685582e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,28191,-0.0350594423402499,0.00392416104754095,-0.0427507979934302,-0.0273680866870697,4.34349101831863e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,27881,-0.0185134469504343,0.00207243056935569,-0.0225754108663714,-0.0144514830344971,4.38749810857983e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,23198,-0.0319666443502669,0.00358153481559322,-0.0389864525888297,-0.0249468361117042,4.76266688277201e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,27965,-0.034455989688268,0.00387347028370141,-0.0420479914443228,-0.0268639879322133,6.16533070773846e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,23846,-0.0657347201595961,0.00739062848080119,-0.0802203519819664,-0.0512490883372258,6.28526525056914e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,23725,-0.0199378521078389,0.00224304259367423,-0.0243342155914404,-0.0155414886242374,6.6102383438578e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,23893,0.0158143664424137,0.00177925882703061,0.0123270191414337,0.0193017137433937,6.64138033925803e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,28422,-0.0352621521553856,0.00397442749069816,-0.043052030037154,-0.0274722742736172,7.57901338434486e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,28307,-0.0154594199732356,0.00174281128375902,-0.0188753300894033,-0.0120435098570679,7.7085659018089e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,28176,-0.052322908236604,0.00589963314285361,-0.0638861891965971,-0.0407596272766109,7.81843551079549e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,23163,-0.0414716635843134,0.00467677729127388,-0.0506381470752102,-0.0323051800934166,8.00427231902981e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,28224,-0.0220973123223607,0.00249427618220607,-0.0269860936394846,-0.0172085310052368,8.52151091469431e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,23775,-0.0185991078845716,0.00210060174618455,-0.0227162873070934,-0.0144819284620499,9.00665649289065e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,23071,-0.0293093841615102,0.003312107377478,-0.0358011146213671,-0.0228176537016534,9.43834669886203e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,23844,-0.0224311570673367,0.00253865908513079,-0.027406928874193,-0.0174553852604803,1.06077430433321e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,23348,-0.0395723987288649,0.00449030215432583,-0.0483733909513435,-0.0307714065063863,1.30335227602226e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,28291,0.0179237241309765,0.00203640340905094,0.0139323734492367,0.0219150748127164,1.42336662956956e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,23188,-0.0300138350325876,0.00342247473676295,-0.036721885516643,-0.0233057845485322,1.9135369354641e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,28187,-0.0309295028253272,0.00352806861986732,-0.0378445173202672,-0.0240144883303873,1.94131725783775e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,28224,-0.032716617471346,0.00373331874677859,-0.040033922215032,-0.0253993127276599,1.99839552158683e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,28091,-0.0326277114055788,0.00372543242421245,-0.0399295589570352,-0.0253258638541224,2.09511988083482e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,23687,-0.0262496970047114,0.00299703149444314,-0.0321238787338199,-0.0203755152756028,2.10740501824769e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,27965,-0.0571574210595469,0.00652814530198641,-0.0699525858514402,-0.0443622562676535,2.14366871522357e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,28224,0.0239361422897812,0.00273447544341712,0.0185765704206836,0.0292957141588787,2.1821857886972e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,23198,-0.0144472419962887,0.00165061925803614,-0.0176824557420395,-0.0112120282505378,2.22409122687348e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,28224,-0.0523228733596898,0.00598763469355437,-0.0640586373590564,-0.0405871093603233,2.49091752804651e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,28091,-0.0462967820097435,0.00530103637961358,-0.0566868133137862,-0.0359067507057009,2.60286325672137e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,23337,-0.0415411098787831,0.00476089666920413,-0.0508724673504232,-0.032209752407143,2.82463043120379e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,23872,-0.0378985564528399,0.00434754250716477,-0.0464197397668829,-0.029377373138797,3.03296487931074e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,23188,-0.026619640540044,0.00305662780326094,-0.0326106310344354,-0.0206286500456525,3.27181025067767e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,23188,-0.0329358647547403,0.00378417998070046,-0.0403528575169131,-0.0255188719925674,3.42659775325369e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,23738,-0.0285609985934208,0.00329512928508817,-0.0350194519921936,-0.022102545194648,4.68877197444245e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",28276,-0.0515366696102098,0.0059474661753396,-0.0631937033138754,-0.0398796359065442,4.73873858497973e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,23862,0.0308776082797769,0.00356741529843126,0.0238854742948516,0.0378697422647022,5.21442548317668e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,28192,-0.0258666941944922,0.00299492761204484,-0.0317367523141001,-0.0199966360748843,6.0791233029717e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,27562,-0.0573652944580766,0.00665542646116703,-0.070409930321964,-0.0443206585941892,7.0896822443372e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,23795,-0.040048955471369,0.0046511181287828,-0.0491651470037833,-0.0309327639389547,7.7107472171032e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,28452,-0.0188337863113605,0.00219033630915846,-0.0231268454773111,-0.0145407271454099,8.47825329037359e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,23163,-0.0410171802884967,0.00477851722683375,-0.0503830740530908,-0.0316512865239025,9.75898802780888e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,23846,-0.0272987053760075,0.00318323023291949,-0.0335378366325297,-0.0210595741194853,1.04303849922e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,28307,-0.0328215924891888,0.00383240818843296,-0.0403331125385174,-0.0253100724398602,1.14243151216388e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,23795,-0.0425165441821337,0.0049830492422603,-0.0522833206969639,-0.0327497676673035,1.51985818933612e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,23893,-0.0178449840066438,0.00209251822362713,-0.021946319724953,-0.0137436482883347,1.57605105959552e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,28031,-0.0269113462462867,0.00316241694872063,-0.0331096834657792,-0.0207130090267943,1.82894473797546e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,28553,0.0168950268287572,0.0019905108927709,0.0129936254789262,0.0207964281785881,2.20670325101307e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,28553,0.0186280095276769,0.00219606291358335,0.0143237262170536,0.0229322928383003,2.30988162542377e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,23733,-0.0187766468554133,0.00221453844348653,-0.0231171422046469,-0.0144361515061797,2.4058444428285e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,28336,-0.0246265610098033,0.0029078024269627,-0.0303258537666502,-0.0189272682529564,2.59021090726062e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,28176,-0.0192284278112397,0.00227349701503794,-0.0236844819607141,-0.0147723736617654,2.85850933223348e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,27562,-0.0571955765202887,0.00676989130333954,-0.0704645634748342,-0.0439265895657432,3.09346417062002e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,28112,-0.0113571759645701,0.00134443880312133,-0.0139922760186879,-0.00872207591045232,3.11712083449595e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",23188,-0.0209634335744584,0.00248299488301737,-0.0258301035451725,-0.0160967636037444,3.27739598779148e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,23775,-0.052508400921409,0.00622038165789593,-0.064700348970885,-0.040316452871933,3.31372677497186e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,28155,-0.0529416766493842,0.00627537923052683,-0.0652414199412168,-0.0406419333575516,3.42697733227867e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,28224,-0.0205147009395662,0.0024355701946198,-0.025288418521021,-0.0157409833581114,3.84298254335736e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,23832,0.0199725467799806,0.00237593929969249,0.0153157057525833,0.0246293878073779,4.47027445090878e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,27682,-0.020099540623344,0.00239329800291823,-0.0247904047090637,-0.0154086765376242,4.74536770214731e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,23775,-0.062229539358006,0.00740985915830922,-0.0767528633082921,-0.0477062154077199,4.78356922291033e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,23846,-0.0181912801858289,0.00216934257583928,-0.0224431916344739,-0.013939368737184,5.32184060774099e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,28291,-0.0149490319267414,0.00178413502790837,-0.0184459365814418,-0.011452127272041,5.58840907758472e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,28091,-0.0316040030737828,0.0037761666222546,-0.0390052896534019,-0.0242027164941638,6.06024640167857e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,27910,-0.0644118896528612,0.00769649763937716,-0.0794970250260404,-0.0493267542796819,6.07987764976142e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,23795,-0.0382061171908023,0.00456617457621997,-0.0471558193601935,-0.0292564150214112,6.22054954968765e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,23846,-0.0196538711798403,0.00235186564864576,-0.024263527851186,-0.0150442145084946,6.79657762121157e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,28307,-0.0549113894560315,0.00657274611327803,-0.0677939718380564,-0.0420288070740065,6.87346031975289e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,28277,-0.0408578915311808,0.0048923871613031,-0.0504469703673349,-0.0312688126950267,7.05534236074161e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,22875,-0.040842003742868,0.00489240108428154,-0.0504311098680598,-0.0312528976176762,7.32881985503315e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,28320,-0.0599857622214376,0.00718806695522253,-0.0740743734536738,-0.0458971509892014,7.42986347065232e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,23846,-0.015252488732272,0.00182756180094086,-0.0188345098621161,-0.0116704676024279,7.4518914375745e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,28521,-0.021858304304635,0.00262068171547515,-0.0269948404669663,-0.0167217681423037,7.71458875454207e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,23700,-0.0235013504086192,0.00281901969929457,-0.0290266290192365,-0.0179760717980018,8.04903918253341e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,23744,-0.0426884885071436,0.00512441851228088,-0.0527323487912141,-0.032644628223073,8.4872950091626e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,27918,-0.026242670167843,0.00315240006776636,-0.032421374300665,-0.0200639660350209,8.83892510182972e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,27544,-0.0488385558999755,0.00587296291365984,-0.0603495632107488,-0.0373275485892022,9.52686869621357e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,28553,-0.0157797963212913,0.0019000278632901,-0.0195038509333399,-0.0120557417092427,1.04155140583973e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,27682,-0.0237556040513854,0.00286213968713778,-0.0293653978381755,-0.0181458102645954,1.08849193164682e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,23766,-0.014732784005054,0.00177625535929748,-0.0182142445092771,-0.011251323500831,1.14965279801707e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,23725,-0.0473611704060877,0.00572131275538308,-0.0585749434066385,-0.0361473974055368,1.3176759357212e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,23393,-0.0321407799993586,0.00388308126645908,-0.0397516192816184,-0.0245299407170988,1.32850934397763e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,23775,-0.0615062058333851,0.00743883277804499,-0.0760863180783533,-0.046926093588417,1.42969423384218e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,23198,-0.0228067389468767,0.00276118505675705,-0.0282186616581206,-0.0173948162356329,1.53681706311269e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,27562,-0.0249345005855753,0.00302105073774646,-0.0308557600315584,-0.0190132411395923,1.60509055486683e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,28320,-0.0220227096608386,0.0026748394389616,-0.0272653949612033,-0.0167800243604738,1.8990911978325e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,28176,-0.0214703768040453,0.00261131247410746,-0.0265885492532959,-0.0163522043547947,2.08548077413801e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,28091,-0.0336466246745919,0.00409255535180977,-0.041668033164139,-0.0256252161850447,2.09690407111878e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,27562,-0.035955002410799,0.00437862031926288,-0.0445370982365542,-0.0273729065850438,2.27921737454243e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,27965,-0.0294982428256931,0.00359254748860164,-0.0365396359033523,-0.0224568497480339,2.28801452063345e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,27562,-0.0252124936224425,0.00307799738151379,-0.0312453684902096,-0.0191796187546755,2.69726371298774e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,28176,-0.0208824054432537,0.00255264148189167,-0.0258855827477614,-0.015879228138746,2.93962909085875e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,23188,-0.0251811998219307,0.00308033068698693,-0.0312186479684251,-0.0191437516754363,3.1130666747123e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,23071,-0.0350989556011389,0.00429723468730198,-0.0435215355882508,-0.026676375614027,3.30032615105892e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,23738,-0.0431474041260135,0.00528738530174084,-0.0535106793174256,-0.0327841289346015,3.50224986772954e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,28182,-0.0169214628753779,0.00207468870130977,-0.0209878527299451,-0.0128550730208108,3.60140452769997e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,27544,0.018891596532951,0.00231680722523207,0.0143506543714962,0.0234325386944059,3.66460109146115e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,23795,-0.0426414900485323,0.00523728939142701,-0.0529065772557292,-0.0323764028413354,4.08047068907532e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,28187,0.0226275333811776,0.00278138322086422,0.0171760222682837,0.0280790444940714,4.27492601079041e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,28238,-0.0366004384150985,0.00450062969627232,-0.0454216726197922,-0.0277792042104047,4.38368476819992e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,23720,-0.0241133109715589,0.00296480326810182,-0.0299243253770385,-0.0183022965660793,4.38451186611408e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,27562,-0.0301987777087617,0.00371600386677838,-0.0374821452876474,-0.0229154101298761,4.59536156256397e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,28428,0.0209171253707466,0.00257872643432941,0.015862821559461,0.0259714291820322,5.20319580107813e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,28428,-0.0354654251780282,0.00437431924291061,-0.044039090894133,-0.0268917594619234,5.36687942743774e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,28500,-0.0335658323901741,0.00414160237502768,-0.0416833730452284,-0.0254482917351198,5.50428395551079e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,23738,-0.0465662777761526,0.00575349801078277,-0.0578431338772868,-0.0352894216750184,6.07043979036353e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,23795,-0.0345728939628081,0.00428404165129273,-0.0429696155993418,-0.0261761723262743,7.35023019715294e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,28320,-0.0696930683857821,0.00863754353642632,-0.0866226537171777,-0.0527634830543866,7.38881999767812e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,28428,-0.0167670327583994,0.00207975229854455,-0.0208433472635467,-0.012690718253252,7.79611249028514e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,23509,-0.0608960252763981,0.0075611525523154,-0.0757158842789363,-0.0460761662738599,8.40438941771278e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,28428,0.0162381487671819,0.00202125064987155,0.0122764974934337,0.0201998000409302,9.82010838894607e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",23795,-0.0233057326914157,0.00290479303422301,-0.0289991270384928,-0.0176123383443386,1.07749428013553e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,28415,-0.0517007504273656,0.00645230124476676,-0.0643472608671084,-0.0390542399876227,1.16429800824983e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,27562,-0.0331346542164749,0.0041380658467472,-0.0412452632760994,-0.0250240451568504,1.21864023400543e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,23393,-0.0243495486707319,0.0030448723159594,-0.0303174984100124,-0.0183815989314515,1.33461412922673e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,28082,-0.0253244474128543,0.00317029713424567,-0.0315382297959758,-0.0191106650297328,1.42321469787603e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,28336,0.024101748858649,0.00301781950113451,0.0181868226364254,0.0300166750808727,1.44078613290872e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,23198,-0.0564075500810876,0.00706570753929365,-0.0702563368581031,-0.0425587633040721,1.49061481419382e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,23775,-0.0414787856674227,0.00519664562527477,-0.0516642110929613,-0.0312933602418842,1.50648621299662e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,27562,-0.0223282990460296,0.00279893738252273,-0.0278142163157742,-0.0168423817762851,1.55186652293768e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,27682,-0.052785177754218,0.00662554657959199,-0.0657712490502183,-0.0397991064582177,1.68895932982394e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,23795,-0.0573889790290606,0.00720815929291028,-0.0715169712431647,-0.0432609868149564,1.77277967928216e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,28140,-0.0134091702176601,0.00168598870779996,-0.016713708084948,-0.0101046323503722,1.8838632065194e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,23725,-0.0473439865686148,0.00595282827819619,-0.0590115299938793,-0.0356764431433503,1.89834766258369e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,23862,-0.025655041338606,0.0032263429464812,-0.0319786735137091,-0.0193314091635028,1.92019303548714e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,28182,-0.0409293425528161,0.00515671288221658,-0.0510364998019606,-0.0308221853036716,2.14610793065758e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,23337,-0.031788671185243,0.00400625840684595,-0.039640937662661,-0.0239364047078249,2.20347395831902e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,28553,0.0135116460051861,0.00170367655269211,0.0101724399619095,0.0168508520484626,2.25515551655866e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,28142,0.0159955220223119,0.00202000274195773,0.0120363166480748,0.0199547273965491,2.49075216470049e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,23775,-0.0471497709268601,0.00595822865261793,-0.0588278990859913,-0.035471642767729,2.61351799808608e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,27682,-0.0511099792717813,0.00646153807429518,-0.0637745938973998,-0.0384453646461627,2.67202028922225e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,28220,-0.0310863328660572,0.00393965705882182,-0.038808060701348,-0.0233646050307664,3.11527484392811e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,23188,-0.0507616032769318,0.0064358605952134,-0.0633758900435501,-0.0381473165103136,3.22348148764075e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",27702,-0.0325421665735381,0.00413249910223352,-0.0406418648139158,-0.0244424683331604,3.54019951234836e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,23071,-0.0197608737727971,0.00250992083746761,-0.0246803186142336,-0.0148414289313606,3.61112781355814e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,28224,-0.0367492847026257,0.00466935182938871,-0.0459012142882276,-0.0275973551170239,3.66355598903302e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,23163,-0.0182077595151066,0.00231336322996114,-0.0227419514458304,-0.0136735675843828,3.68082140600725e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,28187,-0.0283064868849347,0.003601314550741,-0.0353650634043871,-0.0212479103654823,3.97643071419044e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,28224,0.0381416445394843,0.00485488086436358,0.0286260780453317,0.0476572110336369,4.094922611872e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,28224,-0.0418865988269806,0.00533225762681506,-0.0523378237755381,-0.0314353738784231,4.12859606120701e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,27508,-0.0316449142612636,0.00402917494207494,-0.0395420971477305,-0.0237477313747968,4.17789903432639e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,28521,-0.0189062442823085,0.00240752017511868,-0.0236249838255411,-0.0141875047390759,4.20424818662791e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,28521,-0.0226346346189307,0.00288454235207322,-0.0282883376289942,-0.0169809316088672,4.41414018403437e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,23795,-0.0478780676122236,0.00611276005525093,-0.0598590773205154,-0.0358970579039318,4.98249109946576e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,23738,-0.0192727076350014,0.00246363624707313,-0.0241014346792647,-0.0144439805907381,5.37756750951601e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,28276,0.0442753871641747,0.00566354609477347,0.0331748368184187,0.0553759375099307,5.57017169147011e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,23353,0.0166058255713704,0.0021266018843984,0.0124376858779496,0.0207739652647913,6.02404739563204e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,27781,-0.012074541098919,0.00154806521214578,-0.0151087489147247,-0.00904033328311326,6.41919415880318e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,27920,-0.0277730859953001,0.00356214466979457,-0.0347548895480975,-0.0207912824425028,6.57373622037569e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,27682,-0.0196252854275487,0.00251974255369865,-0.0245639808327981,-0.0146865900222993,7.01152341722428e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,28176,-0.0301475431567318,0.00387414079865642,-0.0377408591220984,-0.0225542271913653,7.39780620336878e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,28553,0.0158345071254079,0.00203638957551472,0.0118431835573991,0.0198258306934168,7.75050174610015e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,23795,-0.0572571197375058,0.00737132374837422,-0.0717049142843192,-0.0428093251906923,8.3240123959465e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,28521,-0.0140852433440252,0.00181383420865146,-0.0176403583929821,-0.0105301282950684,8.40748328972233e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,23163,-0.0226301414948162,0.00291488883583027,-0.0283433236130435,-0.0169169593765888,8.59345742557628e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,28063,0.0186473146998561,0.00240741082186791,0.013928789488995,0.0233658399107172,9.81808815254879e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,27556,-0.0420447036962276,0.00543391952472618,-0.0526951859646909,-0.0313942214277643,1.04889300317187e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,23846,-0.0135306323293213,0.00174881467130468,-0.0169583090850784,-0.0101029555735641,1.05788924631955e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",28363,-0.037987736516535,0.00491216571041928,-0.0476155813089568,-0.0283598917241132,1.0817634075243e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,23812,0.00788846701488072,0.00102075134883666,0.00588779437116086,0.00988913965860058,1.1346686630536e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,23738,-0.0376960495762465,0.0048795037631694,-0.0472598769520585,-0.0281322222004345,1.15917396178914e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,23795,-0.0355823016702001,0.00460760639006423,-0.044613210194726,-0.0265513931456742,1.18543129975213e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,23188,-0.0480225162368343,0.00622175253743929,-0.0602171512102153,-0.0358278812634533,1.22461238628706e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,28176,-0.0597676475652283,0.00774793929047073,-0.074953608574551,-0.0445816865559057,1.25948929979939e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,27910,-0.0330609977708246,0.0042865250016468,-0.0414625867740523,-0.0246594087675968,1.27207715904438e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,23738,-0.0301842735176366,0.00391471658964154,-0.037857118033334,-0.0225114290019392,1.30273962741909e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,23795,0.0238667362977631,0.0030993664263518,0.0177919781021135,0.0299414944934126,1.4078076690156e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,23188,-0.0186263854942259,0.00242033264273573,-0.0233702374739879,-0.0138825335144638,1.46214956397991e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,23198,-0.0225630218998594,0.00293610854970087,-0.0283177946572731,-0.0168082491424457,1.59462566993933e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,23846,-0.0252374378506847,0.00329174671775308,-0.0316892614174807,-0.0187856142838886,1.82943236415856e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23188,-0.0236217500580612,0.00308201271699357,-0.0296624949833686,-0.0175810051327538,1.86719618410261e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23198,-0.0196318515851007,0.00256244391012185,-0.0246542416489395,-0.0146094615212619,1.91138748148752e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,23725,-0.0329592525441258,0.00432627261250986,-0.0414387468646451,-0.0244797582236065,2.66444081557352e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,23163,-0.0228164907278805,0.00299750847256109,-0.0286916073341002,-0.0169413741216607,2.80574736657933e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,28276,-0.0273589700256517,0.003595347338151,-0.0344058508084277,-0.0203120892428758,2.83611821717164e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,23725,-0.0207390893096008,0.00273282066743679,-0.0260954178177769,-0.0153827608014246,3.34511137390751e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,28091,-0.0494459622289617,0.00651674572327058,-0.062218783846572,-0.0366731406113513,3.36171497247842e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,28120,-0.0106034203867795,0.00139791297705115,-0.0133433298217997,-0.00786351095175926,3.42283106304446e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23188,-0.0176413059525389,0.00233344738801985,-0.0222148628330578,-0.01306774907202,4.1740372796114e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,27935,-0.0148428984343432,0.00196454274064625,-0.0186934022060098,-0.0109923946626765,4.30369437967693e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,28411,-0.0104928123941137,0.00138887456291669,-0.0132150065374304,-0.007770618250797,4.31782041663371e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,28239,-0.0243276057265305,0.00322018697403193,-0.030639172195633,-0.0180160392574279,4.32471179521867e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,23071,-0.0347722495565327,0.00460835177597842,-0.0438046190374504,-0.025739880075615,4.67270575826609e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,23738,-0.0176188125003858,0.00233576116090967,-0.0221969043757688,-0.0130407206250029,4.75499660994826e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,23738,-0.0351057392777167,0.00465700612989183,-0.0442334712923047,-0.0259780072631287,4.93314751853325e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,23862,-0.0145409388932536,0.00193454526431983,-0.0183326476113205,-0.0107492301751867,5.82580450973595e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",28237,0.0174814709537923,0.00232907405249839,0.0129164858108955,0.0220464560966891,6.28743753446509e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,23725,-0.0210500281232089,0.00280519043836992,-0.0265482013824139,-0.0155518548640038,6.40967125328882e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,27918,-0.0207258431119516,0.00276403258049311,-0.0261433469697181,-0.0153083392541851,6.65173995878412e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,23393,-0.0544932011914374,0.00728800068854359,-0.0687776825409828,-0.0402087198418919,7.86445112092853e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,23662,-0.0177289856492699,0.00237688842265724,-0.0223876869576781,-0.0130702843408617,9.02468749628321e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,23775,-0.0348203582775556,0.0046756269481883,-0.0439845870960047,-0.0256561294591066,9.85823807652249e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",23795,-0.0410684399597329,0.005516828344987,-0.0518814235159075,-0.0302554564035584,1.00835914070381e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",28091,-0.0170880694023716,0.00230453523716747,-0.0216049584672198,-0.0125711803375233,1.25084281322925e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,27965,0.0174369526308263,0.00235208272600862,0.0128268704878494,0.0220470347738032,1.26582532584639e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",28155,0.0285030434486165,0.00385448433400337,0.0209482541539699,0.0360578327432631,1.45596530666406e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,23198,-0.0233444946231294,0.00316465968070018,-0.0295472275973017,-0.017141761648957,1.67811663710443e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",23846,-0.0381513857921225,0.00517657849742683,-0.0482974796470791,-0.0280052919371659,1.76181389998817e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,23663,-0.0224865366396572,0.00305312209794998,-0.0284706559516391,-0.0165024173276752,1.82811557780774e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,23393,-0.0172623872735599,0.00234786225702949,-0.0218641972973377,-0.0126605772497821,2.01101715633423e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,27942,-0.0498211835190045,0.0067777092278528,-0.063105493605596,-0.036536873432413,2.0251805824237e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23198,-0.0186472968058786,0.00254037161151634,-0.0236264251644506,-0.0136681684473066,2.20001541833684e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,23163,-0.04076004150349,0.00555621320806998,-0.0516502193913071,-0.0298698636156728,2.27418190804991e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,27562,-0.0288127907244949,0.00393877455386382,-0.036532788850068,-0.0210927925989218,2.64075774217016e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,28176,-0.0299505511353308,0.00409927402267455,-0.0379851282197729,-0.0219159740508887,2.81876498311732e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,23862,-0.0253691015511884,0.00347340946388369,-0.0321769841004004,-0.0185612190019764,2.88521852208194e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,28176,0.0248999299979043,0.00341206470977171,0.0182122831667518,0.0315875768290569,3.00656627305676e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,28091,-0.0191251820058609,0.00262307672371195,-0.0242664123843364,-0.0139839516273855,3.15494450439704e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,23725,-0.0176424807846184,0.00241956657065087,-0.0223848312630941,-0.0129001303061427,3.15928252842413e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,27500,-0.0357913041411511,0.00491411778289369,-0.0454229749956228,-0.0261596332866795,3.34349172391703e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,27544,-0.0358801566351002,0.00492710136851275,-0.0455372753173851,-0.0262230379528152,3.37215820488627e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23139,-0.0139337239205038,0.00191331959428112,-0.0176838303252947,-0.0101836175157128,3.38209504171725e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,28363,-0.0364714462380616,0.00501280429098119,-0.0462965426483848,-0.0266463498277385,3.53678818829833e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,23393,-0.033407899029209,0.00459179244925609,-0.042407812229751,-0.0244079858286671,3.55840743734197e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23188,-0.0179903450729288,0.00247657765880659,-0.0228444372841898,-0.0131362528616679,3.87126508205904e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,28091,-0.0210310859225411,0.00290005302406538,-0.0267151898497092,-0.015346981995373,4.2138445488814e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,27702,-0.0219708654198742,0.0030301184034826,-0.0279098974907,-0.0160318333490483,4.25087950930441e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,28404,-0.0258777418492872,0.00356940653534599,-0.0328737786585653,-0.0188817050400091,4.27816896640929e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,23778,-0.0325320530372381,0.00448747913093438,-0.0413275121338694,-0.0237365939406067,4.31048102934153e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,23795,-0.0314904728720447,0.00435608072291295,-0.040028391088954,-0.0229525546551353,5.00950312680585e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,23725,-0.0295054429949263,0.0040843193971172,-0.0375107090132761,-0.0215001769765766,5.19753861733487e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,23188,-0.0429710733726291,0.00596107564449633,-0.0546547816358419,-0.0312873651094163,5.82585920262577e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,23795,-0.0239497166282958,0.00332512580742067,-0.0304669632108403,-0.0174324700457513,6.08113549757777e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",23795,-0.0384268386757697,0.00533588850264376,-0.0488851801409514,-0.0279684972105879,6.12885219152975e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,23846,-0.0405241764007412,0.00563038123771393,-0.0515597236266606,-0.0294886291748219,6.31833303176574e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,23188,-0.0287381774209712,0.00399424682696105,-0.0365669012018149,-0.0209094536401275,6.4411836493898e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,23775,-0.0110960451279581,0.00154253871738055,-0.014119421014024,-0.00807266924189226,6.508693878282e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,28428,-0.0112020600412254,0.00155905493147202,-0.0142578077069106,-0.00814631237554028,6.87809672812664e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,28404,0.0153462037940651,0.00213606245520427,0.0111595213818648,0.0195328862062655,6.91948159526768e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,23815,-0.0230982089428631,0.00321838891422323,-0.0294062512147406,-0.0167901666709855,7.33750958174495e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,23163,-0.0359283385849176,0.00501249806201025,-0.0457528347864577,-0.0261038423833776,7.85272781272891e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,23747,-0.0318497940876186,0.0044470353264076,-0.0405659833273775,-0.0231336048478597,8.18101258802134e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,28362,-0.0335960137106419,0.00469159090870031,-0.0427915318916945,-0.0244004955295892,8.21006138007372e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,23337,-0.0250338477435133,0.0034971574876987,-0.0318882764194027,-0.0181794190676238,8.4077834739327e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,28176,-0.0357828237309021,0.00499944875532025,-0.0455817432913298,-0.0259839041704744,8.42613135000326e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,28344,-0.0161370933742212,0.00225850981659111,-0.0205637726147397,-0.0117104141337026,9.2157268940365e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,28320,-0.052077983157167,0.0072900145691133,-0.0663664117126291,-0.037789554601705,9.30176108021883e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,28184,-0.0155824846329527,0.00218397270112011,-0.0198630711271481,-0.0113018981387573,9.91779242875738e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,23198,-0.030070274002624,0.00421560781793971,-0.0383328653257859,-0.0218076826794622,1.01030554370908e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,23775,-0.034905911914486,0.00489703721055756,-0.0445041048471788,-0.0253077189817932,1.04774772137923e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,28224,-0.059909062150347,0.00840840119549087,-0.0763895284935091,-0.0434285958071849,1.06650353103348e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,23893,0.00821101511259952,0.00115363897915425,0.00594988271345719,0.0104721475117418,1.13016786139597e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,28428,-0.0169987330965926,0.00239065493076223,-0.0216844167608866,-0.0123130494322986,1.18361085087704e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,27702,-0.0149409392003049,0.00210225962649045,-0.0190613680682262,-0.0108205103323836,1.2138707234011e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,23795,-0.0288228336321977,0.00405885433522274,-0.0367781881292342,-0.0208674791351611,1.27135700352168e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,27965,-0.0160986195499303,0.00227012697689797,-0.0205480684246503,-0.0116491706752103,1.35812412403527e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",23056,-0.0361420631016837,0.00509807192672036,-0.0461342840780556,-0.0261498421253118,1.38622146806544e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,27965,0.0165200118617195,0.00233113095178007,0.0119509951962305,0.0210890285272084,1.4060859965484e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,23163,-0.0335593714828894,0.00473634043024981,-0.042842598726179,-0.0242761442395997,1.42506691768996e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,27910,-0.0392525514086296,0.00554117153299415,-0.0501132476132981,-0.028391855203961,1.43579194316726e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,28320,-0.0142212723780743,0.00200796802305517,-0.0181568897032625,-0.0102856550528862,1.44965393612751e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,28521,-0.0329067083525147,0.00465320201592088,-0.0420269843037196,-0.0237864324013097,1.56413102805815e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,23775,-0.0401487539318567,0.00567748052452303,-0.0512766157599219,-0.0290208921037916,1.57422209125648e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,28195,-0.0193079881535611,0.00273801232376094,-0.0246744923081326,-0.0139414839989897,1.80653963707827e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,28134,-0.0553983652938292,0.00785619803604763,-0.0707965134444825,-0.0400002171431758,1.81023139116555e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,23587,-0.0213147126382427,0.00302485807138473,-0.0272434344581568,-0.0153859908183286,1.8850182957469e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,27268,-0.0195744954967422,0.00278044679837652,-0.0250241712215602,-0.0141248197719243,1.96716270852561e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,28411,-0.0305933356116631,0.0043487256042194,-0.0391168377959331,-0.022069833427393,2.03758077500946e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,28452,0.0305328966355447,0.00434614523570006,0.0220144519735726,0.0390513412975169,2.18440394386769e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,28187,-0.0436208453268859,0.00621964023085732,-0.0558113401793662,-0.0314303504744055,2.37836925517601e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,23071,-0.0271730482875961,0.00387411444859609,-0.0347663126068444,-0.0195797839683477,2.37995761640851e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,27562,-0.0444337735229839,0.00633814646183524,-0.056856540588181,-0.0320110064577868,2.42884903731662e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,23846,-0.013277286095547,0.00189489138893695,-0.0169912732178634,-0.00956329897323054,2.50169029565267e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,28320,-0.0323482482344095,0.00462164379551132,-0.0414066700736116,-0.0232898263952073,2.62983854561059e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23198,-0.0368393905262893,0.00527804160472483,-0.0471843520715499,-0.0264944289810286,3.03684494822258e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,23795,-0.0264623901182666,0.00379271502008005,-0.0338961115576235,-0.0190286686789097,3.09101304087272e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,23795,-0.0449585847597916,0.00644476382661107,-0.0575903218599493,-0.0323268476596339,3.11693866576592e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,23738,-0.0469117513585127,0.00673204897029514,-0.0601065673402912,-0.0337169353767343,3.28903857041023e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,23828,-0.0229932633698684,0.00329982630397678,-0.0294609229256629,-0.0165256038140739,3.29802919514035e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,28187,0.0129648577879194,0.00186153058824196,0.00931625783496516,0.0166134577408736,3.36511484155686e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,28184,-0.0161585069176367,0.00232368793476873,-0.0207129352697834,-0.01160407856549,3.6328072272569e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,27832,-0.0226457891958074,0.003259557292215,-0.0290345214885489,-0.016257056903066,3.79987941744812e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,28521,-0.0361535755186703,0.00520790765097904,-0.0463610745145892,-0.0259460765227514,3.94712530266521e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,23846,-0.0391087532256792,0.00564697866157417,-0.0501768314023646,-0.0280406750489938,4.45143725054474e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,23188,-0.0274931137988914,0.00397027543108637,-0.0352748536438207,-0.0197113739539621,4.48199589786437e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,28320,-0.0194077149847404,0.00281290069990299,-0.0249210003565502,-0.0138944296129305,5.32698184008888e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23198,-0.0227792746749014,0.00330638534322911,-0.0292597899476304,-0.0162987594021723,5.74301283351044e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,27562,-0.0245519603352532,0.0035683478258456,-0.0315459220739106,-0.0175579985965959,6.0925537392527e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,28091,-0.0132491770519458,0.00192723508842314,-0.0170265578252552,-0.00947179627863645,6.34164967630919e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",27881,-0.0193661975396042,0.00282168836899791,-0.0248967067428401,-0.0138356883363683,6.8678815070155e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,23393,-0.0609359774963064,0.0088856916758086,-0.0783519331808913,-0.0435200218117215,7.16897084017334e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,23862,-0.0107107457859848,0.00156636709472169,-0.0137808252916394,-0.00764066628033033,8.22720329061408e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,27489,-0.0313157504488803,0.00458095237779391,-0.0402944171093564,-0.0223370837884043,8.30918935550181e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,28452,-0.0188556861635239,0.00275834255731959,-0.0242620375758703,-0.0134493347511775,8.31513235884619e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,23872,-0.0325161663582176,0.00476730617454116,-0.0418600864603183,-0.0231722462561169,9.27897404227803e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,28277,-0.030470392095082,0.00447209892888893,-0.0392357059957043,-0.0217050781944597,9.72008814348671e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,28176,-0.0189049916561457,0.00277540178837079,-0.0243447791613524,-0.0134652041509389,9.84436769443975e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,28522,0.0201663558466914,0.00296694636953724,0.0143511409623985,0.0259815707309844,1.08918012009759e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,28452,0.0275001555271057,0.00404840152520062,0.0195652885377125,0.0354350225164989,1.12110106757169e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,27702,-0.0223225379842086,0.00329278948605386,-0.0287764053768742,-0.0158686705915431,1.23253044159186e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,28224,-0.0313120713614296,0.00462353210992682,-0.0403741942968862,-0.022249948425973,1.29213215873377e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,23846,-0.0300838503773904,0.00444244742070242,-0.0387910473219672,-0.0213766534328137,1.30049016355828e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,28521,-0.0263203344820271,0.00389225162421921,-0.0339491476654967,-0.0186915212985574,1.38497483401501e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,28091,-0.00980236910939225,0.00144962313547487,-0.012643630454923,-0.0069611077638615,1.38754569400124e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,23815,0.0227788072693829,0.00337090668656195,0.0161718301637215,0.0293857843750443,1.43661961498364e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,23738,-0.0220136308275367,0.0032583588221247,-0.0284000141189011,-0.0156272475361723,1.45087484010045e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,28521,-0.0158539987140229,0.00234829720699604,-0.0204566612397352,-0.0112513361883107,1.49361977413979e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,28134,-0.0316189679045227,0.00468372897969735,-0.0407990767047295,-0.0224388591043159,1.49878427113319e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,23725,-0.0223740260191145,0.00331474646221013,-0.0288709290850463,-0.0158771229531826,1.51417378886468e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,27562,-0.0339588476582902,0.00503189472150412,-0.0438213613124383,-0.0240963340041422,1.52111003982164e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,23826,-0.0166733519816244,0.00247568411060613,-0.0215256928384124,-0.0118210111248364,1.67840045853766e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,28521,-0.0257657456578944,0.00382917498117589,-0.0332709286209991,-0.0182605626947896,1.74307070252603e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,23188,-0.0195639909817433,0.0029094230149192,-0.0252664600909849,-0.0138615218725017,1.80475303595222e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",27682,-0.0409428851737878,0.00609602977070449,-0.0528911035243686,-0.028994666823207,1.89979350329637e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,27682,-0.0264674880450481,0.0039437175244206,-0.0341971743929125,-0.0187378016971837,1.96615464942256e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,23862,-0.0408348080465887,0.00608424036087145,-0.0527599191538967,-0.0289096969392806,1.96858760055264e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,23163,-0.0227937291903394,0.00339875025582488,-0.0294552796917561,-0.0161321786889226,2.03936781355829e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,23198,-0.0238874684224702,0.00356988551287291,-0.0308844440277011,-0.0168904928172393,2.26113260618509e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,23795,-0.0388174479552664,0.00580186714413792,-0.0501891075577767,-0.027445788352756,2.27334642558426e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,28091,0.0129981842180885,0.00194596850720318,0.00918408594397025,0.0168122824922067,2.44158778873084e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,23337,-0.0340815310241157,0.00510206116551776,-0.0440815709085306,-0.0240814911397009,2.44398902286723e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",23846,-0.040640250285225,0.00609925760582586,-0.0525947951926437,-0.0286857053778063,2.73870326351008e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,23337,-0.0329400608638978,0.004943603780118,-0.0426295242729291,-0.0232505974548665,2.73960749731471e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,23775,-0.0136963140213185,0.0020560545735247,-0.0177261809854269,-0.00966644705721012,2.77055394619496e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,28521,-0.0225777497330483,0.00339100064742667,-0.0292241110020045,-0.015931388464092,2.82351671638585e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,23327,-0.00981692385929015,0.00147432411253254,-0.0127065991198539,-0.00692724859872638,2.82609729479459e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,23725,-0.0253839036393475,0.00381324668336895,-0.0328578671387507,-0.0179099401399444,2.86024483633098e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,23725,-0.0273167798769159,0.0041103300556362,-0.0353730267859628,-0.0192605329678689,3.07940374452455e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,28072,-0.0386064827279341,0.00581033393170723,-0.0499947372340803,-0.027218228221788,3.09915328169168e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,24857,0.0143116088388833,0.00215637468790678,0.0100851144505861,0.0185381032271806,3.26979567132096e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,27682,-0.0161760949681555,0.00243783860367658,-0.0209542586313616,-0.0113979313049494,3.29539943417355e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,23615,-0.0276299243751342,0.00416614574644754,-0.0357955700381714,-0.0194642787120971,3.38303000126925e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",28121,-0.0300527122053968,0.0045368588745187,-0.0389449555994534,-0.0211604688113401,3.55617221093374e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,28521,-0.0400537657796391,0.00604771246044356,-0.0519072822021085,-0.0282002493571697,3.58330663158399e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,23795,-0.0305513648499498,0.00461501526672634,-0.0395967947727335,-0.0215059349271662,3.66869555316669e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,28033,-0.0276068921695474,0.00417174820728961,-0.035783518655835,-0.0194302656832597,3.71700104732247e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,28096,-0.0145905578111245,0.0022057363037521,-0.0189138009664787,-0.0102673146557704,3.78673568908701e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,28553,-0.0179567557920718,0.00271555079384038,-0.023279235347999,-0.0126342762361447,3.84381768664918e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,23163,-0.0369579789157364,0.00559735787657823,-0.0479288003538297,-0.0259871574776431,4.1233117084959e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,27544,-0.0336434792940018,0.00509724661526301,-0.0436340826599173,-0.0236528759280863,4.17711278652877e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,23337,-0.0351867266079346,0.00533206569768322,-0.0456375753753937,-0.0247358778404755,4.2259331154919e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,23846,-0.024343892398137,0.00369722947432923,-0.0315904621678223,-0.0170973226284517,4.66352105661545e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,28224,-0.0531440864988911,0.0080747439610303,-0.0689705846625105,-0.0373175883352718,4.73823366881078e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,23795,-0.0342835373327318,0.0052138660313838,-0.0445027147542441,-0.0240643599112196,4.95108614878973e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,23393,-0.0341949355556837,0.00520684291976655,-0.0444003476784262,-0.0239895234329413,5.2309114470979e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,28176,-0.0404960279622624,0.00617167685075396,-0.0525925145897402,-0.0283995413347846,5.41594893112746e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,27682,-0.0343528813195334,0.00523813307817209,-0.0446196221527507,-0.0240861404863161,5.54096236404933e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,23071,-0.0358818975306111,0.00547194741573628,-0.0466069144654542,-0.0251568805957679,5.59027099915207e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,22978,-0.0229749900670913,0.00350774759048526,-0.0298501753444424,-0.0160998047897402,5.88392240867812e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,27682,0.00970779008784639,0.00148296994434732,0.00680116899692565,0.0126144111787671,6.00594785741993e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,27562,-0.0212686293752902,0.00324909543786045,-0.0276368564334966,-0.0149004023170837,6.01305491871713e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,28320,-0.0386479521099417,0.00590505852886144,-0.0502218668265101,-0.0270740373933733,6.05567038930765e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,23188,-0.0410097191839428,0.00626792415853107,-0.0532948505346637,-0.0287245878332219,6.16414648770147e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,23198,-0.010262406049566,0.0015689039543518,-0.0133374578000955,-0.00718735429903644,6.23279938437626e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,22492,-0.0556286794364255,0.00850703610697435,-0.0723024702060952,-0.0389548886667557,6.32035630911177e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,27562,-0.0172995099238362,0.00264631969422842,-0.0224862965245239,-0.0121127233231485,6.37783464340326e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,28091,-0.0404671959276344,0.00619124783817095,-0.0526020416904494,-0.0283323501648193,6.41852672743354e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,28452,-0.0206503515091902,0.00316204016870418,-0.0268479502398503,-0.01445275277853,6.65643424393299e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,28176,0.0236758360174308,0.00363493918794277,0.016551355209063,0.0308003168257986,7.47030846860322e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,28428,-0.027295708098134,0.00419195904637046,-0.0355119478290201,-0.0190794683672479,7.56728709057707e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,28176,-0.0339449762614993,0.00522042818286542,-0.0441770154999155,-0.023712937023083,8.04058013057454e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",23738,-0.0656337714383452,0.0100971164593727,-0.0854241196987156,-0.0458434231779748,8.1780234886369e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,27965,-0.0351191867564538,0.00540795170325286,-0.0457187720948294,-0.0245196014180782,8.49944299281737e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,28210,-0.0179038254609556,0.0027629424010124,-0.0233191925669399,-0.0124884583549713,9.32442512366948e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,28521,-0.0176845876538911,0.0027349503712258,-0.0230450903814937,-0.0123240849262886,1.02159852585365e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",23287,-0.0382237305550411,0.00591164547370506,-0.049810555683503,-0.0266369054265792,1.02738459757599e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,27544,-0.0257343173505002,0.00398399631438265,-0.0335429501266902,-0.0179256845743102,1.06856120182482e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,23795,-0.0216271140001768,0.00334996169949291,-0.028193038931183,-0.0150611890691707,1.09632102086504e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,27084,-0.0167954998449844,0.0026039222837426,-0.0218991875211199,-0.0116918121688489,1.13679049773919e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,23775,-0.0412244056937096,0.00639174026976037,-0.0537522166224399,-0.0286965947649793,1.14274631936358e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,27786,-0.0189557435021779,0.0029393778124195,-0.0247169240145201,-0.0131945629898357,1.1451832502775e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,23893,0.0234856395041725,0.00364170382953598,0.016347899998282,0.030623379010063,1.14683938917017e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,23337,-0.0187565340149742,0.00290886965718327,-0.0244579185430534,-0.013055149486895,1.15517382103565e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,23738,-0.0235765987610477,0.00365720528113631,-0.0307447211120749,-0.0164084764100205,1.16574135276414e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,28233,-0.0471031912476882,0.00731110378260703,-0.061432954661598,-0.0327734278337784,1.19262856067907e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,23488,0.00361385369314399,0.000561036094378828,0.00251422294816149,0.00471348443812649,1.20675627070468e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,27489,-0.0204820859637601,0.00318034707281223,-0.0267155662264721,-0.0142486057010481,1.21283444682221e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,27965,-0.0428322320417864,0.00665225707902425,-0.055870655916674,-0.0297938081668989,1.22414025010436e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,28553,-0.0135449984239141,0.00210444402423313,-0.0176697087114111,-0.00942028813641721,1.24298428141042e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,28428,-0.0252049735547605,0.00392079637585722,-0.0328897344514407,-0.0175202126580804,1.30883112796001e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,23738,-0.0286802280035783,0.00446113849215741,-0.0374240594482068,-0.0199363965589498,1.30972495655785e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,28274,-0.0125821912574384,0.00195855703253534,-0.0164209630412076,-0.0087434194736691,1.34659473008474e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,28132,-0.0210223300577137,0.00327267696416144,-0.0274367769074701,-0.0146078832079572,1.35224990631001e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,28092,-0.0482652823316551,0.00751492967220499,-0.0629945444891769,-0.0335360201741334,1.36120565141448e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,28336,0.0211967163946743,0.00330066866416543,0.01472740581291,0.0276660269764385,1.36674637849439e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,23135,-0.0374993557864755,0.00584622902457718,-0.0489579646746467,-0.0260407468983042,1.44226277456484e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,27136,0.0140000285104221,0.00218309844532836,0.00972115555757853,0.0182789014632657,1.45111076564205e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,28428,-0.0102350597435196,0.00159959509034226,-0.0133702661205904,-0.00709985336644873,1.59320269122027e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,28288,0.0136963783726716,0.00214176955518467,0.00949851004450962,0.0178942467008335,1.63171888872863e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,23056,-0.0242006992234985,0.00378550039462868,-0.0316202799969708,-0.0167811184500263,1.65780279140727e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,28174,0.0202511688892868,0.00317450268706485,0.0140291436226397,0.0264731941559339,1.80636980640199e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,28320,-0.0150822040289731,0.00236581926478333,-0.0197192097879484,-0.0104451982699978,1.85726423690663e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,28384,-0.0216760223763158,0.00340311798829625,-0.0283461336333765,-0.0150059111192552,1.92600341352028e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,28320,-0.0405648108550696,0.00637509808276597,-0.0530600030972909,-0.0280696186128483,2.00862619750301e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",28187,0.0106626570578444,0.00167653845291335,0.0073766416901342,0.0139486724255545,2.04948213301669e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,23188,-0.0386161568274085,0.00608888525130407,-0.0505503719199645,-0.0266819417348525,2.30877869959247e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,23337,-0.0161775859921525,0.00255382264439152,-0.0211830783751599,-0.0111720936091451,2.42215100412016e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,23188,-0.0191680568092725,0.00303564290610482,-0.0251179169052379,-0.013218196713307,2.76253816932867e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,28363,0.0150476212711951,0.00238433646807048,0.0103743217937769,0.0197209207486132,2.81279283417297e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,23337,-0.0292618509758517,0.00463843194214991,-0.0383531775824655,-0.0201705243692379,2.86692351689847e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,23738,-0.0394050088952586,0.00624710053383434,-0.0516493259415739,-0.0271606918489433,2.88158599546064e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,28291,0.0119162702047516,0.00189118839801837,0.00820954094463562,0.0156229994648676,3.00196287207943e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,27702,-0.0238440431393716,0.00379075446829196,-0.0312739218972238,-0.0164141643815193,3.22099975043976e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,27682,0.0148728879528474,0.00236472440577678,0.0102380281175249,0.0195077477881699,3.23289989913056e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,28307,-0.0303982679561957,0.00484071208404305,-0.0398860636409201,-0.0209104722714713,3.44131062770977e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,28091,-0.0382183847582335,0.00608760460530924,-0.0501500897846396,-0.0262866797318274,3.4782153592695e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,23845,-0.0160687327411859,0.00256427825434123,-0.0210947181196947,-0.0110427473626771,3.75872092218396e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,28452,0.0167020590153818,0.00266586314678494,0.0114769672476833,0.0219271507830803,3.77774855796502e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,23198,-0.0388975259945294,0.00621991094831992,-0.0510885514532364,-0.0267065005358223,4.07810018634031e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,27373,-0.036268291019202,0.00580699847083826,-0.047650008022045,-0.024886574016359,4.28335607591221e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,27196,-0.0396009743712107,0.00634174674497129,-0.0520307979913544,-0.0271711507510669,4.3147289442075e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,23795,-0.0127174250481235,0.00203813395793061,-0.0167121676056675,-0.0087226824905795,4.45693507192128e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,23775,-0.0196143657160613,0.00314428976504565,-0.0257771736555508,-0.0134515577765718,4.50413254917998e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,28224,-0.0292516922982744,0.0046928545948906,-0.03844968730426,-0.0200536972922889,4.63346248544866e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,28176,-0.0434643053235172,0.00697354118749068,-0.0571324460509989,-0.0297961645960354,4.6482386689878e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,23071,-0.0286642262342595,0.00460032757051225,-0.0376808682724635,-0.0196475841960555,4.71759096888142e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,28452,-0.0231523996144039,0.00371633063864657,-0.0304364076661511,-0.0158683915626566,4.73242773988908e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,28091,-0.036182796036162,0.00581426914534022,-0.0475787635610289,-0.0247868285112952,4.94300566816588e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,28452,-0.0238773325386592,0.0038380899065815,-0.031399988755559,-0.0163546763217595,5.00396763404186e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,27702,-0.0342263693468688,0.00550321971022486,-0.0450126799789095,-0.0234400587148281,5.06398507992186e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,27970,-0.0291383461536199,0.00468729467533976,-0.0383254437172859,-0.019951248589954,5.15701829513524e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,23163,-0.0207866515374672,0.0033437655254044,-0.0273404319672598,-0.0142328711076746,5.16918247499574e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",28307,-0.0262919463938106,0.00423203745725527,-0.0345867398100309,-0.0179971529775902,5.28412594782453e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,23071,-0.0120633258212777,0.00194246726835616,-0.0158705616672558,-0.00825608997529964,5.37831050798569e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,23846,-0.0117809096579683,0.00189891344716797,-0.0155027800144175,-0.0080590393015191,5.5942148808162e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,28176,-0.026111988653613,0.00420947904880287,-0.0343625675892666,-0.0178614097179593,5.61169926187824e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,27965,0.0490385706584146,0.00790825973655267,0.0335383815747714,0.0645387597420579,5.69154309680875e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,23775,-0.0142032257529826,0.00229444045510151,-0.0187003290449815,-0.00970612246098363,6.10406442907167e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,28195,-0.0118362464199859,0.00191729966305166,-0.0155941537595672,-0.00807833908040469,6.77505984098059e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,28307,0.0127628596840532,0.00206863281421844,0.00870833936818508,0.0168173799999214,6.93432573836896e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,23393,-0.0300138368940902,0.00487335742478341,-0.0395656174466657,-0.0204620563415148,7.45120681351895e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,28452,-0.0254792782840097,0.00414581052162083,-0.0336050669063865,-0.0173534896616329,8.06229917645953e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,23188,-0.032933048424826,0.00536028917595516,-0.0434392152096982,-0.0224268816399539,8.18343821578819e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,27544,-0.017526537781273,0.00285389248203426,-0.0231201670460601,-0.0119329085164858,8.2981327054597e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,23545,-0.013487146020715,0.00220051914524734,-0.0178001635453998,-0.00917412849603021,8.97962597496349e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,28470,-0.0138266741413751,0.00225801890711555,-0.0182523911993216,-0.00940095708342858,9.28175238718167e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,27623,-0.0309398302675051,0.00505620644965153,-0.0408499949088221,-0.0210296656261881,9.53234842418139e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,28023,0.00973467710041532,0.0015919814350064,0.00661439348780277,0.0128549607130279,9.79444480902281e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,23846,-0.0168745329922669,0.00277009077990332,-0.0223039109208774,-0.0114451550636564,1.13436378708742e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,23071,-0.0280060461433591,0.00459756059591702,-0.0370172649113565,-0.0189948273753618,1.13627653764685e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,23071,-0.0150390300508405,0.00247301273773888,-0.0198861350168087,-0.0101919250848723,1.21118215032557e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23198,-0.0177348984743384,0.00291639685986869,-0.023451036319681,-0.0120187606289958,1.21228214442156e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,23795,-0.0149414118661598,0.00246000578045742,-0.0197630231958563,-0.0101198005364632,1.26868568779219e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,23757,-0.0406271434813785,0.0066926019153929,-0.0537446432355486,-0.0275096437272085,1.29481968225461e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,27965,-0.0338100707410412,0.00557367858511599,-0.0447344807678686,-0.0228856607142139,1.32797611211182e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,28521,-0.0255738054891124,0.00421955512850595,-0.0338441335409841,-0.0173034774372408,1.37159352672894e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,23198,-0.0165091826782725,0.00272952805482602,-0.0218590576657315,-0.0111593076908135,1.48563357794742e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,27562,-0.0273080018518636,0.00452002225899711,-0.0361672454794979,-0.0184487582242292,1.54583914865029e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,23775,-0.0159679542443051,0.00264729557792334,-0.0211566535770348,-0.0107792549115753,1.64540686450198e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,27562,-0.0183179140921262,0.00303888162235985,-0.0242741220719515,-0.0123617061123009,1.68268603117158e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,28336,-0.0417865678689974,0.00693637562829789,-0.0553818641004613,-0.0281912716375336,1.71973071324549e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",28176,-0.0399330272480604,0.00662888833417516,-0.0529256483830437,-0.026940406113077,1.72170231793457e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",23846,-0.0125642570278909,0.00208707859416453,-0.0166549310724534,-0.00847358298332844,1.76944164845156e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,23337,-0.0250194824106924,0.00416058166473612,-0.0331742224735752,-0.0168647423478096,1.84309119628507e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,23738,-0.0242215581911095,0.00403189185315263,-0.0321240662232887,-0.0163190501589304,1.9115989453218e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,23738,-0.0177580216121518,0.00295619338492342,-0.0235521606466017,-0.0119638825777019,1.91672758875861e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,23198,-0.0132076748867619,0.00220718465475043,-0.0175337568100727,-0.00888159296345104,2.20992446260064e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",23198,-0.0398583395261559,0.00667984222439002,-0.0529508302859603,-0.0267658487663515,2.4522668864352e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,23337,-0.0351129507502486,0.00590510695590361,-0.0466869603838196,-0.0235389411166775,2.78344579268765e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,23147,-0.0113127125858239,0.00190513593553844,-0.0150467790194792,-0.00757864615216857,2.92624554032903e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,23738,-0.0281863313931249,0.0047496294404166,-0.0374956050963415,-0.0188770576899084,2.98967102314029e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,28470,-0.00836699626223633,0.00141138097616798,-0.0111333029755256,-0.00560068954894708,3.09737383924078e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,23561,0.017114082141732,0.0028874604971504,0.0114546595673172,0.0227735047161467,3.12745836167434e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,28176,-0.0343003117387969,0.0057904101467093,-0.0456495156263472,-0.0229511078512467,3.18544030079681e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,23725,-0.033931951114897,0.00573588825547938,-0.0451742920956366,-0.0226896101341574,3.34946153472419e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,23725,-0.020927978172898,0.00354497958580558,-0.027876138161077,-0.0139798181847191,3.6059577064719e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,23846,-0.0368889681916197,0.00625242978075396,-0.0491437305618975,-0.024634205821342,3.68543775159008e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,28187,-0.010838357139796,0.00183735746861531,-0.014439577778282,-0.00723713650131001,3.70145939917867e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,27562,-0.02143366333435,0.00363681273056245,-0.0285618162862524,-0.0143055103824476,3.82428572031707e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,28553,-0.0292015962932363,0.00495582653768314,-0.0389150163070952,-0.0194881762793773,3.84949576356738e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,27562,-0.0216271305198192,0.00367484840536955,-0.0288298333943435,-0.0144244276452949,4.02228485059986e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,23795,0.0188372100670112,0.00320508270286334,0.0125552479693991,0.0251191721646233,4.22591570870926e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,23301,-0.023368498327651,0.00397807392717301,-0.0311655232249101,-0.0155714734303919,4.30341995426531e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,23725,-0.01797008146286,0.00306042681448822,-0.0239685180192569,-0.0119716449064631,4.36948072197249e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,27562,-0.0236303408317047,0.00402580155814014,-0.0315209118856594,-0.01573976977775,4.41519847587871e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,23198,-0.0310340599267569,0.00528872692818612,-0.0413999647060017,-0.0206681551475121,4.47177495419653e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,27544,-0.0250709541652283,0.00427697634834794,-0.0334538278079902,-0.0166880805224663,4.62979612608375e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,28307,-0.025323526403847,0.00432469137666489,-0.0337999215021102,-0.0168471313055838,4.8062871934023e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,27965,-0.00943418749779915,0.00161325831321707,-0.0125961737917046,-0.0062722012038937,5.03325396678255e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,28553,-0.0177589621658716,0.00304120954540537,-0.0237197328748661,-0.0117981914568771,5.29434278754873e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,23163,-0.0527594231285777,0.00906532723304961,-0.0705274645053549,-0.0349913817518005,5.96543781626682e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,28142,-0.016184852626201,0.00278148058544037,-0.0216365545736641,-0.0107331506787379,5.99171451800774e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,23738,-0.0338895789262492,0.00582788145636488,-0.0453122265807244,-0.022466931271774,6.13831867311718e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,23075,-0.0166071348220846,0.0028558933972852,-0.0222046858807636,-0.0110095837634056,6.14191267928725e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,28275,0.0109064889229598,0.00188120270282823,0.00721933162541644,0.0145936462205031,6.79796695800309e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,28132,0.0192352902720162,0.00332098611862025,0.0127261574795205,0.0257444230645119,7.0275975534786e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",23862,-0.016669199639768,0.00288111289656839,-0.0223161809170421,-0.011022218362494,7.31223914534283e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,27969,-0.0134605061333037,0.00232702038183804,-0.0180214660817062,-0.00889954618490112,7.3529900094114e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,23775,-0.0543264537170256,0.00940616727110768,-0.0727625415683967,-0.0358903658656546,7.76257739513834e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,23795,-0.0157081990499196,0.00272255342737802,-0.0210444037675805,-0.0103719943322586,8.04185576451611e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,27829,0.0109856726621611,0.00190556142469001,0.00725077226976863,0.0147205730545535,8.24921045785603e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,23779,-0.00790427541636425,0.00137291370791324,-0.0105951862838742,-0.0052133645488543,8.65223868414196e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,27562,-0.0230146028712032,0.0039979228773031,-0.0308505317107173,-0.0151786740316892,8.67148095942727e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,23647,-0.0191644495924259,0.00332969861551558,-0.0256906588788364,-0.0126382403060153,8.73965476516754e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,23071,-0.0178659522110043,0.00310424799631969,-0.0239502782837909,-0.0117816261382177,8.75718786866347e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,28428,0.0508731742347164,0.00884732361029152,0.033532419958545,0.0682139285108877,9.00930191044533e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,23188,-0.0129326928232474,0.00224930340909303,-0.0173413275050697,-0.00852405814142501,9.0555133742467e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,27544,-0.0184824599233331,0.00322416247500453,-0.024801818374342,-0.0121631014723242,1.00003782742163e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,27965,-0.0222438880435499,0.00388129084370801,-0.0298512180972176,-0.0146365579898822,1.00833804343416e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,28452,-0.0436202678565703,0.00762603648129921,-0.0585672993599167,-0.0286732363532238,1.0764638562842e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,23188,-0.0172383092794117,0.00301592889775845,-0.0231495299190183,-0.0113270886398051,1.10558826948157e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,27562,-0.0157455514337555,0.00275523839920884,-0.0211458186962049,-0.0103452841713062,1.109855828044e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,23725,-0.01658208838574,0.00290446117489451,-0.0222748322885333,-0.0108893444829468,1.14878058774918e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,27544,-0.0266477185544055,0.00467039099004772,-0.035801684894899,-0.017493752213912,1.17073143824008e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,28291,-0.0129899918661801,0.00227741398049321,-0.0174537232679467,-0.00852626046441336,1.1830964366296e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,23751,-0.0332788225319995,0.00583561502755595,-0.0447166279860092,-0.0218410170779899,1.19317457394724e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,27682,0.0525530163168434,0.00925144461973792,0.0344201848621571,0.0706858477715298,1.35632263164648e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,23198,0.0237554155062316,0.00418225878415438,0.015558188289289,0.0319526427231742,1.3627189901773e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,28380,0.0099810209294403,0.0017576792484025,0.0065359696025714,0.0134260722563092,1.37190029309388e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,27544,-0.0251721518175029,0.00443483229414021,-0.0338644231140177,-0.0164798805209881,1.39257886372546e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,28091,-0.0303684062154548,0.00536709020577605,-0.0408879030187759,-0.0198489094121338,1.54400765964206e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,28224,-0.0068763858350292,0.00121743457588542,-0.00926255760376462,-0.00449021406629377,1.6363956674173e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,28176,-0.0259647529658907,0.00460054488709361,-0.0349818209445941,-0.0169476849871872,1.67892869068442e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,28438,-0.0103697720335166,0.00183827647475133,-0.0139727939240292,-0.00676675014300398,1.70641572408204e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,23163,0.0123849733297094,0.00219664097556531,0.00807955701760135,0.0166903896418174,1.73897168194609e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",23393,-0.0192949765169858,0.0034242160034396,-0.0260064398837274,-0.0125835131502441,1.77216973134476e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",23738,-0.040042993889911,0.00712236082442149,-0.0540028211057771,-0.0260831666740449,1.90713021890853e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,22978,-0.0218041596343021,0.00388069626083736,-0.0294103243055433,-0.0141979949630609,1.94717967818566e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,28428,0.00839138054396696,0.00149443031300768,0.00546229713047191,0.011320463957462,1.98277886918987e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,28176,0.0103062975377928,0.00183729989677728,0.00670518974010934,0.0139074053354763,2.04838246839051e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,27562,-0.0328617406450425,0.00586038267323291,-0.044348090684579,-0.021375390605506,2.07307885069747e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,28437,-0.00924686675293751,0.00164982166803923,-0.0124805172222944,-0.00601321628358062,2.10466051683688e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,23872,-0.0182914214863533,0.0032665283898559,-0.0246938171304708,-0.0118890258422357,2.17145884064755e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,27918,-0.0178586283922538,0.00319156332861603,-0.0241140925163412,-0.0116031642681664,2.21954438960342e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,23841,-0.021573856593685,0.0038589896325476,-0.0291374762734783,-0.0140102369138917,2.288354204563e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,27965,-0.0151656391574649,0.00271421523402276,-0.0204855010161495,-0.00984577729878025,2.32524341945872e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,28521,-0.017904169589287,0.00320665810825444,-0.0241892194814657,-0.0116191196971082,2.37958196567537e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,27910,-0.0291421871687635,0.00521938120298747,-0.039372174326619,-0.0189122000109081,2.37977213949944e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,28381,-0.01438772781598,0.00257857500546418,-0.0194417348266898,-0.00933372080527022,2.43102163728625e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,23198,-0.0271259683828918,0.00487232653076477,-0.0366757283831908,-0.0175762083825929,2.61499380221392e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,23862,-0.0321994838309979,0.00578414150385373,-0.0435364011785512,-0.0208625664834446,2.62166521521329e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,23198,-0.0345453365142155,0.00621753172389218,-0.0467316986930442,-0.0223589743353868,2.78871104607382e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,23862,-0.0138500528582366,0.00249334665228713,-0.0187370122967193,-0.00896309341975379,2.80887417099153e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,28307,0.010737304419803,0.00193351174019429,0.00694762140902221,0.0145269874305838,2.82897833331277e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",28091,-0.0395941108431593,0.00714758840430804,-0.0536033841156031,-0.0255848375707156,3.06042557317897e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",23790,-0.00867180525827033,0.00156878722793471,-0.0117466282250224,-0.0055969822915183,3.2783821629108e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,27702,-0.0162544490016004,0.0029411352242339,-0.0220190740410988,-0.010489823962102,3.2945358107226e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,23862,-0.00885181121592,0.00160385880745182,-0.0119953744785256,-0.00570824795331443,3.44340672026189e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",28307,0.0132609569595099,0.00240716092164125,0.00854292155309301,0.0179789923659267,3.64096800382791e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,23893,-0.00820634014573989,0.00148958058482037,-0.0111259180919878,-0.00528676219949197,3.64266115526799e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23188,-0.0212782127136424,0.00386242471680844,-0.028848565158587,-0.0137078602686979,3.64652369898014e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,23071,-0.0139051808225318,0.0025294882150855,-0.0188629777240994,-0.00894738392096426,3.89889009191926e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,28521,-0.0206676988771567,0.00376000074246721,-0.0280373003323925,-0.013298097421921,3.90215852515897e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,23845,-0.00857095686300008,0.00155969646568457,-0.0116279619357418,-0.00551395179025832,3.94100797507508e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,27877,-0.0136977929272599,0.0024985900973163,-0.0185950295179998,-0.00880055633651993,4.23688794209496e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,28521,-0.0102327354030656,0.00186704756883108,-0.0138921486379745,-0.00657332216815667,4.27221375599656e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",28320,-0.0415794568647602,0.00759097163521034,-0.0564577612697724,-0.0267011524597479,4.35074424883471e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,27761,-0.0113345382397673,0.00207029245688401,-0.0153923114552599,-0.0072767650242746,4.41676950709411e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,23188,-0.0179786219148007,0.00328822592626271,-0.0244235447302756,-0.0115336990993258,4.60943227343697e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,28091,-0.0338921932616197,0.00619976536319458,-0.0460437333734811,-0.0217406531497583,4.62418577652602e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,23795,-0.0445292640391606,0.00814796116395539,-0.0604992679205131,-0.028559260157808,4.67341768377092e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,23795,-0.0183138511561055,0.00335211933399682,-0.0248840050507393,-0.0117436972614717,4.71877335022538e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,23198,-0.0345963505132799,0.00633295469827566,-0.0470089417219002,-0.0221837593046596,4.73213175229499e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23194,-0.0146768523682153,0.00268781499227477,-0.0199449697530739,-0.00940873498335679,4.79631472255774e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",27910,-0.0274953498381935,0.00504208710410586,-0.037377840562241,-0.017612859114146,4.98998093694285e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,23071,-0.0249734014117217,0.00458178232385761,-0.0339536947664826,-0.0159931080569608,5.07184957429621e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,23725,-0.015834611519914,0.0029054579601686,-0.0215293091218444,-0.0101399139179835,5.08847764476614e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,28428,-0.0185917811952439,0.00341452429633894,-0.0252842488160682,-0.0118993135744196,5.22602565808856e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,23163,-0.0256549643618878,0.00471893418773839,-0.0349040753698551,-0.0164058533539206,5.48552884995761e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,23707,-0.0353967357287849,0.00651158884985151,-0.0481594498744938,-0.0226340215830759,5.50401101704334e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,23188,-0.0338983675034805,0.00624018800044489,-0.0461291359843525,-0.0216675990226086,5.62025864902325e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,23071,-0.0235707151068382,0.00433926519380601,-0.0320756748866979,-0.0150657553269784,5.6302118829529e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,27531,-0.011937005842379,0.0021981856471599,-0.0162454497108124,-0.00762856197394556,5.67066194139637e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,23198,-0.0191713671994543,0.00353216679239118,-0.026094414112541,-0.0122483202863676,5.76732217471369e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,28187,0.0183816026613862,0.00339165261627769,0.0117339635334819,0.0250292417892904,6.02021486279212e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,23636,-0.0113136241290894,0.00209104092916489,-0.0154120643502526,-0.00721518390792626,6.34519096750535e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,23188,-0.0108071989985769,0.00199887664858057,-0.0147249972297949,-0.00688940076735901,6.48539111445982e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,28091,-0.0271645353370025,0.00502978801271923,-0.0370229198419322,-0.0173061508320728,6.69082329275326e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,28176,-0.0388117433692703,0.00719450846370923,-0.0529129799581404,-0.0247105067804002,6.92162670590826e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,28274,0.0144325591947866,0.00268236242112446,0.00917512884938265,0.0196899895401906,7.48526661243155e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,28336,-0.0170862007180761,0.00317666365696454,-0.0233124614857266,-0.0108599399504256,7.5635498730845e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",23775,-0.014841809671954,0.00276311823806573,-0.0202575214185628,-0.00942609792534517,7.88621737542501e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",23846,-0.0272349454348857,0.00507480519221797,-0.0371815636116329,-0.0172883272581384,8.09397738013868e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,23198,-0.0253595721752291,0.00472669863554375,-0.0346239015008948,-0.0160952428495633,8.16452747946918e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,23738,-0.0173835391129911,0.00325263987742941,-0.0237587132727528,-0.0110083649532295,9.15337221628751e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,23738,-0.0367365741272666,0.00689306838395276,-0.0502469881598141,-0.0232261600947192,9.93849855508783e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,23846,-0.0365630276972862,0.00688233988937958,-0.0500524138804702,-0.0230736415141022,1.0904976678498e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,23198,-0.0187943871099685,0.00353858115029082,-0.0257300061645385,-0.0118587680553985,1.09862565733791e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,23795,0.0138632973095838,0.00261081217529273,0.00874610544601009,0.0189804891731576,1.10635956591615e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,23198,-0.0106730388268732,0.00201070143278312,-0.0146140136351281,-0.00673206401861827,1.1178187271247e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,28452,-0.0140429838737598,0.00265399950186303,-0.0192448228974113,-0.00884114485010826,1.22379726265146e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,27682,-0.0195498365252116,0.00369514261086909,-0.026792316042515,-0.0123073570079082,1.22785312659366e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,23872,-0.00979954500835149,0.00185284682322856,-0.0134311247818795,-0.00616796523482352,1.2412955421827e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,27940,-0.0173234215353077,0.00328224880007797,-0.0237566291834605,-0.0108902138871548,1.31638853877813e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,23775,-0.00806575674574223,0.0015288426661125,-0.0110622883713227,-0.00506922512016173,1.33389038877273e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,23623,-0.034152659750961,0.00648238771182927,-0.0468581396661463,-0.0214471798357756,1.38725950122801e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,23738,-0.0111958355738397,0.00212624284096528,-0.0153632715421317,-0.00702839960554775,1.40988265662374e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,23577,-0.035981109459035,0.00684981028265891,-0.0494067376130465,-0.0225554813050235,1.51054341430137e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,23663,0.00982296121343941,0.00187141826185063,0.00615498142021217,0.0134909410066667,1.54297384143203e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,28224,-0.00931186381719053,0.00177521506825806,-0.0127912853509763,-0.00583244228340474,1.5699589761668e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,23276,-0.0195083923573798,0.00372703081764388,-0.0268133727599618,-0.0122034119547978,1.67049791024445e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,23725,-0.0163191202036491,0.00312120856971771,-0.0224366890002958,-0.0102015514070024,1.72374943442596e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,28320,-0.0171187746134167,0.00327455341328139,-0.0235368993034483,-0.0107006499233852,1.72737392036233e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,27544,-0.0187450004012929,0.00358855599194218,-0.0257785701454995,-0.0117114306570862,1.76801604628086e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,27385,0.02518930747012,0.00482364048001256,0.0157349721292953,0.0346436428109446,1.78242711778166e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,23337,-0.0297451061570808,0.00570320282319304,-0.0409233836905392,-0.0185668286236225,1.84877809863042e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,23071,-0.0243366134375399,0.00466646540579127,-0.0334828856328907,-0.015190341242189,1.85190656924285e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,27918,-0.0110955690450902,0.0021284692059686,-0.0152673686887886,-0.00692376940139175,1.87200106261482e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,28452,-0.0140919752108989,0.00270579270697959,-0.0193953289165789,-0.00878862150521893,1.92135904883308e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,23893,-0.0116566557265471,0.00223947345798721,-0.016046023704202,-0.00726728774889219,1.95509002350753e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,28091,0.00859130916463967,0.00165424194280661,0.00534899495673872,0.0118336233725406,2.07813171290914e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,27562,-0.0142055998052842,0.00273739608007174,-0.0195708961222248,-0.00884030348834356,2.12402032924944e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,23188,-0.0228365164114258,0.0044022044666201,-0.0314648371660012,-0.0142081956568504,2.14907967371752e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,23188,-0.0155919649409777,0.00300766509457483,-0.0214869885263444,-0.00969694135561108,2.1890996345795e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,23687,-0.0315196181230341,0.00608211837230207,-0.0434405701327461,-0.019598666113322,2.20914396903154e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,28428,-0.0164359197148567,0.00317567562870852,-0.0226602439471254,-0.010211595482588,2.28765038725114e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,23725,-0.015613681015088,0.00301816463355869,-0.021529283696863,-0.00969807833331295,2.31944450297625e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,23393,-0.0265803414472804,0.00513958659715432,-0.0366539311777029,-0.0165067517168579,2.33899791684676e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,28521,-0.0225478947509526,0.00436396419487821,-0.0311012645729139,-0.0139945249289913,2.39690169291888e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,23198,-0.0200998016654825,0.00389461083723358,-0.0277332389064603,-0.0124663644245046,2.47755931558494e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,23163,-0.0223712248056317,0.00433640063372988,-0.0308705700477422,-0.0138718795635211,2.50401095642724e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,28411,-0.0106477198134198,0.00206414552645297,-0.0146934450452676,-0.00660199458157195,2.50720775701192e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,27702,-0.0193103848151432,0.00374517676348721,-0.0266509312715781,-0.0119698383587082,2.53923314316222e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,23820,0.0260208907010218,0.00504848638741974,0.0161258573816791,0.0359159240203645,2.56755281830863e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,23664,-0.0165290777496349,0.00320696161644078,-0.0228147225178588,-0.010243432981411,2.56867972857319e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,28103,-0.0317172187873007,0.00615426514157476,-0.0437795784647872,-0.0196548591098142,2.57127655003485e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,27702,-0.0140576813153598,0.00272915200551531,-0.0194068192461698,-0.00870854338454982,2.60967463424004e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,28091,-0.0138317582746685,0.00268709101897452,-0.0190984566718586,-0.00856505987747848,2.65781381973063e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,27702,-0.0234982541504424,0.004567647889668,-0.0324508440141916,-0.0145456642866931,2.70065360563825e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,28224,-0.0100943355076695,0.00196324950999397,-0.0139423045472576,-0.00624636646808127,2.74158244088184e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,28142,-0.0236102893530997,0.00459395772273614,-0.0326144464896626,-0.0146061322165369,2.77425630330792e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,23460,-0.00482519960444423,0.000938869222677263,-0.00666538328089167,-0.0029850159279968,2.77866797665852e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,27887,0.0221884199785059,0.00432264898550192,0.0137160279669222,0.0306608119900897,2.8698083511705e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,27412,-0.0395218268140174,0.0077035530695853,-0.0546207908304046,-0.0244228627976302,2.91193834500915e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,28320,-0.0460563879608129,0.00897868544660964,-0.0636546114361679,-0.028458164485458,2.92389105870984e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,27615,-0.0315997771542705,0.00616546224711865,-0.043684083158623,-0.0195154711499179,2.99082941903978e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,28091,-0.0160830306925126,0.00313800581721417,-0.0222335220942524,-0.00993253929077282,2.99128103757389e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,23071,-0.0248663507351689,0.00485367226376778,-0.0343795483721537,-0.015353153098184,3.02808039391354e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,28224,-0.0282774504999213,0.00552532187576485,-0.0391070813764204,-0.0174478196234221,3.11158699363446e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,28428,-0.0239860808326034,0.00468926280006761,-0.0331770359207359,-0.0147951257444709,3.15599477568228e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,27374,0.0135836859916952,0.0026595800164698,0.00837090915941439,0.018796462823976,3.28715978586957e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,23795,-0.0401071708067411,0.00786014881159069,-0.0555130624774588,-0.0247012791360233,3.37600412465032e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,28194,-0.017632344265404,0.00345671353810013,-0.0244075028000803,-0.0108571857307278,3.40234971096746e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,28223,0.018415586888896,0.00361039921518398,0.0113392044271354,0.0254919693506566,3.40577347101823e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,28224,-0.0232677187394181,0.0045644724678652,-0.0322140847764339,-0.0143213527024023,3.46261549429068e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,23198,-0.0284165933402215,0.00557485277900642,-0.0393433047870741,-0.0174898818933689,3.47273096404664e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,27544,-0.0251728732500571,0.00493883708368655,-0.0348529939340828,-0.0154927525660315,3.47500647637352e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,23056,-0.0226433369901483,0.00444498973049042,-0.0313555168619095,-0.0139311571183871,3.53117026502101e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,28176,0.0120688209276104,0.00237031144799134,0.00742301048954739,0.0167146313656734,3.57226078594337e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",28187,-0.0271278154017584,0.00532807688420194,-0.0375708460947942,-0.0166847847087226,3.57558427791004e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,28452,-0.00909478878658156,0.00178988915113931,-0.0126029715228146,-0.00558660605034852,3.77425194848278e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,27682,-0.0406405404496494,0.00800662152057127,-0.0563335186299691,-0.0249475622693297,3.88231536606429e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23188,-0.0280883393484444,0.0055346409327167,-0.0389362355765691,-0.0172404431203197,3.90476927526478e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,23846,-0.0113443342090156,0.00223540856446703,-0.015725734995371,-0.00696293342266023,3.90741907918583e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,23795,-0.0184300857450564,0.00364968545202207,-0.0255834692310197,-0.0112767022590932,4.45600780569523e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,28428,0.0104585911751805,0.00207193439352842,0.00639759976386483,0.0145195825864963,4.4981925466076e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,27702,-0.0321776454949872,0.0063894524503985,-0.0447009722977682,-0.0196543186922061,4.78201492503399e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,27508,-0.00995057409665154,0.00198092730280683,-0.0138331916101529,-0.00606795658315014,5.11382206280888e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,23198,0.014742550907614,0.00293498820449276,0.0089899740268082,0.0204951277884198,5.12385810218892e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,27965,-0.0123342281293452,0.00245786189109677,-0.0171516374358949,-0.00751681882279553,5.24570335926847e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,28553,-0.0121511903800312,0.00242549007490246,-0.01690515092684,-0.00739722983322233,5.48151603461596e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,23071,-0.0409123507117037,0.00816947701109225,-0.0569245256534445,-0.0249001757699629,5.54180274386332e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,28496,-0.00710944112583649,0.00142147255452838,-0.00989552733271212,-0.00432335491896086,5.72350620686867e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,28091,-0.0195144260110176,0.00390247902983688,-0.0271632849094979,-0.0118655671125374,5.75200035274015e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,23738,-0.0136992616038742,0.00274034278458527,-0.0190703334616613,-0.00832818974608704,5.80071234820089e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,23738,-0.0306810056796699,0.00613962695985044,-0.0427146745209768,-0.0186473368383631,5.85792584216833e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,28496,-0.0177184914506173,0.00354746489896528,-0.0246715226525893,-0.0107654602486454,5.92781633683241e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,27777,-0.0258027517948501,0.00516810430291369,-0.035932236228561,-0.0156732673611393,5.99039015054138e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,27562,-0.0126049531854679,0.00252706843862095,-0.017558007325165,-0.00765189904577084,6.13863854311519e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,27562,-0.0180992579030285,0.00363648980908907,-0.025226777928843,-0.0109717378772139,6.49251430387186e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,28224,-0.0234865252929117,0.00472817373689858,-0.0327537458172329,-0.0142193047685905,6.82680564802356e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,28529,-0.0116491198605573,0.00234592212129578,-0.016247127218297,-0.00705111250281755,6.88525442597746e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,28187,-0.0157358376565569,0.0031705968646636,-0.0219502075112976,-0.00952146780181629,6.97983622686351e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,23738,-0.0280495654196659,0.00565452296178775,-0.0391324304247699,-0.016966700414562,7.07782451852684e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,28520,-0.0080673962391899,0.00162897556636944,-0.011260188349274,-0.00487460412910579,7.37090557029313e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,28553,0.0103611432887852,0.00209668148162159,0.00625164758480694,0.0144706389927636,7.78877582587208e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,27682,-0.0177917793839516,0.00360228846306269,-0.0248522647715545,-0.0107312939963487,7.89729525426838e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,28320,-0.00878983951154733,0.00178111008003794,-0.0122808152684217,-0.00529886375467296,8.05914201211596e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,23337,-0.0128037829906506,0.00259486508087699,-0.0178897185491695,-0.00771784743213166,8.1002252538828e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,28187,0.00671287871019044,0.00136095394474369,0.00404540897849282,0.00938034844188806,8.16539425406948e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,27682,-0.0181965451914023,0.00369137862042759,-0.0254316472874404,-0.0109614430953642,8.29290827543118e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,23337,-0.0367517566370798,0.007455814076881,-0.0513651522277666,-0.0221383610463931,8.31015898580027e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,23337,-0.00971666555548136,0.00197204632815995,-0.0135818763586749,-0.00585145475228785,8.39879024004683e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,23198,-0.0261864782360787,0.00531495493822162,-0.0366037899149931,-0.0157691665571644,8.41016287346121e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,23198,-0.0108562136823355,0.00220447099818717,-0.0151769768387823,-0.00653545052588864,8.50993852131613e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,28388,0.00771518954992901,0.00156761010320304,0.00464267374765104,0.010787705352207,8.63092598716078e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,28237,-0.00821138962868337,0.00167040358846332,-0.0114853806620715,-0.00493739859529526,8.89110367764499e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,28428,-0.00792531151393135,0.00161345724344222,-0.0110876877110781,-0.0047629353167846,9.06498733079714e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,28452,0.0111701018499484,0.00227809965062332,0.00670502653472673,0.0156351771651701,9.47811797023006e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",27682,-0.0314136322288845,0.00641194374585036,-0.0439810419707512,-0.0188462224870178,9.67526598823411e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,23198,-0.0206893281419634,0.00422301799409376,-0.0289664434103872,-0.0124122128735397,9.68857431526883e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,23337,-0.0288398176771686,0.00588909404174469,-0.0403824419989882,-0.017297193355349,9.78835698455797e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,28176,-0.0198591044037405,0.00405618408133051,-0.0278092252031483,-0.0119089836043327,9.83447881588496e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,27544,-0.0144388822536082,0.00295020265065423,-0.0202212794488905,-0.00865648505832593,9.9264157878762e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,28336,-0.0144995207027619,0.00296334740044533,-0.0203076816076347,-0.00869135979788904,9.98790300572388e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,28307,-0.024388273718836,0.00499351134011484,-0.0341755559454611,-0.0146009914922109,1.04525873028959e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,27965,-0.0267065996943514,0.00546940066126823,-0.0374266249904371,-0.0159865743982656,1.05107413321985e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",28176,-0.0145952043798533,0.00298980638848943,-0.0204552249012926,-0.00873518385841401,1.05774401449131e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,23846,-0.0301525020999515,0.00618357703609801,-0.0422723130907036,-0.0180326911091994,1.08832434658879e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,28187,0.0120945276921602,0.00248443857619205,0.00722502808282376,0.0169640273014966,1.13278368079214e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,23026,-0.0331217467767499,0.00680397563969651,-0.0464575390305551,-0.0197859545229447,1.13480750669466e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,23862,0.0134626148683755,0.00276924979149778,0.00803488527703988,0.0188903444597112,1.17260312406374e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,28307,0.0110052587420144,0.00226906597663705,0.00655788942780573,0.015452628056223,1.24037439853578e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,28091,0.00889807046717071,0.00183560999520225,0.0053002748765743,0.0124958660577671,1.25711527606505e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,23738,-0.0142754515020066,0.00295600036211751,-0.0200692122117569,-0.00848169079225628,1.37858448585612e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,23140,-0.019379248290531,0.00401806175508981,-0.0272546493305071,-0.011503847250555,1.42290193791589e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,23393,-0.022450667785276,0.00466507592757794,-0.0315942166033288,-0.0133071189672233,1.49985386592876e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,28307,-0.0109182611792272,0.00227004849712897,-0.0153675562336,-0.00646896612485444,1.51931147486122e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,23337,-0.0134099565234955,0.00279101308508899,-0.0188803421702699,-0.00793957087672106,1.55953585503092e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,22978,-0.0221122805476442,0.00460274810556886,-0.0311336668345592,-0.0130908942607293,1.56392808290253e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,23188,-0.0132841675050744,0.00276649415139293,-0.0187064960418045,-0.00786183896834424,1.58222407188992e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,23198,-0.010946583961062,0.00228557217618034,-0.0154263054263755,-0.00646686249574851,1.68290117321486e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,27965,-0.0310777896870785,0.00649343343419747,-0.0438049192181056,-0.0183506601560515,1.70978352157924e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,23738,-0.0201336980942833,0.00421188926645935,-0.0283890010565437,-0.011878395132023,1.76164690954367e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,28307,-0.0089076086545408,0.00186467835947803,-0.0125623782391177,-0.00525283906996387,1.78801721098841e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,28176,-0.0168844068666437,0.00353999608358273,-0.0238227991904659,-0.00994601454282159,1.85504499016302e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,28224,-0.0117529160111399,0.0024646522842036,-0.0165836344881789,-0.00692219753410082,1.86445383570704e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,23775,-0.0276394369254995,0.00579716699395135,-0.0390018842336442,-0.0162769896173549,1.87398762874403e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,23163,-0.020162738533104,0.00422978631370959,-0.0284531197079748,-0.0118723573582332,1.88269089165195e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,27870,-0.0188404674294468,0.00395399374745709,-0.0265902951744627,-0.0110906396844309,1.89879440912967e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,23337,-0.0224954060093954,0.00473255606971788,-0.0317712159060424,-0.0132195961127483,2.01285295808546e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,23738,-0.0160606164557902,0.00338202419801331,-0.0226893838838963,-0.00943184902768416,2.05804173010646e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,23163,-0.0166588552318298,0.00350822264903424,-0.0235349716239369,-0.00978273883972269,2.06139766728526e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,23775,-0.0152022703572512,0.00320225710403258,-0.0214786942811551,-0.00892584643334737,2.0728823313174e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,28194,-0.0104286843776143,0.00220292447610859,-0.0147464163507871,-0.00611095240444148,2.21186982000108e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,28091,-0.00792241959717198,0.00167352275029432,-0.0112025241877488,-0.00464231500659511,2.21234807391932e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,28176,-0.0307137313368699,0.00649163486036517,-0.0434373356631857,-0.0179901270105542,2.24192090446496e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,23056,-0.0249104396732964,0.00526504452255562,-0.0352299269375055,-0.0145909524090874,2.24422810202588e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,23725,-0.0350553150907541,0.00743018617987599,-0.049618480003311,-0.0204921501781972,2.39579763052102e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,28091,-0.0285735503367263,0.00605982299897776,-0.0404508034147227,-0.0166962972587299,2.4257884157965e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,23188,-0.0148944055540313,0.00316421454466825,-0.0210962660615811,-0.00869254504648154,2.52666439692594e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,23188,-0.0132013536939676,0.00280526831500375,-0.018699679591375,-0.0077030277965603,2.54189232669759e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,28224,-0.00791386371316023,0.00168360332579551,-0.0112137262317194,-0.00461400119460103,2.60684858971192e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,27562,-0.0116330716060873,0.00247615826555993,-0.0164863418065847,-0.00677980140558982,2.63947012842664e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,23795,-0.0187427212109286,0.00399041860178793,-0.0265639416704329,-0.0109215007514242,2.65574425697227e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,28195,-0.0177408530869097,0.00377939743671764,-0.0251484720628763,-0.0103332341109431,2.69047390226898e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,28224,-0.0269264266456329,0.00574742267885482,-0.0381913750961883,-0.0156614781950774,2.81324050349126e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,27562,-0.0141985432416001,0.00303432008276651,-0.0201458106038225,-0.00825127587937774,2.892005484119e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,23738,-0.0140859428029911,0.00301131889315071,-0.0199881278335664,-0.00818375777241566,2.91758107691276e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",23393,-0.0147576380384356,0.0031622105436922,-0.0209555707040723,-0.00855970537279886,3.07511758911991e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,28140,-0.0093119742280279,0.0019960185963997,-0.0132241706769713,-0.0053997777790845,3.09623160662801e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,28452,-0.0108163394687502,0.00232276346153294,-0.0153689558533548,-0.00626372308414563,3.22818721109858e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",23795,-0.0151130427063885,0.00325199953258343,-0.021486961790252,-0.00873912362252493,3.38098179159351e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,28553,-0.0102173161438199,0.00220053155323781,-0.014530357988166,-0.00590427429947381,3.44726277961888e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,23738,-0.0111592448091457,0.00240429465765271,-0.015871662338145,-0.00644682728014637,3.47941048027832e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,22783,-0.012551012294637,0.00270622857634772,-0.0178552203042785,-0.00724680428499545,3.54052441044023e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,23240,-0.0136511592310925,0.0029479141205988,-0.0194290709074662,-0.00787324755471889,3.66252913679112e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,28336,-0.0148846711403655,0.00321531704853231,-0.0211866925554889,-0.0085826497252422,3.68528393004273e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,27965,-0.0105330302022168,0.00228123503799776,-0.0150042508766924,-0.00606180952774117,3.90590107550211e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,28135,0.00903760794484548,0.00195772285729351,0.00520047114455019,0.0128747447451408,3.92201915442657e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,23795,-0.0252010641941475,0.00546503877821736,-0.0359125401994535,-0.0144895881888415,4.02194400303901e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,28184,-0.0126210553536107,0.00274252712797139,-0.0179964085244347,-0.00724570218278681,4.20316624372415e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,28307,-0.0092076241203639,0.00200145098888673,-0.0131304680585819,-0.00528478018214591,4.23356169321664e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,28095,-0.0588209390738572,0.0128099835428161,-0.0839285068177767,-0.0337133713299377,4.41334618812925e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,28307,-0.00768864664351019,0.00167575021382628,-0.0109731170626097,-0.00440417622441068,4.49040691276832e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,23775,0.00972583008664034,0.00212184811205112,0.00556700778702014,0.0138846523862605,4.59232338097683e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,27544,-0.0194686070163857,0.00424997881352551,-0.0277985654908957,-0.0111386485418757,4.65070667895423e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,28411,-0.0191094580418913,0.00417485032402801,-0.0272921646769862,-0.0109267514067964,4.73055703741703e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,23393,-0.0167930341405052,0.00367248124367871,-0.0239910973781155,-0.00959497090289492,4.84022749470164e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,28120,0.0116942591622112,0.00256251999984262,0.00667171996251966,0.0167167983619027,5.05018547963324e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,23893,-0.013033544614507,0.00286071887208131,-0.0186405536037863,-0.0074265356252276,5.23853493496145e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,28087,-0.0109574152153038,0.00240844159540379,-0.0156779607422953,-0.00623686968831239,5.39761555468246e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,23872,-0.0125732266383234,0.00277206969632957,-0.0180064832431294,-0.00713997003351744,5.76971207383979e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,28307,0.00862854013955394,0.00190435377976272,0.004896006731219,0.0123610735478889,5.89577905448208e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",23775,-0.030490370240301,0.0067332588016214,-0.043687557491479,-0.0172931829891231,5.9742444763901e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,27562,-0.0211504804783331,0.0046781380928122,-0.030319631140245,-0.0119813298164212,6.17658344451131e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",28224,-0.022874844813815,0.00506190914035647,-0.0327961867289137,-0.0129535028987163,6.23800078588972e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,28176,-0.0150811662805436,0.00333782216028087,-0.0216232977146941,-0.00853903484639312,6.26015770618168e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,28091,-0.00675757626905392,0.00149631513056071,-0.0096903539249529,-0.00382479861315493,6.32316436512258e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,23071,-0.0183919230358742,0.00407643351758929,-0.0263817327303493,-0.0104021133413992,6.46067557282995e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,22833,-0.0251448613829066,0.00558144440017713,-0.0360844924072538,-0.0142052303585594,6.6676531979225e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,23188,-0.0120375562333154,0.00267370057031371,-0.0172780093511302,-0.00679710311550051,6.75786890657118e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,23337,-0.00960342566284938,0.00213541345190788,-0.0137888360285888,-0.00541801529710993,6.9179306224558e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,23738,-0.0198937134936361,0.0044331045906094,-0.0285825984912306,-0.0112048284960417,7.23904248707999e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,28553,-0.00716918053849712,0.00159979000511355,-0.0103047689485197,-0.00403359212847456,7.44688347016333e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,27682,0.0103556596550085,0.00231117865328768,0.00582574949456461,0.0148855698154523,7.47023907973936e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,27562,-0.0190073738080102,0.00424386134154751,-0.0273253420374433,-0.0106894055785771,7.53679298704734e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,27544,-0.0114808249427422,0.00256425154318357,-0.016506757967382,-0.00645489191810244,7.59099825200941e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,27638,-0.0154939433456628,0.0034647280881384,-0.022284810398414,-0.00870307629291151,7.783359771091e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",28187,-0.0118046284554183,0.00264595031531909,-0.0169906910734437,-0.00661856583739292,8.17429692484016e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,27682,-0.014499529415145,0.00325265733009322,-0.0208747377821277,-0.00812432104816226,8.3150083768376e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,23795,-0.0161952936573825,0.00364116139026795,-0.0233319699823077,-0.00905861733245737,8.71321528203633e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,28187,-0.00882102710048211,0.00198534822480963,-0.012712309621109,-0.00492974457985524,8.90249038458476e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,28521,-0.0107570304864405,0.00242239008670679,-0.0155049150563858,-0.00600914591649518,9.00167712546285e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,23846,-0.018874492029018,0.00425291043615511,-0.027210196483882,-0.010538787574154,9.11981367500738e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,23188,-0.010766784144584,0.00242665354341085,-0.0155230250896692,-0.00601054319949871,9.16901483496277e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,23738,0.0215619777556306,0.00486257295422348,0.0120313347653526,0.0310926207459086,9.27980325125153e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,28276,-0.0253315342254101,0.0057212848781624,-0.0365452525866084,-0.0141178158642118,9.56463517511674e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,23071,-0.0260780192663025,0.00590290485695255,-0.0376477127859295,-0.0145083257466755,1.0015162382077e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,27806,-0.0208994280866365,0.00473366620287901,-0.0301774138442794,-0.0116214423289937,1.01361675648292e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,23100,-0.0120501746234008,0.00272968922083843,-0.0174003654962442,-0.00669998375055751,1.01709452828449e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,23862,-0.025248828732892,0.00572453238750243,-0.0364689122123967,-0.0140287452533872,1.03518359910683e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,28143,0.0124978988700818,0.00284068109145001,0.00693016393083981,0.0180656338093238,1.08842153344629e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,27562,-0.0229123867322158,0.00521626430720479,-0.0331362647743372,-0.0126885086900944,1.12477673518646e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,27562,-0.0203627512210763,0.00464804396623411,-0.0294729173948952,-0.0112525850472575,1.18610361568654e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,23862,0.0150404699621441,0.00343368987739709,0.00831043780244583,0.0217705021218424,1.19040389028809e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,23071,-0.0209962029498507,0.00479372432057821,-0.030391902618184,-0.0116005032815174,1.19237545395571e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,28187,0.00866171760589166,0.00197792625946282,0.00478498213734454,0.0125384530744388,1.1954962512917e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,27965,-0.0302946205127169,0.00691838453779533,-0.0438546542067958,-0.0167345868186381,1.19736149756798e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,23071,-0.0299469989062065,0.00684681255113166,-0.0433667515064246,-0.0165272463059885,1.22603723174762e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,28276,-0.0229437630639222,0.00525870962535563,-0.0332508339296193,-0.0126366921982252,1.28743727781431e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,27657,-0.0167420031732405,0.00383784424616052,-0.0242641778957151,-0.00921982845076589,1.2914090511156e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",23337,-0.0312947802966333,0.00717404594909858,-0.0453559103568665,-0.0172336502364001,1.29300359031622e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,23198,-0.0351993614871151,0.00807915705397642,-0.0510345093129089,-0.0193642136613213,1.32537735811542e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,27966,-0.0137220804788096,0.00315122757761469,-0.0198984865309344,-0.00754567442668477,1.33833279522723e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,27682,-0.0146748269954938,0.00337457762878678,-0.0212889991479158,-0.00806065484307166,1.37472908013704e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,23738,0.0102806238305553,0.00236435895384299,0.00564648028102305,0.0149147673800876,1.37852749813358e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,28187,-0.00775690507027918,0.00178431810356097,-0.0112541685532587,-0.00425964158729967,1.38328027600758e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,27562,-0.0155682974504554,0.00358478788073466,-0.0225944816966954,-0.00854211320421548,1.41129948809078e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",23795,-0.0142293893956484,0.00327730285731651,-0.0206529029959888,-0.00780587579530808,1.41904794994736e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,23071,-0.0180877397179715,0.00416677900328181,-0.0262546265644039,-0.00992085287153917,1.42478237978992e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,23775,-0.00811265558871515,0.00186942204079113,-0.0117767227886658,-0.00444858838876453,1.43292426885485e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,28378,-0.0208216564699383,0.00480488651755464,-0.0302392340443454,-0.0114040788955312,1.47306224815262e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,27562,-0.0100547300948078,0.00232279632078522,-0.0146074108835468,-0.00550204930606876,1.50508510108815e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,28176,-0.0203303942663648,0.0047005920028701,-0.0295435545919902,-0.0111172339407394,1.53006763749053e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,22978,-0.0126324373311305,0.00292669838301941,-0.0183687661618485,-0.00689610850041242,1.5934751639402e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,28237,-0.00976888779830055,0.00227042975619229,-0.0142189301204374,-0.00531884547616367,1.69326907866678e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,28224,-0.038001290108184,0.00883456374124436,-0.0553170350410229,-0.020685545175345,1.70266709058896e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,27702,-0.019864137186553,0.00461812629977248,-0.028915664734107,-0.0108126096389989,1.70348480199512e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,28165,-0.0282770867333361,0.0065746958273483,-0.0411634905549388,-0.0153906829117334,1.70680910431878e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,28135,0.00684610777998377,0.00159409692862884,0.00372167779987125,0.00997053776009629,1.75545710458863e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,23738,-0.0259571571029955,0.00604582448285853,-0.0378069730893982,-0.0141073411165928,1.76653849072959e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,28307,-0.0248117377182555,0.00578131834347025,-0.0361431216714572,-0.0134803537650538,1.7789181798099e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,28187,0.0130067934019289,0.00303215975565945,0.00706376028083638,0.0189498265230214,1.79580188196328e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,28176,-0.0115118922122448,0.00268483474590264,-0.016774168314214,-0.00624961611027562,1.8109460014711e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,23188,0.00956273688388481,0.0022332822665642,0.00518550364141898,0.0139399701263506,1.86032254161983e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,23738,-0.0225218550181393,0.00526616228842927,-0.0328435331034606,-0.0122001769328179,1.90416107739494e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,28125,-0.0304641580192645,0.00713061168355841,-0.044440156919039,-0.01648815911949,1.94097084151203e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,23071,0.00813171873940433,0.00190816354200929,0.00439171819706613,0.0118717192817425,2.03826986416828e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,23337,-0.0125425736823926,0.00295156987108372,-0.0183276506297167,-0.00675749673506855,2.15119481576697e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,27900,0.010083756433804,0.00237466447976247,0.00542941405346955,0.0147380988141384,2.17943333836974e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,23163,-0.0180955718239089,0.00429210501889592,-0.0265080976609449,-0.00968304598687294,2.49602489605216e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,27702,-0.0141206855238503,0.00335050999166275,-0.0206876851075093,-0.00755368594019134,2.51137811949081e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,28367,0.00588481012776995,0.00139862186193418,0.00314351127837896,0.00862610897716094,2.58915953678396e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,23893,0.00536349606833825,0.0012750299971885,0.00286443727384879,0.0078625548628277,2.60227431885963e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,28494,0.00870682804686479,0.00207262029672664,0.00464449226528058,0.012769163828449,2.66688662572327e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,23872,-0.0207326138037926,0.00493547729578543,-0.030406149303532,-0.0110590783040532,2.67020126029156e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,28091,-0.0130186252650482,0.00310418337067179,-0.0191028246715649,-0.00693442585853151,2.75043039596782e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,27562,-0.0152122536596385,0.00363879065424541,-0.0223442833419595,-0.00808022397731749,2.91664580007066e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,27702,0.0115819900221384,0.00277110789382245,0.00615061855024635,0.0170133614940304,2.92979832822432e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,23198,-0.0294230643656766,0.00703968799637659,-0.0432208528385747,-0.0156252758927785,2.93095413686794e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,28553,0.0118279062663209,0.00283116940177004,0.00627881423885158,0.0173769982937902,2.95287207456737e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,28336,0.00995894065928145,0.00238550870750047,0.00528334359258054,0.0146345377259824,2.99183268525379e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,23795,-0.0111003131773785,0.00266349209498142,-0.016320757683542,-0.00587986867121488,3.0894005015788e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,22978,-0.0175968060288577,0.00422553747317233,-0.0258788594762754,-0.00931475258143991,3.13318821695378e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,27965,-0.00984989735650976,0.00236728978682731,-0.0144897853386913,-0.00521000937432823,3.18036324583458e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,23198,-0.0209728280454043,0.00504062630468908,-0.0308524556025949,-0.0110932004882137,3.18335261897762e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,28307,0.0114826912015315,0.00276202441185338,0.00606912335429892,0.0168962590487641,3.22913408326542e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,27928,-0.0201801138559041,0.00485480455308145,-0.0296955307799437,-0.0106646969318645,3.2379671833857e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,28320,-0.0117061748223958,0.00281696085371183,-0.017227418095671,-0.00618493154912067,3.25381361638325e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,23725,-0.0202608877645944,0.00488379089385965,-0.0298331179165594,-0.0106886576126295,3.35682105490021e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,28260,0.0140410654051631,0.00339878639359357,0.00737944407371968,0.0207026867366065,3.61913168184073e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,28091,-0.0331634235893665,0.00802812528750851,-0.0488985491528832,-0.0174282980258499,3.62383371093795e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23149,-0.010239533264374,0.00248333683511262,-0.0151068734611948,-0.00537219306755331,3.74791742135548e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,23725,-0.00971176499687221,0.00235535962007379,-0.0143282698522168,-0.00509526014152759,3.74815515870418e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,23071,0.00582855580300411,0.00141467207370105,0.00305579853855005,0.00860131306745817,3.80069874224992e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,23738,-0.0292141644888796,0.0070946264206378,-0.0431196322733297,-0.0153086967044295,3.8382159013084e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,28176,-0.0192259992606346,0.00467769501685975,-0.0283942814936797,-0.0100577170275895,3.96531890542308e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,23188,-0.0145376133971147,0.00353816940630723,-0.0214724254334768,-0.00760280136075249,3.99095185165574e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,27544,-0.019101265888985,0.00464924713118783,-0.0282137902661132,-0.00998874151185689,3.99450155907737e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,23755,-0.00868437554044802,0.00211398597237316,-0.0128277880462994,-0.00454096303459663,4.00338343113745e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,28325,0.0116610385405616,0.00284907468964578,0.00607685214885588,0.0172452249322674,4.27152579240819e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,23056,-0.012400544041067,0.00303002513593484,-0.0183393933074993,-0.00646169477463469,4.28098611498767e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,28524,-0.0162641721576044,0.00397471675406952,-0.0240546169955807,-0.00847372731962819,4.29015920019264e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,27562,-0.0167313487750061,0.00408972439908244,-0.0247472085972077,-0.00871548895280454,4.30608139835112e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,28336,0.00855018994497539,0.00209450655963484,0.0044449570880911,0.0126554228018597,4.47341512039573e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,22397,-0.00687982507035505,0.00168876317211156,-0.0101898008876937,-0.00356984925301639,4.63947773379032e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",23198,-0.0244356382137637,0.00600575093412944,-0.0362069100446574,-0.0126643663828699,4.74312677885088e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,23198,-0.0180160692179115,0.00442937918261358,-0.0266976524158341,-0.00933448601998888,4.76971447780687e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,28553,-0.00894765937526671,0.0022041018053411,-0.0132676989137353,-0.00462761983679816,4.92985894448618e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,27320,-0.0342817611338217,0.00845063268489051,-0.0508450011962071,-0.0177185210714363,4.99071777605372e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,23795,-0.0213836557438227,0.0052805995402015,-0.0317336308426177,-0.0110336806450278,5.14952986218262e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,23665,-0.0138930841546558,0.00344081363977035,-0.0206370788886057,-0.00714908942070591,5.41404537667755e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,23862,0.00598086320607305,0.00148158945492003,0.0030769478744298,0.0088847785377163,5.4357060821642e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,23738,-0.0315856362049507,0.00782888408169947,-0.0469302490050817,-0.0162410234048198,5.48899430659482e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,23163,-0.0165663513634635,0.00411486078418783,-0.0246314785004717,-0.00850122422645539,5.69189112820162e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,23725,-0.0096584825557331,0.00240360245394865,-0.0143695433654724,-0.00494742174599375,5.87914188616367e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,28452,-0.0123382644006148,0.0030831082378181,-0.0183811565467383,-0.0062953722544913,6.29972947109497e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",28142,-0.0302206003691265,0.00756597811610201,-0.0450499174766865,-0.0153912832615666,6.50573778702704e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,27702,-0.01189428611808,0.00297871411324034,-0.0177325657800311,-0.00605600645612898,6.53848907338539e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,23198,-0.00846214390202018,0.00212077948702369,-0.0126188716965866,-0.00430541610745374,6.62455433440817e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,23795,-0.0233059461556547,0.00587416109316223,-0.0348193018982526,-0.0117925904130567,7.28324391101513e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,28091,0.00804271440910078,0.00202773645600202,0.00406835095533682,0.0120170778628647,7.31623890842232e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,23071,0.0113560801702954,0.00286343755712555,0.00574374255832935,0.0169684177822615,7.33431784871531e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,27682,0.00844493705986029,0.00213043912446426,0.00426927637591034,0.0126205977438102,7.390730575683e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,27544,-0.0288306394703023,0.00727826057657201,-0.0430960302003835,-0.0145652487402212,7.4762018844344e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",23862,-0.0171021512315622,0.00432019566490149,-0.0255697347347691,-0.00863456772835524,7.55924788855138e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,28182,0.008767741584438,0.0022172308403531,0.00442196913734592,0.0131135140315301,7.6925510714211e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,27544,-0.00963535965860633,0.00243677532695684,-0.0144114392994417,-0.00485928001777093,7.70012952771684e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,27885,-0.00805585073915167,0.00204109603563331,-0.012056398968993,-0.00405530250931037,7.93883026364421e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,28237,0.00909025399971908,0.00230684111962643,0.00456884540525128,0.0136116625941869,8.14860984305901e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",23198,-0.0173427800901774,0.00440519090668373,-0.0259769542672775,-0.00870860591307723,8.27833066275101e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,28452,-0.0103089755226285,0.00262141910340221,-0.0154469569652969,-0.0051709940799602,8.42335297502656e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,20725,-0.0285549614686703,0.00727544928037522,-0.0428148420582058,-0.0142950808791349,8.70685440906127e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,27965,0.00697387506288005,0.00177740209622364,0.00349016695428171,0.0104575831714784,8.74318469176515e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,23110,-0.018352477595732,0.00467802471856488,-0.0275214060441192,-0.00918354914734484,8.76605118142114e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,28553,0.0196464082678463,0.0050098154346184,0.00982717001599423,0.0294656465196984,8.81746703020078e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,23188,-0.0145360206298534,0.00370661540652439,-0.0218009868266412,-0.00727105443306557,8.82006277587561e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",28091,-0.0163814082752131,0.00418017687533735,-0.0245745549508743,-0.00818826159955193,8.91901871040996e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,23071,-0.0123718043906755,0.00315738772492963,-0.0185602843315375,-0.00618332444981341,8.9408019279847e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,27682,-0.0228396160682073,0.00582964824545073,-0.0342657266292907,-0.0114135055071239,8.95614499432368e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,28091,0.01222415302816,0.00312038979547566,0.0061081890290277,0.0183401170272923,8.96806935302278e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,23846,-0.00882801890777112,0.00225453394154696,-0.0132469054332032,-0.00440913238233908,9.04031207179212e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,28307,-0.0185380346223364,0.00473740297254554,-0.0278233444485257,-0.00925272479614715,9.1323640295034e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,23775,-0.0268717318735551,0.00687483019258757,-0.0403463990510267,-0.0133970646960834,9.30467962083804e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,23188,0.00708406022107625,0.00181248717038293,0.00353158536712571,0.0106365350750268,9.31447303449651e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,28115,-0.0179607038592353,0.00459860246257796,-0.0269739646858881,-0.00894744303258247,9.41775462853476e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,28363,-0.0166174520382988,0.00425768412876308,-0.0249625129306745,-0.00827239114592318,9.52540063160567e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,27544,-0.0172325925104889,0.00441552425634922,-0.0258870200529334,-0.00857816496804441,9.53406802778271e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,28046,-0.00824458183202579,0.00211555441892237,-0.0123910684931136,-0.00409809517093795,9.75672737002113e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,28224,-0.012251755274937,0.00314511993789212,-0.0184161903532056,-0.00608732019666847,9.82299818469386e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23198,0.00938391105529701,0.00241100068310391,0.00465834971641334,0.0141094723941807,9.96488097900383e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,28182,-0.00802579040881213,0.00206292295152461,-0.0120691193938004,-0.0039824614238239,0.000100270043386621
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,28187,0.00847729170593804,0.00217965955808312,0.00420515897209512,0.012749424439781,0.000100775589593001
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,28452,0.00760007862521592,0.00196193666881886,0.00375468275433096,0.0114454744961009,0.000107407425310053
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,27965,0.0350217856730195,0.0090420992073567,0.0172992712266004,0.0527443001194386,0.000107663790684756
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,23337,-0.0335338907206829,0.00865858846352484,-0.0505047241091915,-0.0165630573321742,0.000107839221589179
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,27562,-0.0125487946646055,0.00324027534088353,-0.0188997343327372,-0.00619785499647378,0.000107860243172768
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,28470,-0.00739124051626711,0.00191060916747091,-0.0111360344845101,-0.00364644654802413,0.00010973924388798
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,27702,-0.00950124269390301,0.00245717561265604,-0.0143173068947088,-0.00468517849309717,0.000110554940530727
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,27918,0.00853843548943148,0.00221840646994985,0.00419035880832977,0.0128865121705332,0.000118911362487025
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,28553,-0.0233675877192068,0.00607634782862148,-0.0352772294633049,-0.0114579459751087,0.000120487794648864
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,22978,-0.0193027001406974,0.00502051528741907,-0.0291429101040388,-0.00946249017735604,0.000120993504937888
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,28187,-0.0108163401788126,0.00281582001478253,-0.0163353474077864,-0.00529733294983884,0.000122664724614069
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,23775,-0.0141560153271029,0.0036867914590682,-0.0213821265868766,-0.00692990406732928,0.000123525664606186
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,28206,0.0102272499263213,0.0026641826152941,0.00500545200034482,0.0154490478522977,0.000123909700510687
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,28117,0.0111338839373035,0.00290329031662452,0.00544343491671947,0.0168243329578876,0.0001258795776335
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,23725,-0.0118518689267216,0.00309429033658744,-0.0179166779864329,-0.00578705986701017,0.000128348844027412
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,28176,0.0160184097683644,0.00418229597321979,0.0078211096608536,0.0242157098758752,0.000128393928703004
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,28091,-0.00908141798632973,0.00237405994636817,-0.0137345754812113,-0.00442826049144811,0.000130911909642546
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,27965,0.00954526365776698,0.00249753048913715,0.00465010389905816,0.0144404234164758,0.00013272454023246
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,22978,-0.0147523421493318,0.0038663596733833,-0.022330407109163,-0.00717427718950052,0.000136228286266692
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,23393,0.00903901641531644,0.00237642735625817,0.00438121879705042,0.0136968140335825,0.000142961978466814
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,28320,-0.00939326108580437,0.0024750000083252,-0.0142442611021217,-0.00454226106948698,0.00014779778401535
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,27702,-0.015618562515044,0.00411669052163935,-0.0236872759374571,-0.00754984909263083,0.000148578369410903
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,28187,0.00629976459200712,0.00166678620644802,0.003032863627369,0.00956666555664524,0.00015741191589064
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,22978,-0.00953513219037962,0.00252534740115569,-0.0144848130966448,-0.00458545128411446,0.000159915531237907
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,23775,-0.00999876257913833,0.00264849502606395,-0.0151898128302237,-0.004807712328053,0.000160228408246503
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,23071,0.00982957207510743,0.0026082712528034,0.00471736041961276,0.0149417837306021,0.000164564175052863
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,23795,-0.00663689500287696,0.00176335053957377,-0.0100930620604415,-0.00318072794531237,0.000167754296071115
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,23893,-0.00541640945679216,0.00144175445408204,-0.00824224818679296,-0.00259057072679137,0.000172496315376157
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,27965,-0.00738795261601036,0.00197227761951678,-0.0112536167502632,-0.00352228848175748,0.000180109855940879
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23188,-0.00902673658329949,0.00241190568561066,-0.0137540717270964,-0.0042994014395026,0.000182584230965303
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,28176,-0.0119754041663747,0.0032009912932708,-0.0182493471011855,-0.00570146123156396,0.000183539883536183
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,23692,-0.00733157913710744,0.00196253329442478,-0.01117814439418,-0.00348501388003486,0.000187578440644426
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,23056,-0.0255904601302899,0.00685991469896725,-0.0390358929402657,-0.0121450273203141,0.000191608523922399
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,28195,-0.00647407159281767,0.00173748907554995,-0.00987955018089558,-0.00306859300473976,0.000194838873821594
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,23846,-0.0181758612055458,0.00489011957983816,-0.0277604955820286,-0.00859122682906302,0.000202180180669913
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,28320,0.0165919049613495,0.00446706456964105,0.00783645840485307,0.025347351517846,0.000204178677294159
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,27842,-0.0152032058479867,0.00409328363383366,-0.0232260417703007,-0.00718036992567273,0.000204259153315745
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,28235,0.00705865049146432,0.00190333573404026,0.00332811245274542,0.0107891885301832,0.000208833643228767
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,23198,-0.00765794387600132,0.00206502353083064,-0.0117053899964294,-0.00361049775557327,0.000209054959466863
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,28174,0.0169093279884664,0.00457582291418642,0.00794071507666102,0.0258779409002718,0.000219988409812328
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,23725,-0.0172183285032969,0.00466097134710025,-0.0263538323436134,-0.00808282466298038,0.000221118951510382
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,23198,-0.0156262188109564,0.00423290713982093,-0.0239227168050054,-0.00732972081690737,0.00022335453415169
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,27702,-0.00806717096028916,0.00218600599801577,-0.0123517427164001,-0.00378259920417825,0.000224357201469757
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,23188,-0.0103348555312679,0.00280058040714153,-0.0158239931292653,-0.0048457179332705,0.000224542382863093
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,28187,0.00935846295491757,0.00253845007933933,0.00438310079941248,0.0143338251104227,0.000227621562835617
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,23775,-0.0147424134983007,0.0040199694819351,-0.0226215536828935,-0.00686327331370793,0.000245664725114217
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,27562,-0.0193262947964869,0.00527970236466517,-0.0296745114312307,-0.00897807816174319,0.000252204183231459
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,23846,-0.0247251915328159,0.00675761182754762,-0.0379701107148093,-0.0114802723508226,0.000253880613580208
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,23775,-0.0140184377566905,0.00383371791114943,-0.0215325248625433,-0.00650435065083758,0.000256117248179932
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,23188,-0.0141648879866833,0.00388788688597306,-0.0217851462831905,-0.00654462969017611,0.000269711807179794
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,27232,-0.00902519521585798,0.00248308960393272,-0.0138920508395661,-0.00415833959214984,0.00027885615429851
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,28452,-0.00533192347200397,0.00146805910489293,-0.00820931931759411,-0.00245452762641383,0.000281777308755325
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,23725,-0.00877040027262434,0.00242146368157134,-0.0135164690885042,-0.00402433145674451,0.000293010016601899
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,23071,0.0105398488676295,0.00291226599164411,0.00483180752400706,0.016247890211252,0.000296235427706701
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,28123,0.0157538793686203,0.00436400311559591,0.00720043326205235,0.0243073254751883,0.000306775702271406
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,27750,-0.00849351017501215,0.00235371798504698,-0.0131067974257042,-0.00388022292432007,0.000308454109372656
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,23775,-0.011590979001307,0.0032131128474101,-0.0178886801822308,-0.00529327782038326,0.000309916477085726
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,27682,-0.0111629486687874,0.00309533474332926,-0.0172298047657128,-0.00509609257186204,0.0003110463093367
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,28091,-0.0076007960511091,0.00210777355890893,-0.0117320322265706,-0.0034695598756476,0.000311398287354148
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,27977,0.0100622173208467,0.00279796689819908,0.00457820220037653,0.0155462324413169,0.000323380729283855
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,23056,0.0118312594745421,0.0032900477504642,0.00538276588363224,0.0182797530654519,0.0003237294552438
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,27562,-0.0114529036685569,0.00318833936124207,-0.0177020488165914,-0.00520375852052244,0.00032856726678818
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,28176,-0.00875023976257935,0.0024393590449047,-0.0135313834905926,-0.00396909603456615,0.000334934620271805
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,23738,-0.0125418313588976,0.00350248157080545,-0.0194066952376763,-0.00567696748011892,0.000343173590834896
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,27519,0.0114724290740011,0.00320772062911651,0.00518529664093273,0.0177595615070694,0.000348815832351234
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,23775,0.0167423263981142,0.0046827355015629,0.00756416481505091,0.0259204879811775,0.000350479615071302
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,23846,-0.00698606543029609,0.00196158764714572,-0.0108307772187017,-0.00314135364189048,0.00036955321554635
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,23071,-0.0302132711910871,0.0084932760934926,-0.0468600923343326,-0.0135664500478416,0.000375414036846945
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,28553,0.00669367225028424,0.00188414683253132,0.00300074445852286,0.0103866000420456,0.000382018693643976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,23775,-0.0154486359020224,0.00435028728329037,-0.0239751989772715,-0.00692207282677325,0.000384255363131608
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,28176,-0.013708094964003,0.00386166844971474,-0.0212769651254439,-0.0061392248025621,0.0003861730277579
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,23725,-0.0125715951250818,0.00354373082928513,-0.0195173075504806,-0.00562588269968292,0.000389568782207737
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",27965,-0.0142440312970896,0.00401687415247495,-0.0221171046359405,-0.00637095795823867,0.000391693203690605
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,28176,0.0137752830692912,0.00388643234402413,0.00615787567500395,0.0213926904635785,0.000394063459823311
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,23163,-0.0109987284958136,0.0031041164552797,-0.0170827967481618,-0.00491466024346536,0.000395972903748314
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,23738,-0.013137820188983,0.00370859669749028,-0.020406669716064,-0.00586897066190208,0.000397066769276229
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,28348,-0.0101267639933412,0.00285945430450954,-0.0157312944301799,-0.00452223355650251,0.000398493892742059
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,23795,-0.00672512966083173,0.00189910942529098,-0.010447384134402,-0.00300287518726142,0.00039907030235443
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,28428,0.0185730908673822,0.00524978546005352,0.00828351136567734,0.0288626703690871,0.000404002223397652
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,27702,-0.00954959589278777,0.00269940622787984,-0.0148404320994323,-0.00425875968614329,0.000404341625273093
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,28091,0.00796587482281265,0.0022539606999561,0.00354811185089869,0.0123836377947266,0.000409719024521835
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,23071,-0.009407090096713,0.00266354692739302,-0.0146276420744033,-0.00418653811902268,0.000413561812847491
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,23393,-0.0179631324382617,0.00508759120778691,-0.0279348112055241,-0.00799145367099938,0.000415143232079369
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,23188,-0.00907514333610899,0.00257314990169114,-0.0141185171434236,-0.00403176952879436,0.000421329221862999
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,23188,-0.00828142632444038,0.00235110541766764,-0.012889592943069,-0.0036732597058118,0.000428554614453677
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,23198,-0.00720673100497228,0.00204605549270464,-0.0112169997706734,-0.00319646223927118,0.000428713338282623
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,23393,-0.00928969250260501,0.00264167042275915,-0.014467366531213,-0.00411201847399707,0.000437943682691129
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,23846,-0.0173854793762453,0.00494820257070344,-0.027083956414824,-0.00768700233766651,0.000443073879006691
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,28521,-0.00889501356037148,0.00253478830211666,-0.0138631986325201,-0.00392682848822282,0.000450193357973377
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,23393,0.00683391251217431,0.00194938004558459,0.00301312762282851,0.0106546974015201,0.00045628667086698
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,28307,0.00776562738865713,0.00221642596251389,0.0034214325021299,0.0121098222751843,0.000459600437349814
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,28553,0.00729083743558853,0.00208425073981315,0.00320570598555475,0.0113759688856223,0.000469365995966557
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,28307,-0.00527302097298247,0.00150860402327688,-0.00822988485860516,-0.00231615708735979,0.000474256965631378
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,27500,-0.00872156371701283,0.00249591613746447,-0.0136135593464432,-0.00382956808758246,0.000475994551638956
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,23071,-0.00871494072105102,0.00249598413933439,-0.0136070696341464,-0.00382281180795561,0.000481061879799935
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,28428,-0.00645031312550153,0.00184920294338144,-0.0100747508945292,-0.0028258753564739,0.000487094980439389
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,28428,0.0109957278113414,0.00315272899567503,0.00481637897981832,0.0171750766428644,0.000487956858447118
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",23795,0.0101925983095629,0.00292305652063366,0.00446340752912091,0.0159217890900049,0.000489415340727129
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,23337,-0.00720473325648144,0.00206622085859653,-0.0112545261393307,-0.00315494037363224,0.000489528584665768
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,23725,-0.006814663264206,0.00195443228866887,-0.010645350549997,-0.00298397597841501,0.000489769388719211
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,23287,-0.0247309786430266,0.0070958438417419,-0.0386388325728407,-0.0108231247132125,0.000492533475238054
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,22395,0.0266945625211325,0.00765985433382425,0.011681248026837,0.041707877015428,0.000493085957449979
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,23188,-0.00779249637156405,0.00223731565292974,-0.0121776350513063,-0.00340735769182176,0.000496804107348906
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,28053,0.0159667645410484,0.00460554211562329,0.00693990199442678,0.0249936270876701,0.000527367007036867
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",23846,-0.0127474911492316,0.00368596029515611,-0.0199719733277376,-0.00552300897072566,0.00054436153613564
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,23775,-0.0230545024906698,0.00667416740542158,-0.0361358706052961,-0.00997313437604355,0.000552708125502152
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,23725,-0.00693052151865743,0.00200661215014243,-0.0108634813329366,-0.00299756170437828,0.000553626203509153
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,27702,-0.00805142547942558,0.00233643875790592,-0.0126308454449212,-0.00347200551392997,0.000569742285109898
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,23163,-0.0184043743684908,0.00534584634651675,-0.0288822332076636,-0.00792651552931797,0.000576864547939613
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,23337,-0.0282363840093703,0.0082031167055605,-0.0443144927522689,-0.0121582752664717,0.000578115378326281
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,23738,-0.0183752492657989,0.00535525487780906,-0.0288715488263047,-0.00787894970529318,0.000601817348673305
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,28428,-0.0290645791529601,0.00847201596215613,-0.0456697304387861,-0.0124594278671341,0.000602977716322881
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,23893,-0.00457501710867291,0.00133423335343776,-0.00719011448141092,-0.0019599197359349,0.000606948073193839
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,23007,-0.0130690234419826,0.00381162399460748,-0.0205398064714133,-0.00559824041255194,0.000607479097480795
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,23337,0.0122393360170042,0.00357210714552638,0.00523800601177254,0.0192406660222359,0.000612776557553878
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,23337,-0.00950177979066001,0.00277396314956849,-0.0149387475638142,-0.00406481201750578,0.000615077253354061
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,28138,0.0186416016644992,0.00544740271347579,0.00796469234608668,0.0293185109829118,0.000622259811487359
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,23862,-0.0143336720255419,0.00419925559476211,-0.0225642129912756,-0.00610313105980815,0.000642681031221976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,28452,0.013573331812284,0.00397801712971495,0.00577641823804273,0.0213702453865253,0.00064557778573634
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,23188,-0.0148726882965899,0.00436304381906991,-0.0234242541819669,-0.00632112241121286,0.000653633957646667
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,23337,-0.0263268202820912,0.0077291862037863,-0.0414760252415124,-0.0111776153226701,0.000659954204912875
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,23337,-0.00675609111095995,0.00198400596879213,-0.0106447428097925,-0.00286743941212738,0.000662081716832613
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,23071,-0.00865899311173037,0.00254309993147576,-0.0136434689774229,-0.00367451724603787,0.000663017779671666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,23071,-0.0131082986265087,0.0038500206614067,-0.0206543391228658,-0.00556225813015155,0.000663411720814906
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,23393,-0.012498363309397,0.00367585512439829,-0.0197030393532177,-0.00529368726557636,0.000674678558208522
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,23893,0.00528641256187997,0.00155812908581632,0.00223247955367998,0.00834034557007996,0.000692956836746895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,28553,0.0145173415433497,0.00428069923307134,0.00612717104652988,0.0229075120401695,0.000696439786649863
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,28276,0.0208375211127489,0.00615321449929278,0.00877722069413507,0.0328978215313628,0.000709009417780518
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,27713,0.00967068151632336,0.00285769788279146,0.00406959366605211,0.0152717693665946,0.000715158651146402
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,28270,-0.011422866196295,0.00339874048513136,-0.0180843975471524,-0.00476133484543748,0.000777885729021343
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,27562,-0.0187333012536162,0.00557417851115348,-0.0296586911354771,-0.00780791137175542,0.000778427366226569
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,23071,-0.00922357130433583,0.00274595721145847,-0.0146056474387944,-0.00384149516987722,0.000783619756954674
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,27489,-0.00981959824775095,0.00292636521773841,-0.0155552740745182,-0.00408392242098367,0.000793112996007311
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,23198,-0.0145061467129605,0.00432658757525922,-0.0229862583604686,-0.00602603506545242,0.000801288818399062
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,28176,-0.0231070615440136,0.00690204493261191,-0.036635069611933,-0.00957905347609429,0.000815455886068007
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,23893,0.00533537357160095,0.0015969846701156,0.00220528361817438,0.00846546352502753,0.0008363388204702
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,28553,0.00378591184806137,0.00113377168049341,0.00156371935429429,0.00600810434182845,0.00084121865505648
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,23163,-0.0112568925192231,0.00337295805718064,-0.0178678903112971,-0.00464589472714901,0.000847009384246964
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,27442,0.0207750060546876,0.00623622047328696,0.00855201392704515,0.03299799818233,0.00086541317179345
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,27965,0.00970096351862115,0.00291661907940123,0.00398439012299474,0.0154175369142476,0.000881841095136688
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,23893,-0.00389919387093202,0.00117755809272111,-0.00620720773266539,-0.00159118000919865,0.000930166201666533
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,28187,-0.0167281922983999,0.00507136550755051,-0.0266680686931989,-0.00678831590360086,0.000973032872643984
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,28091,-0.00646391351627141,0.00196173971975664,-0.0103089233669944,-0.0026189036655484,0.000985469344030051
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,23795,-0.0150875533343778,0.00458585318594242,-0.0240758255788249,-0.00609928108993067,0.00100325567502694
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,23299,-0.0083383668559452,0.00253966018862352,-0.0133161008256473,-0.00336063288624309,0.00102764898465613
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,23549,0.0244650514623118,0.00746218980545249,0.00983915944362492,0.0390909434809987,0.00104498714019557
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,28276,-0.0130242842064238,0.00397394611259186,-0.0208132185871038,-0.0052353498257437,0.0010488735606148
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,23071,0.00716385641304844,0.00218909808518035,0.00287322416609495,0.0114544886600019,0.00106751938270113
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,23163,-0.00710568034330978,0.00217145064821637,-0.0113617236138139,-0.00284963707280569,0.00106825139637486
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,23393,-0.00659611342314485,0.00201956629838804,-0.0105544633679854,-0.0026377634783043,0.00109195201417281
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,23725,-0.0138932992710003,0.00425637141648755,-0.0222357872473159,-0.00555081129468467,0.00109960876530354
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,28224,-0.00593326682515229,0.00181902768769423,-0.00949856109303299,-0.00236797255727159,0.00110846753639605
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,28299,-0.00526950665701449,0.0016165753028098,-0.0084379942505217,-0.00210101906350729,0.00111672538825431
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,27237,-0.01348230507746,0.00414957736397476,-0.0216154767108506,-0.0053491334440695,0.00115919679551812
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,23071,-0.0148526869177637,0.00457324654135803,-0.0238162501388254,-0.00588912369670196,0.00116494398699095
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,23775,-0.00829736796437771,0.00255567158906534,-0.0133064842789458,-0.00328825164980965,0.00116934206416745
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,27682,-0.0172110278010603,0.00530310720482921,-0.0276051179225255,-0.00681693767959502,0.00117399944580365
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,28320,-0.00641121862899773,0.00197693775728386,-0.0102860166332741,-0.00253642062472137,0.00118413208593892
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,23444,-0.00943851526482401,0.00291665686668923,-0.0151551627235349,-0.00372186780611312,0.00121354527964537
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",23775,-0.023647117632708,0.00731538517177762,-0.0379852725693921,-0.00930896269602385,0.00122871505575414
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,28224,-0.0080743598261509,0.00249793955586229,-0.012970321355641,-0.00317839829666083,0.00122892593624803
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,23188,0.0129602270764852,0.00402171717683086,0.00507766140989673,0.0208427927430737,0.00127225917255332
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,27917,-0.012968077234626,0.00402997684853205,-0.0208668318577488,-0.00506932261150317,0.00129278616536221
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,23795,-0.0078428216856335,0.00243837054986866,-0.0126220279633761,-0.00306361540789093,0.00129974707925331
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,22978,-0.0170302238144555,0.00529773674155906,-0.0274137878279113,-0.00664665980099979,0.00130796695507317
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23198,-0.013899962422019,0.00432813175175212,-0.0223831006554531,-0.00541682418858482,0.00132206318499351
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,27702,-0.0128999076589772,0.00401788519340766,-0.0207749626380562,-0.00502485267989818,0.00132599495194449
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,23738,-0.0211972529669391,0.00660895047620965,-0.0341507959003101,-0.00824371003356821,0.00134139122233571
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,23198,-0.00616970027468289,0.00192786158929904,-0.009948308989709,-0.00239109155965677,0.00137478187972557
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23198,-0.0116977029146355,0.00365625429804178,-0.0188639613387974,-0.00453144449047362,0.00137914531095828
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,27702,-0.0181910176758082,0.00568745530163709,-0.0293384300670168,-0.00704360528459947,0.00138325951454744
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,27682,-0.00851224668802621,0.00266159150367035,-0.0137289660352201,-0.00329552734083233,0.00138453962183167
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,27562,-0.00834892591428426,0.00261274887601916,-0.0134699137112818,-0.00322793811728671,0.00139767063435857
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,28091,-0.016525055376181,0.005171508266795,-0.0266612115790992,-0.00638889917326283,0.00139789882076359
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,23872,0.00572856188225512,0.00180023833618288,0.00220009474333667,0.00925702902117357,0.00146392094151563
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,28187,0.0261570622608925,0.00822441989624443,0.0100371992642534,0.0422769252575315,0.00147223921633819
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,23188,-0.0140780180624411,0.00443958139556415,-0.0227795975977468,-0.00537643852713537,0.00152100561061406
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,27965,-0.0125639798342262,0.00397389888375931,-0.0203528216463945,-0.00477513802205795,0.00157058787307445
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,23071,-0.0134205961814167,0.00425148937788157,-0.0217535153620646,-0.00508767700076885,0.00159781190897193
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,23893,-0.00322356747171992,0.00102252602629077,-0.00522771848324983,-0.00121941646019002,0.00162049665992931
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,27562,-0.0105690450156493,0.00335333227288143,-0.0171415762704969,-0.00399651376080172,0.00162439166049293
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,23337,-0.00843849707924989,0.00267925581997284,-0.0136898384863967,-0.00318715567210312,0.00163718703695721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,28091,-0.00645322081830565,0.00204991865491661,-0.0104710613819422,-0.0024353802546691,0.00164542615549372
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,28195,-0.0167979210764713,0.00533810473555704,-0.0272606063581631,-0.0063352357947795,0.00165242534903148
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,28494,0.010023604763698,0.00318537837666295,0.00378026314543863,0.0162669463819574,0.00165263405939945
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,23846,-0.0059775902667851,0.00190400638334982,-0.00970944277815074,-0.00224573775541946,0.0016945447608353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,28358,-0.0127864793404455,0.00408798246867774,-0.0207989249790538,-0.0047740337018371,0.00176285404922419
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,28061,-0.00904844320619845,0.00289628648004683,-0.0147251647070902,-0.00337172170530665,0.00178499130547541
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,23163,-0.0113067622195747,0.00361998827864462,-0.0184019392457181,-0.00421158519343119,0.00178979821864807
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,28276,-0.0186696205151528,0.00598953561153373,-0.0304091103137589,-0.00693013071654668,0.00182860086274548
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,28187,0.0083619976911221,0.00268545580772076,0.00309850430798941,0.0136254910742548,0.00184873755681847
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,27702,-0.0101370132886749,0.00325888702218083,-0.0165244318521493,-0.00374959472520046,0.00186912945047163
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,28176,-0.0102620168186029,0.0032994217372904,-0.0167288834236921,-0.0037951502135137,0.00187117477189237
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",23846,-0.015001214780376,0.00482663446676595,-0.0244614183352373,-0.00554101122551473,0.001885750349307
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,27965,-0.00818462130293108,0.00264160478661052,-0.0133621666846877,-0.00300707592117445,0.00194793141552637
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,23795,-0.0269878502423362,0.00872177333201352,-0.0440825259730827,-0.00989317451158974,0.00197501603852795
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',23071,-0.00920619383336064,0.00297960553511786,-0.0150462206821916,-0.00336616698452963,0.00200573000406126
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,23071,-0.014580272384439,0.00472290770028104,-0.0238371714769898,-0.00532337329188814,0.00202332823656632
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,28176,-0.0140116398356765,0.00454119829703846,-0.0229123884978718,-0.00511089117348109,0.00203441442361929
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,23163,-0.00490792003582572,0.00159113331689175,-0.00802654133693354,-0.00178929873471789,0.00204104874706473
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,23795,-0.00683654299034425,0.00221640888113886,-0.0111807043973764,-0.00249238158331209,0.00204119152067466
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,23337,-0.0185670266025343,0.00602772965107344,-0.0303813767186383,-0.00675267648643037,0.00207054519098533
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,23071,0.00941604999912465,0.00305842833747989,0.00342153045766407,0.0154105695405852,0.00208134861331367
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23188,-0.00663653120125417,0.00216129518611528,-0.0108726697660401,-0.00240039263646822,0.00213857071109824
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,28251,0.0104340127819174,0.00340523819452572,0.00375974592064694,0.0171082796431878,0.00218526842071188
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,28237,-0.00648083158884618,0.00211514255289997,-0.0106265109925301,-0.00233515218516224,0.00218592769914744
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,23795,-0.00811325576834918,0.00265109778966313,-0.0133094074360889,-0.00291710410060944,0.00221333475791666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,23846,-0.0062574238167914,0.00204671546864596,-0.0102689861353375,-0.00224586149824533,0.00223587753888235
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,23725,-0.0171054938328542,0.00559977051700244,-0.028081044046179,-0.00612994361952945,0.00225552548542284
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,27910,0.0101719830759014,0.0033493930913609,0.00360717261683402,0.0167367935349687,0.00239195386684582
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,23862,0.00832296716544709,0.00274072487001776,0.00295114642021229,0.0136947879106819,0.0023938138930548
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,23071,0.00682148773006125,0.00225297967099665,0.00240564757490782,0.0112373278852147,0.00246643689420516
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",27910,-0.0200947504366753,0.00663911820884878,-0.033107422126019,-0.00708207874733174,0.00247448477198071
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,28048,-0.00642062943865278,0.00213764286986827,-0.0106104094635946,-0.00223084941371098,0.00267039098386574
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,28224,0.0071024429157884,0.00236543329032194,0.00246619366675741,0.0117386921648194,0.00267921090546007
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,28176,-0.00779747250106433,0.00259812987460576,-0.0128898070552916,-0.00270513794683705,0.0026916526298192
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,28307,-0.0204383219104046,0.00682043400093954,-0.0338063725522461,-0.00707027126856309,0.00273217847175259
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,27544,-0.0151555794993649,0.00505961903322022,-0.0250724328044765,-0.00523872619425324,0.00274329586000006
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,28276,-0.0062127318504537,0.00207505462703519,-0.0102798389194427,-0.00214562478146472,0.00275576186324854
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,23872,-0.0188803893774025,0.00630602347306685,-0.0312401953846136,-0.00652058337019148,0.00275605920878445
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,23393,-0.0110616288761842,0.00369516171651032,-0.0183041458405444,-0.00381911191182393,0.0027604605916687
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,23725,-0.0194847460937588,0.00651195652341926,-0.0322481808796606,-0.00672131130785708,0.00277305775648675
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,23775,-0.00987449154565032,0.00330161466243159,-0.0163456562840162,-0.00340332680728441,0.00278526685782491
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,28029,-0.005425645072447,0.00181638318758018,-0.00898575612010415,-0.00186553402478986,0.00281918439043447
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,23775,-0.00555601608485382,0.00186754878878788,-0.00921641171087807,-0.00189562045882956,0.00293253216303793
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,28553,-0.00558701224752092,0.00187927431261189,-0.00927038990024022,-0.00190363459480162,0.0029518664913206
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,23056,0.0059347928248125,0.00199884244654646,0.00201706162958143,0.00985252402004356,0.00298966350186626
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,28224,-0.00919268952155263,0.00310842395295784,-0.01528520046935,-0.00310017857375526,0.00310555416036536
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23188,-0.00905464184404219,0.00306436861961867,-0.0150608043384948,-0.0030484793495896,0.00313171378516215
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,23056,0.0125479867811045,0.00425097361425483,0.004216078497165,0.0208798950650439,0.00316254767159164
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,28428,-0.00705674840494481,0.00239144355227566,-0.0117439777674051,-0.00236951904248453,0.00317177779542267
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,27562,-0.0155541225673431,0.00527450520731894,-0.0258921527736883,-0.005216092360998,0.00319148696380994
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,28176,0.00873418340465187,0.00296361186991024,0.00292550413962779,0.0145428626696759,0.0032098933925082
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,23056,0.00573648438824173,0.00194997618203071,0.00191453107146154,0.00955843770502193,0.00326611328207289
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,28176,-0.0138627094895469,0.00471317911108151,-0.0231005405472666,-0.0046248784318271,0.00327140587894299
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,27562,-0.00964488934049688,0.00328446312190192,-0.0160824370594247,-0.00320734162156911,0.00332192666649366
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,28391,-0.00569909005932619,0.00194623390093,-0.00951370850514899,-0.00188447161350339,0.00341129446856102
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,23738,-0.00528804920467958,0.00180637704316972,-0.00882854820929222,-0.00174755020006693,0.00342096354710445
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,27965,0.0119214028793456,0.00407354261564887,0.00393725935267386,0.0199055464060174,0.0034302663320726
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,23198,0.00503371927335767,0.00172031421503216,0.00166190341189463,0.00840553513482071,0.00343632704362576
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,23738,-0.00608866748154383,0.00208127755100768,-0.0101679714815189,-0.00200936348156878,0.00344287407829448
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,23469,-0.0112664719700408,0.00385531511285772,-0.018822889591242,-0.00371005434883967,0.00347763790789857
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,23393,-0.00890347255265268,0.00304872648114061,-0.0148789764556883,-0.00292796864961708,0.00349926698881445
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,23393,-0.00884318074169962,0.00302858363344883,-0.0147792046632593,-0.00290715682013992,0.0035047077547609
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,28411,0.00851216124107106,0.00292278202149353,0.00278350847894374,0.0142408140031984,0.00359000889119797
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,23071,-0.00888810966788145,0.00305302769618329,-0.0148720439524007,-0.00290417538336221,0.0036033706808089
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,28091,0.00674565548219353,0.0023174433076499,0.00220346659919972,0.0112878443651873,0.00360767340128575
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,27965,0.00701132660561443,0.00241789594224334,0.00227225055881749,0.0117504026524114,0.00373734978211423
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,28204,0.0375922714434098,0.0129667073986921,0.0121775249419732,0.0630070179448464,0.00374479061987076
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,23845,0.00374248699343325,0.00129532437683319,0.0012036512148402,0.0062813227720263,0.00386537450219532
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",23725,-0.0102685107460437,0.00355438422287842,-0.0172351038228854,-0.00330191766920197,0.00386855471647914
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,28521,0.0117172894315159,0.00407141734035582,0.00373731144441854,0.0196972674186133,0.00400580265891284
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,23337,-0.0102500620969388,0.00356292422819881,-0.0172333935842085,-0.00326673060966915,0.00402007951381737
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,23188,-0.0238844007695358,0.00832320835733968,-0.0401978891499216,-0.00757091238915009,0.00411343897541414
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,27544,-0.0221594920077731,0.00772482452543469,-0.0373001480776251,-0.00701883593792116,0.00412596052596872
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,28195,-0.0103306248278808,0.00360244610432264,-0.0173914191923531,-0.00326983046340839,0.0041381393699797
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,28187,0.0069803625501884,0.00243595224827575,0.00220589614356793,0.0117548289568089,0.00416582974024758
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,22878,-0.00866582176254063,0.00302921405941569,-0.0146030813189954,-0.00272856220608589,0.0042302424266515
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,28237,-0.00984725278832227,0.00344269614972575,-0.0165949372417847,-0.0030995683348598,0.0042350869171562
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,23056,0.00994134235371457,0.00347665944220464,0.00312708984699348,0.0167555948604357,0.00424754029461796
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,27682,-0.0113272154736875,0.00397725521760289,-0.0191226357001891,-0.00353179524718583,0.00440275995492433
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,28553,0.0049122901258408,0.00172657710260962,0.00152819900472594,0.00829638124695565,0.00444286286633848
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",27562,-0.00987914035747189,0.00347704229226925,-0.0166941432503196,-0.00306413746462417,0.00449702874954611
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,28266,-0.00743713322310663,0.00262105244722577,-0.0125743960196691,-0.00229987042654413,0.00455063273593177
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,23337,-0.0072219802183383,0.00254857673836199,-0.0122171906255278,-0.0022267698111488,0.00460475758352987
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,22744,-0.00909362256184979,0.0032097304072819,-0.0153846941601223,-0.00280255096357727,0.00461334505542529
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,23393,-0.0136202514299903,0.00480978315712262,-0.0230474264179506,-0.00419307644202996,0.00463291169011422
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,23393,-0.0113543022147485,0.00401088734579823,-0.019215641412513,-0.00349296301698392,0.00464611372973299
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,27544,-0.0165105826426711,0.00583253462039789,-0.0279423504986509,-0.0050788147866912,0.00464692780689653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,28091,-0.00448158855279975,0.00158324347196645,-0.00758474575785398,-0.00137843134774551,0.004648831384171
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,23725,-0.010601145373576,0.00374661266580665,-0.017944506198557,-0.00325778454859494,0.00466558746625065
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,23071,-0.0100713883751438,0.00356234703955089,-0.0170535885726635,-0.00308918817762404,0.00470006868659017
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,23543,-0.0060816926764818,0.00215191405334482,-0.0102994442210377,-0.00186394113192595,0.00471467421712133
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,27905,-0.0054922042407301,0.0019457319694432,-0.00930583890083877,-0.00167856958062143,0.00476558358831884
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,28307,-0.00652982132106818,0.00231367250784428,-0.011064619436443,-0.0019950232056934,0.00477174400406081
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,23775,-0.00819519052042152,0.0029039122246636,-0.0138868584807622,-0.00250352256008086,0.00477468383589173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,27702,-0.0085999800560776,0.00304743682692214,-0.014572956236845,-0.00262700387531021,0.00477536359605536
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,23056,0.017693338465079,0.00630722469132298,0.00533117807008599,0.0300554988600721,0.00503197761313629
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,27544,-0.00748213692399571,0.00266817049946058,-0.0127117511029384,-0.00225252274505297,0.00504738033642848
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,23071,-0.00883956755859205,0.00316415476217527,-0.0150413108924556,-0.00263782422472853,0.0052158481399779
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,28471,0.00692197665887603,0.00248076503649673,0.00205967718734244,0.0117842761304096,0.00527009529157471
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,28176,-0.00657438208311762,0.00235655578193538,-0.011193231415711,-0.00195553275052428,0.00527717063776483
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,23071,0.00605901436324487,0.00217187785227357,0.00180213377278869,0.0103158949537011,0.00527906821599208
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,23846,-0.0125772918853792,0.00451054045448664,-0.0214179511761731,-0.00373663259458541,0.00530074198189631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,28187,-0.00880036845794057,0.00315940703656955,-0.0149928062496169,-0.00260793066626424,0.00534892806102753
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,23393,-0.00710714353280984,0.00255203144334773,-0.0121091251617714,-0.00210516190384829,0.00535878692744179
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,27702,0.00716702763409853,0.00257752522896877,0.00211507818531974,0.0122189770828773,0.00542977180411035
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,23795,-0.0130038349094387,0.00467928155124043,-0.02217522674987,-0.00383244306900748,0.00545653085439577
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,23056,0.00825153822141539,0.00297010948436587,0.00243012363205828,0.0140729528107725,0.0054706312257648
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,28176,-0.0117751352864012,0.00425013919082835,-0.0201054081004247,-0.0034448624723776,0.00560019346440261
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,28187,0.00997265065188438,0.00362153254768451,0.00287444685842273,0.017070854445346,0.00589617033238203
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,27872,-0.00486025509914334,0.00176748477713779,-0.00832452526233341,-0.00139598493595327,0.00596674775760228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,28215,0.0074026110986846,0.00269919443804929,0.002112190000108,0.0126930321972612,0.00610070774575687
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,28428,-0.0050867272598903,0.00186468079497052,-0.00874150161803252,-0.00143195290174807,0.006377139290119
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,28091,-0.0154223809361326,0.00567781607488328,-0.0265509004429038,-0.00429386142936133,0.00660660010386899
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,23071,0.00672091121104047,0.00247444128390711,0.00187100629458254,0.0115708161274984,0.00660986424582628
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,23163,-0.00884192985599244,0.00325665993350248,-0.0152249833256573,-0.00245887638632758,0.00663188667005843
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,28411,-0.00570297315676824,0.00210805687019751,-0.00983476462235537,-0.00157118169118112,0.00682788659886995
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,22978,-0.00674995586756079,0.00249601757565345,-0.0116421503158416,-0.00185776141928003,0.00685009096128539
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,23071,-0.00901007224965917,0.00334150339438015,-0.0155594189026443,-0.00246072559667408,0.00701416584144452
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,28070,-0.014698120719807,0.00545462468619969,-0.0253891851047584,-0.00400705633485559,0.00705116751149211
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,27544,-0.00948450180889402,0.00353090312389635,-0.0164050719317309,-0.00256393168605718,0.00723260515271057
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,23198,0.00704152900312835,0.0026239246147698,0.00189863675817955,0.0121844212480771,0.00728888113830797
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",23056,-0.00596924241039017,0.00222703065218702,-0.0103342224886767,-0.0016042623321036,0.00735954708381868
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",23846,-0.009354276244931,0.0034976484766298,-0.0162096672591254,-0.00249888523073659,0.00749036241689284
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,23738,-0.0102192402888923,0.00382473693826022,-0.0177157246878823,-0.00272275588990222,0.00754790054525975
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,28362,-0.0151223494327146,0.00568450638693997,-0.0262639819511169,-0.00398071691431224,0.00781208431270532
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,23862,0.00611765244770077,0.00230235772966991,0.00160503129754775,0.0106302735978538,0.00788626946844329
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,23393,-0.0158495580792118,0.00597824500640429,-0.0275669182917642,-0.00413219786665944,0.00802590085169927
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,28126,-0.00601159616822367,0.00227185405843618,-0.0104644301227586,-0.00155876221368875,0.00814665008593934
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,23163,-0.0110273000989825,0.00417157517054361,-0.019203587433248,-0.00285101276471707,0.00821240956159117
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,22978,-0.0053375307285603,0.00202488358599569,-0.00930630255711186,-0.00136875890000875,0.00839537537045393
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",23198,-0.0154617955405768,0.00586802609576308,-0.0269631266882725,-0.00396046439288122,0.00842123907393075
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,23775,-0.0172043576421278,0.00652992099275292,-0.0300030027879236,-0.00440571249633211,0.00842672543773852
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,27871,-0.012205876019512,0.0046499841894141,-0.0213198450307636,-0.00309190700826036,0.00867144804927269
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,23725,-0.00943244843272651,0.0036060271477414,-0.0165002616422997,-0.00236463522315336,0.00890893516757562
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,28176,-0.0116424864511669,0.00445389605235833,-0.0203721227137892,-0.00291285018854458,0.00895365226190008
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,23188,-0.00859489585424731,0.00328962914567644,-0.0150425689797731,-0.00214722272872148,0.00898815609434349
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,23056,0.00597320443064309,0.00229585229415535,0.00147333393409861,0.0104730749271876,0.00928122009534093
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,28187,-0.00434730722436523,0.0016717063415054,-0.00762385165371581,-0.00107076279501466,0.00931309610121668
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,27544,-0.0122361119986663,0.00470838410185387,-0.0214645448382998,-0.00300767915903268,0.00936022507968728
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,23056,0.00684247344460048,0.00263387760880715,0.00168007333133846,0.0120048735578625,0.00938634820546353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,27965,-0.0053410535576956,0.00205724207329333,-0.00937324802135054,-0.00130885909404067,0.00943049361505626
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,28176,-0.0146869421268053,0.00565965672377638,-0.0257798693054071,-0.00359401494820363,0.00946334913689043
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,23071,0.00605988709054679,0.0023437220058078,0.0014661919591635,0.0106535822219301,0.00972753131499232
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,23795,-0.00536620580115349,0.00207613710746043,-0.00943543453177594,-0.00129697707053105,0.00975208194120935
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,28176,0.0108864714291491,0.00422202859392333,0.00261129538505938,0.0191616474732388,0.00992825827961581
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,27544,-0.0118852540167751,0.00465177887149576,-0.0210027406049068,-0.0027677674286434,0.010624377766701
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,28031,0.00677434004392727,0.00265886951703357,0.00156295579054148,0.0119857242973131,0.0108449075053474
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,28307,-0.00796828681273516,0.00312878473236817,-0.0141007048881768,-0.00183586873729356,0.0108778379199724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23071,0.00453644491446961,0.00179000140457889,0.00102804216149498,0.00804484766744425,0.0112729850408207
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,23725,-0.0064441563470872,0.00254713763572439,-0.011436546113107,-0.00145176658106741,0.0114139719543171
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,27544,0.00785699200672565,0.00310605554279511,0.00176912314284724,0.0139448608706041,0.0114256964548225
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,28091,-0.00935605277394322,0.00370017495462317,-0.0166083956850046,-0.0021037098628818,0.0114591260489699
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,28224,-0.0118104875973405,0.00467813534949458,-0.0209796328823499,-0.00264134231233112,0.0115879690023221
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,23188,-0.00709386858947296,0.00281368232462086,-0.0126086859457298,-0.00157905123321607,0.0117020368700031
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,23198,-0.0150635873375009,0.00597500359732798,-0.0267745943882637,-0.00335258028673805,0.0117054774440541
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,28336,-0.00538228829829244,0.00213797945856968,-0.00957272803708902,-0.00119184855949587,0.0118257454004622
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,28553,0.00395605976626245,0.00157270904110566,0.00087355004569536,0.00703856948682955,0.0118937395765562
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,23725,-0.00469163784903332,0.00186849626625397,-0.00835389053089111,-0.00102938516717553,0.0120484195637132
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,27965,-0.0121326237090637,0.00483223361699825,-0.0216038015983803,-0.00266144581974716,0.0120524379978573
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,23071,-0.0155869222353088,0.00621791937897874,-0.0277740442181071,-0.00339980025251049,0.012190663033104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,28091,0.0113708568700416,0.00454663588840236,0.00245945052877299,0.0202822632113103,0.0123921182618263
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,23769,0.0032965561051429,0.00132078150181076,0.000707824361593812,0.00588528784869198,0.0125700570105572
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",23163,-0.00676713493757387,0.00271136379474355,-0.0120814079752712,-0.00145286189987652,0.0125727680277411
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,23198,-0.00698369574979513,0.00279896981948443,-0.0124696765959846,-0.00149771490360564,0.012599239198565
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,27702,-0.00971450060139379,0.00389634638563552,-0.0173513395172394,-0.00207766168554818,0.0126643562371845
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,27965,-0.00703249688599932,0.00282478319869248,-0.0125690719554366,-0.00149592181656207,0.0127955228730293
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,27544,-0.0103038074478196,0.00415161901989646,-0.0184409807268166,-0.00216663416882252,0.0130751593069253
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,27562,-0.00815814200902789,0.00328788399707271,-0.0146023946432904,-0.00171388937476538,0.0130972790667157
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,23056,-0.00848077396740402,0.00342553244838489,-0.0151948175662384,-0.00176673036856963,0.0133026652046257
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,23700,-0.0119952647585995,0.00484570620328037,-0.021492848917029,-0.00249768060016994,0.013314077276816
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,27702,0.00491117339740624,0.0019872321110386,0.00101619845977058,0.00880614833504191,0.0134658539548045
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,23188,-0.00515963142640674,0.00208827760317762,-0.00925265552863487,-0.00106660732417861,0.0134897910583235
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,27562,-0.00865503572929652,0.00350632516550254,-0.0155274330536815,-0.00178263840491155,0.0135776367457663
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,23163,0.0107786862224843,0.00436855668409411,0.00221631512165983,0.0193410573233087,0.0136195324334309
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",23071,0.00739293990858443,0.00299904751962853,0.00151480677011252,0.0132710730470563,0.0137048881834462
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,23071,0.00682349493087884,0.00277116055470815,0.00139202024365086,0.0122549696181068,0.0138112524158603
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,23071,-0.0102600456964876,0.00416860162632126,-0.0184305048840773,-0.00208958650889798,0.0138519609302636
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",23725,-0.00629279107484408,0.00256084834407845,-0.0113120538292378,-0.00127352832045033,0.0140053996757079
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,23795,-0.00762779960969379,0.00312260515243416,-0.0137481057084647,-0.00150749351092283,0.0145823334925084
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,23738,-0.00432435565608875,0.00177408401928417,-0.00780156033388573,-0.000847150978291771,0.0147959118022236
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,28428,-0.00529359387386015,0.002175188032071,-0.00955696241671931,-0.00103022533100099,0.0149545581263538
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,23703,-0.0146452393982395,0.0060432186366761,-0.0264899479261247,-0.00280053087035438,0.0153827032022938
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,27544,-0.00931378812012895,0.00384689139876262,-0.0168536952617037,-0.00177388097855422,0.0154791640734983
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,28080,0.0057305215122784,0.00236760912833737,0.00109000762073717,0.0103710354038196,0.015510461958988
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,23337,-0.0106265584764181,0.00439131781590557,-0.019233541395593,-0.00201957555724318,0.0155322859312636
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,23846,-0.017659322814108,0.00730078186302001,-0.0319688552656272,-0.00334979036258875,0.0155781166083834
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,27520,-0.0145252341911169,0.00600838945082571,-0.0263016775147353,-0.00274879086749853,0.0156343302523398
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,23165,0.0116141545738375,0.00481526215085399,0.00217624075816366,0.0210520683895113,0.0158753391336494
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,23235,0.00570891137047402,0.00236750510474691,0.00106860136517007,0.010349221375778,0.0159007846930802
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,23862,0.00548324141020602,0.00227437748356679,0.00102546154241512,0.00994102127799692,0.0159217839462555
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,28156,0.0100447424463365,0.00418524351291527,0.00184166516102255,0.0182478197316504,0.0163998363038639
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,23725,-0.0110081844802083,0.00461102710076153,-0.0200457975977009,-0.00197057136271566,0.0169776221763332
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23071,-0.0075427677679407,0.00316822862822587,-0.0137524958792634,-0.00133303965661799,0.0172853955312227
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,23725,-0.00735401776005664,0.00309126752231146,-0.0134129021037871,-0.00129513341632619,0.017369184191151
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,28182,-0.00795921461940857,0.00334570267700151,-0.0145167918663315,-0.00140163737248561,0.0173692840006851
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,27702,0.0079492878188423,0.00334399155211823,0.00139506437669057,0.014503511260994,0.0174520708321604
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,22978,-0.00977344080078256,0.00411481727041296,-0.017838482650792,-0.00170839895077315,0.017548450811624
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,23337,0.00866862509193432,0.00365033349465206,0.00151397144241627,0.0158232787414524,0.0175689373164552
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",28553,-0.00477996115017424,0.00201491705952223,-0.00872919858683781,-0.000830723713510668,0.0176849532339883
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,27682,-0.00937103722798052,0.00395110668470504,-0.0171152063300024,-0.00162686812595864,0.0177108687930992
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,28428,-0.0128816115374575,0.00544085726386642,-0.0235456917746357,-0.00221753130027936,0.017911981272221
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,27702,0.0133195214300705,0.00563137385032902,0.00228202868342559,0.0243570141767153,0.0180254956280565
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,28307,-0.0116237116693037,0.00492065993174179,-0.0212682051355176,-0.00197921820308974,0.0181722868440952
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,27682,-0.00994664851722988,0.00421147399501001,-0.0182011375474495,-0.00169215948701026,0.0181934625992079
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,23738,-0.00485194361114776,0.00205464664532437,-0.00887905103598352,-0.00082483618631199,0.0182117022993723
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,28082,-0.0127829375458441,0.00541585606692304,-0.0233980154370132,-0.0021678596546749,0.0182679399709297
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,27863,0.00543676079070604,0.00230348197832888,0.000921936113181432,0.00995158546823065,0.0182701736331598
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,28291,0.00381110893900212,0.00161644444887004,0.000642877819216847,0.00697934005878739,0.0183947714373896
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,23795,-0.00358405107329656,0.00152021266894118,-0.00656366790442128,-0.000604434242171841,0.0184016293041296
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,23337,-0.0154355666251238,0.00655002837450173,-0.0282736222391472,-0.00259751101110038,0.0184530686300406
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,23188,-0.0141031903796484,0.0059919173032407,-0.0258473482940002,-0.0023590324652966,0.0185957870262141
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,27965,-0.00989785241647997,0.00421757811558276,-0.0181643055230222,-0.00163139930993777,0.0189418742878078
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,28224,-0.0093422979197145,0.00398326144575651,-0.0171494903533973,-0.00153510548603174,0.0190141224549341
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,28176,-0.0148092689986724,0.00633116156802311,-0.0272183456719977,-0.00240019232534714,0.0193368116732119
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,23071,-0.00766705510930553,0.00328917071241718,-0.0141138297056432,-0.00122028051296785,0.0197619635677732
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,23071,-0.0118522986850957,0.00509895467696506,-0.0218462498519472,-0.00185834751824419,0.0201096775298383
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,23071,-0.00815206620362537,0.00352194377545001,-0.0150550760035074,-0.00124905640374334,0.0206408487237573
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,23795,-0.00711269237481215,0.00307652112736399,-0.0131426737844456,-0.00108271096517873,0.0207902046941645
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,23056,-0.00700479438175684,0.00304164048339509,-0.0129664097292112,-0.00104317903430245,0.0212896237801695
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,27682,-0.00980703270820504,0.00426369534595055,-0.0181638755862681,-0.00145018983014196,0.0214485384518649
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,23071,0.00633814017646337,0.00278025715546732,0.000888836151747421,0.0117874442011793,0.0226348364817372
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,28319,-0.017632053877851,0.00774041459910822,-0.0328032664921031,-0.00246084126359889,0.0227386982782169
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,23893,0.00492852259554594,0.00216554252665429,0.000684059243303526,0.00917298594778835,0.0228617964896686
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,22614,-0.0169400931492482,0.00745184067307951,-0.0315457008684841,-0.00233448543001238,0.023018873265419
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,23872,-0.0114191722712932,0.00502515327971979,-0.021268472699544,-0.00156987184304241,0.0230710513174053
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,27734,-0.00689504820862421,0.00303887991963536,-0.0128512528511095,-0.000938843566138902,0.0232793865925621
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,28404,-0.0104733563307758,0.00462775448951507,-0.0195437551302253,-0.00140295753132623,0.0236332468685827
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,23795,0.00730551680622127,0.00323036765119184,0.000973996209885256,0.0136370374025573,0.0237365315724982
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,22978,0.00406987471207087,0.00180364344814431,0.000534733553708017,0.00760501587043372,0.0240503183127809
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,23188,-0.00770690662211765,0.00341577272682203,-0.0144018211666888,-0.00101199207754647,0.0240629864330197
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,27126,-0.00490386224381805,0.00217815522880974,-0.00917304649228514,-0.000634677995350965,0.0243692458324286
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",23071,0.00742322698461617,0.00330176251688939,0.000951772451512965,0.0138946815177194,0.0245688989481619
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,28428,-0.0101162013376066,0.00452892647016486,-0.0189928972191297,-0.00123950545608348,0.0255114670380919
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,28176,-0.00374818502913556,0.00168025380694013,-0.00704148249073822,-0.000454887567532906,0.0257071610018692
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,28187,0.00522464007824598,0.00235018582750646,0.000618275856333325,0.00983100430015863,0.026218625606062
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,23393,-0.0133326820903865,0.00601713370815412,-0.0251262641583686,-0.00153910002240441,0.0267157399687519
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,23337,0.00390586375055349,0.00176409285856682,0.000448241747762517,0.00736348575334447,0.026832090544911
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,23862,-0.00933573833925586,0.004222951874312,-0.0176127240129074,-0.00105875266560433,0.0270651110014779
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,28070,0.00435381485721227,0.00197173993981112,0.000489204575182472,0.00821842513924207,0.0272447986547203
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,23795,-0.0176270065053536,0.00798565200181896,-0.0332788844289187,-0.00197512858178842,0.0273002004363045
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,28378,-0.00442890345875422,0.00200679109118911,-0.00836221399748487,-0.00049559292002357,0.0273249796983653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,23795,-0.0117747646608537,0.00533988071683444,-0.0222409308658492,-0.00130859845585819,0.0274593238033745
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,23738,-0.00914109468795814,0.00414853100043061,-0.0172722154488021,-0.00100997392711415,0.0275723821733516
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,23071,0.00822775096639175,0.00373487717881913,0.00090739169590626,0.0155481102368772,0.0276080661581379
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,23775,-0.00427903828766203,0.0019446581408981,-0.00809056824382231,-0.000467508331501744,0.0277876591006349
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,28143,-0.00393556300960236,0.00178948487086086,-0.00744295335648965,-0.000428172662715071,0.0278667333085538
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,28553,0.00623957278446363,0.0028424062156909,0.00066845660170946,0.0118106889672178,0.0281592289596848
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,27431,-0.00876373580451471,0.00399544284134627,-0.0165948037735534,-0.00093266783547602,0.0282845699645922
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,27544,-0.0123919099208253,0.00566949991777648,-0.0235041297596671,-0.00127969008198336,0.0288448719396863
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,28428,-0.00793509435857265,0.003633376672904,-0.0150565126374645,-0.000813676079680813,0.0289744469315893
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,23188,-0.00390968334363387,0.00179510027298332,-0.00742807987868117,-0.000391286808586569,0.0294179532099715
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,28144,0.0106596405834769,0.00489929357068208,0.00105702518493998,0.0202622559820137,0.0295822149029039
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,28091,-0.020180761832525,0.00931627068788254,-0.0384406523807748,-0.00192087128427521,0.0303054724524522
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23198,-0.00387488849917944,0.00179239232430771,-0.00738797745482256,-0.000361799543536329,0.0306397168160621
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,23163,-0.00975646413710344,0.00451507091334071,-0.0186060031272512,-0.000906925146955638,0.0307158996378144
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,28389,-0.00642021138513001,0.0029758705684279,-0.0122529176992487,-0.000587505071011323,0.0309810937961173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,23163,-0.0124783297140644,0.00579248601099822,-0.0238316022956209,-0.00112505713250793,0.0312326617724757
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,23733,-0.00570138093765285,0.00265407590695047,-0.0109033697152758,-0.000499392160029924,0.0317111058492125
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,27702,-0.00939134893799865,0.00437231160241242,-0.017961079678727,-0.000821618197270304,0.031729245100543
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,28320,-0.012989767352867,0.00605219324697602,-0.02485206611694,-0.00112746858879405,0.0318582505349145
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,28122,-0.00883211787087754,0.0041162068840633,-0.0168998833636416,-0.000764352378113477,0.031905988062772
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",23738,0.0151973910231192,0.00708989895047562,0.00130118908018702,0.0290935929660515,0.0320809283705705
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,27682,-0.0164213581070371,0.00766528876579648,-0.0314453240879982,-0.00139739212607604,0.032177945289716
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,28176,0.0069303610346783,0.00323682256267736,0.000586188811830672,0.0132745332575259,0.0322745264522866
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",28187,0.00558596510373911,0.00261233746191908,0.000465783678377723,0.0107061465291005,0.0325008574372541
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,28072,0.0102600237162462,0.0048058320482313,0.000840592901712863,0.0196794545307795,0.0327769181513839
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,28091,-0.00223125806977291,0.00104554325278979,-0.00428052284524089,-0.000181993294304918,0.0328460355928227
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,28521,-0.00381602427588957,0.00179088564316677,-0.00732616013649644,-0.000305888415282703,0.0331139184673235
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,28224,-0.0112368194332436,0.00527901172065313,-0.0215836824057237,-0.000889956460763473,0.0332973403952524
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,23163,-0.00527427061991826,0.00248183788320387,-0.0101386728709979,-0.000409868368838667,0.0335849001594274
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,28307,0.00351680690873475,0.00165715830332852,0.000268776634210859,0.00676483718325865,0.0338303415015413
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,23775,-0.00548002049380811,0.00258249585213061,-0.0105417123639841,-0.000418328623632109,0.0338492167487494
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,28120,-0.00597294973001998,0.00281976186906754,-0.0114996829933924,-0.000446216466647597,0.0341629776146831
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",22978,-0.013548215664664,0.00640424855414146,-0.0261005428307813,-0.00099588849854677,0.0343977211920171
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,28320,0.00628530310986203,0.00297564434691609,0.000453040189906487,0.0121175660298176,0.0346737946862515
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,28553,0.00381691292456991,0.0018072478200147,0.000274707197341094,0.00735911865179873,0.0346948522727
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23198,-0.00721911252217843,0.00342033393493129,-0.0139229670346438,-0.000515258009713096,0.0348134707895798
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,23198,0.0138959802767078,0.00659353999221271,0.000972641891970863,0.0268193186614447,0.0350837257674716
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,27702,-0.00601128745905301,0.00285420163734382,-0.0116055226682469,-0.000417052249859119,0.035203019390228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,27281,-0.00383805221429156,0.00182425561142828,-0.00741359321269098,-0.000262511215892141,0.0353962640936509
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,27562,-0.00453319995877959,0.00215467047797575,-0.00875635409561205,-0.000310045821947119,0.0353966667814976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,26395,0.00713223368701268,0.00339254814238174,0.000482839327944477,0.0137816280460809,0.0355343997021054
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,22936,-0.0126823515866893,0.00604779448260126,-0.0245360287725877,-0.000828674400790807,0.0360026507369756
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,28553,-0.00614954160941392,0.00293260626993737,-0.0118974498984912,-0.000401633320336675,0.0360063899641803
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,27528,-0.0157987796574493,0.00754801804271185,-0.0305928950211645,-0.00100466429373407,0.0363490896191982
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,23872,0.0208371487121731,0.00996250626577143,0.00131063643126112,0.0403636609930851,0.0364887188150721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,28320,-0.00381717538489149,0.00183062108867979,-0.00740519271870387,-0.000229158051079109,0.0370618569105748
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,28078,-0.00637585043944442,0.00305850737605789,-0.0123705248965179,-0.000381175982370953,0.0371120894048339
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,28152,-0.00253421757076392,0.00121735073120404,-0.00492022500392385,-0.000148210137603998,0.0373745005243955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,28521,-0.00559637271847352,0.00268881433308829,-0.0108664488113266,-0.000326296625620478,0.0374104773495919
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,28176,-0.00489301266546503,0.00235127149249127,-0.00950150479074792,-0.000284520540182145,0.0374422700020182
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,23738,0.00722713005782384,0.00348409262758938,0.000398308507748647,0.014055951607899,0.0380601723585313
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,23738,-0.00639413998009665,0.00308640698968752,-0.0124434976798842,-0.000344782280309104,0.0383032826015738
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,27489,-0.00688469132292333,0.00332609279691529,-0.0134038332048773,-0.000365549440969359,0.0384706991063478
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,23163,-0.0131655534004062,0.00636317221633888,-0.0256373709444304,-0.000693735856382041,0.0385549461131658
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,23188,0.00472775358941731,0.00228561744478229,0.000247943397644024,0.0092075637811906,0.0386059906824579
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,28320,-0.00478549887944017,0.0023144468921912,-0.00932181478813492,-0.000249182970745416,0.0386806799093772
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,28176,0.00523633791599955,0.0025376486603781,0.000262546541658483,0.0102101292903406,0.0390780337807781
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,23393,-0.0106447584449195,0.005174053622575,-0.0207859035451665,-0.000503613344672554,0.0396651375771054
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,27477,-0.0107606804463016,0.00523048711835294,-0.0210124351982733,-0.000508925694329787,0.0396668108040537
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,28428,0.00413566101195187,0.0020121461836862,0.000191854491926922,0.00807946753197682,0.0398545052502703
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,23893,0.00429948691975682,0.00209564140452715,0.000192029766883611,0.00840694407263002,0.0402162316987301
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,28521,0.00664812272343619,0.00324306619044193,0.000291712990169995,0.0130045324567024,0.0403784624050083
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,23163,0.00536968472118258,0.00262477813530248,0.000225119575989727,0.0105142498663754,0.0407905683051308
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,27434,-0.00997493953758316,0.00487998018814655,-0.0195397007063504,-0.000410178368815916,0.040957816014611
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23163,0.00587302681463939,0.00288167936083461,0.00022493526740355,0.0115211183618752,0.0415555751693277
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",27544,-0.007598888111818,0.00373111552711943,-0.0149118745449721,-0.000285901678663911,0.0416970507590139
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,28091,-0.00296245139314148,0.00145844158886256,-0.0058209969073121,-0.000103905878970857,0.0422396028111056
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,22978,-0.0082884584224934,0.00409101533715044,-0.0163068484833083,-0.000270068361678545,0.0427747858191229
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,23071,0.00655341631770757,0.00323861929950457,0.000205722490678615,0.0129011101447365,0.0430309046917156
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,23862,0.00336416985011156,0.0016691409053522,9.26536756212363e-05,0.00663568602460188,0.0438624562256177
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,27544,-0.00717115253251569,0.00356870370169943,-0.0141658117878466,-0.000176493277184801,0.0444985529708104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,23393,-0.00896528785598795,0.00447221792834153,-0.0177308349955373,-0.00019974071643856,0.0450106426215466
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,28187,0.00584736883685634,0.00292023532051447,0.000123707608647973,0.0115710300650647,0.0452553565465327
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,23725,-0.00668375284180443,0.00335797714435913,-0.0132653880447483,-0.000102117638860535,0.0465571996180536
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,23862,-0.00363530308302958,0.00182809296416195,-0.007218365292787,-5.22408732721489e-05,0.0467593545468703
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,23056,0.0105520451175242,0.00532723742346041,0.000110659767541826,0.0209934304675066,0.0476286692848167
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,22043,-0.00728648199010936,0.00368346521788751,-0.0145060738171689,-6.68901630498427e-05,0.0479231466560618
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,28268,-0.0162882543210866,0.00825437106454349,-0.0324668216075918,-0.000109687034581328,0.0484724484628889
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,28195,-0.00404542807483346,0.00205051988458089,-0.008064447048612,-2.64091010549229e-05,0.0485190821115672
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,23163,-0.00735506079248481,0.00372816845644847,-0.0146622709671238,-4.7850617845807e-05,0.0485262562647038
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,28194,-0.0127772161378293,0.00650358918353812,-0.025524250937564,-3.01813380945634e-05,0.0494656461784434
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,22936,0.00709813250735878,0.00361430921088822,1.4086454017871e-05,0.0141821785606997,0.0495540569718863
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,23775,-0.00498883938829114,0.00254451784988851,-0.00997609437407262,-1.58440250966948e-06,0.0499347209450037
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,23337,0.00290354647403694,0.00148200008813536,-1.17369870836605e-06,0.00580826664678225,0.0501003243317999
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,23163,-0.00371413998290658,0.00189639394050373,-0.00743107210629388,2.7921404807266e-06,0.0501801188015484
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,23188,-0.00747246680818259,0.00381566259439012,-0.0149511654931872,6.2318768220479e-06,0.0501989699656266
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,23775,0.00535994960754878,0.00273706289580138,-4.6936682219249e-06,0.0107245928833195,0.050208245894134
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,27652,-0.00577610324394427,0.00295372484422608,-0.0115654039386274,1.31974507388468e-05,0.0505303800755586
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,23056,-0.00640658227100682,0.00327827640091461,-0.0128320040167995,1.88394747858206e-05,0.0506833543847481
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,23393,-0.00976991344710943,0.00500025902213458,-0.0195704211304932,3.05942362743457e-05,0.0507271434779862
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,23738,-0.00675594097416841,0.00345910063658425,-0.0135357782218735,2.38962735367243e-05,0.0508204620448431
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",23775,-0.00739696397144216,0.00379524761202524,-0.0148356492910116,4.17213481273123e-05,0.0513063462187449
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",23163,-0.0113935893208149,0.00584670481942609,-0.0228531307668901,6.59521252602061e-05,0.0513409627428652
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,27702,-0.00501333413147988,0.00257700646699465,-0.0100642668067894,3.75985438296252e-05,0.0517357603032324
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,23163,0.00495233558442084,0.00255419679443302,-5.38901326678845e-05,0.00995856130150956,0.0525254903325639
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,23738,-0.00378949136512131,0.00195499714311016,-0.00762128576561722,4.23030353746013e-05,0.0525909705780733
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",22978,-0.00685864111885123,0.00353981610208878,-0.0137966806789452,7.9398441242772e-05,0.0526879632309553
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,28452,0.00222450046577111,0.00114820280818347,-2.59770382684938e-05,0.00447497796981071,0.0527092977872522
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,23846,-0.00986957188142119,0.00509624079592416,-0.0198582038414325,0.000119060078590163,0.0528014560620711
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,28452,-0.00431159231423093,0.0022319963694088,-0.00868630519827218,6.31205698103186e-05,0.0534039818523688
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,27562,-0.00408368342502321,0.00211760423194414,-0.00823418771963372,6.68208695873106e-05,0.053810054848892
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,23056,0.0120118991791432,0.00623611664623523,-0.000210889447477875,0.0242346878057642,0.0540938685902683
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,28187,-0.0161105775156377,0.00839142308531654,-0.0325577667628581,0.000336611731582726,0.0548823596057682
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,23188,0.00388311220443463,0.00202286283377057,-8.16989497556932e-05,0.00784792335862495,0.0549191639890008
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,23337,0.00477072918931525,0.00248534714323925,-0.000100551211433679,0.00964200959006419,0.054927913376977
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,22978,-0.00975483929571157,0.00508455399201087,-0.0197205651200529,0.000210886528629732,0.0550569750708809
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,23725,0.00554422664961967,0.00289147477222924,-0.000123063903949647,0.011211517203189,0.0551941780983508
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,28146,-0.00397405943648853,0.00208236705511216,-0.00805549886450837,0.000107379991531306,0.0563453535509258
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,27562,-0.00435683561442294,0.00228313640821087,-0.00883178297451625,0.000118111745670372,0.0563670005632509
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,23337,-0.004513186169274,0.00237216678467826,-0.00916263306724338,0.000136260728695384,0.0571104775443852
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,23188,-0.00403916651497753,0.00212736558670319,-0.00820880306491579,0.000130470034960727,0.0576202076618453
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",27682,-0.0110074442674446,0.00580534915817397,-0.0223859286174656,0.000371040082576367,0.0579590136177677
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,28210,-0.0123884621823969,0.00654998740691778,-0.0252264374999557,0.000449513135161962,0.0585849553828643
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,23071,0.0049274638486128,0.00260713189488497,-0.000182514665361746,0.0100374423625874,0.0587712828582437
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,23056,-0.0100152222789517,0.00530018377457922,-0.020403582477127,0.000373137919223597,0.0588241448725206
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,23056,-0.0110759582616957,0.00586778436677777,-0.0225768156205801,0.000424899097188715,0.0590938627191794
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,27702,-0.00565187408096944,0.00299955842563567,-0.0115310085952154,0.000227260433276484,0.0595436122036582
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,28264,0.00717745957856717,0.00381009082449251,-0.000290318437438144,0.0146452375945725,0.0596019223981947
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,27632,0.00683977194880294,0.00363610305184803,-0.000286990032819204,0.0139665339304251,0.0599726246626217
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,23872,-0.0031585533577386,0.00168327423351717,-0.00645777085543226,0.000140664139955056,0.0606078773151216
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,23393,-0.00454741035774265,0.00242518118415643,-0.00930076547868925,0.000205944763203948,0.0607940817117382
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,28187,0.00311154776363243,0.00166389934973941,-0.000149694961856821,0.00637279048912168,0.0614895083108742
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,23846,0.00356029120809505,0.00190574397381959,-0.000174966980591339,0.00729554939678144,0.061747899091414
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,27281,0.0110502836407943,0.00591562898826043,-0.000544349176196149,0.0226449164577847,0.0617754113224489
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,28195,-0.0381576320807544,0.0204623348812027,-0.0782638084479116,0.00194854428640293,0.0622234619456769
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,23725,-0.00513288149275393,0.00275362989676173,-0.0105299960904069,0.000264233104899063,0.0623281702821743
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,27702,0.00628600669823182,0.00337502668825692,-0.000329045610751748,0.0129010590072154,0.0625424155467563
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,23056,-0.00766903586744058,0.00412286380821252,-0.0157498489315371,0.000411777196655964,0.0628807869331359
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,28320,-0.0054555627194544,0.00293451583895109,-0.0112072137637985,0.000296088324889724,0.0630231260791425
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,27544,-0.00392689953619289,0.00211564813502624,-0.00807356988084432,0.000219770808458543,0.0634469496925668
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,23795,0.00419356331467917,0.00226051348476663,-0.000237043115463438,0.00862416974482177,0.0635889616096458
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,23795,-0.00346607113884808,0.00186850272710516,-0.00712833648397419,0.000196194206278031,0.0636087022976832
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,23071,0.0049335764861227,0.00266027056536197,-0.000280553821986753,0.0101477067942322,0.0636747920809774
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,23795,0.00457943749285509,0.00247351783409678,-0.000268657461974591,0.00942753244768478,0.0641263602944916
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,27951,0.00360626225326851,0.00195502019681127,-0.000225577332481581,0.00743810183901859,0.0651039435712969
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23163,0.0060525894522897,0.00328833973106406,-0.000392556420595847,0.0124977353251752,0.0656898069642646
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,27544,0.00922439013755273,0.00502706923296066,-0.000628665559050152,0.0190774458341556,0.0665247819352926
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,23738,-0.0187042673315544,0.0101947116476407,-0.0386859021609302,0.00127736749782144,0.0665622323351203
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,28176,-0.00438959542630012,0.00240253157024995,-0.00909855730399003,0.00031936645138979,0.0676996936847752
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,27702,0.00775216427319914,0.0042436504728609,-0.000565390653608219,0.0160697192000065,0.0677454414415861
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,27562,0.00405548276632916,0.00222737936159367,-0.000310180782394425,0.00842114631505275,0.0686569544080262
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,23188,-0.00488862923506643,0.00268911478172672,-0.0101592942072508,0.000382035737117937,0.0690873513295356
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,23071,-0.00558614876389451,0.00308598209703684,-0.0116346736740867,0.00046237614629769,0.070282614651939
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,23163,0.00470948973784353,0.00260219929838019,-0.000390820886981644,0.0098098003626687,0.0703380156643452
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,23893,0.00244979171425689,0.0013538733235569,-0.000203799999914647,0.00510338342842842,0.0703907515567103
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,23738,0.00581208573323821,0.00321346320459282,-0.000486302147763721,0.0121104736142401,0.0705153651492546
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,28082,-0.00535572054421943,0.00296248707543678,-0.0111621952120755,0.000450754123636663,0.0706411650542374
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,23071,-0.012267316562882,0.00679195370776841,-0.0255795458301081,0.00104491270434404,0.0709072715837173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,27831,0.00476166296779094,0.00263644857860472,-0.000405776246274313,0.00992910218185619,0.0709151132246232
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,23337,0.0116422226689507,0.00644679473628838,-0.000993495014174532,0.0242779403520759,0.0709479131750817
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,28291,-0.00345130714169235,0.0019159502318301,-0.00720656959607934,0.000303955312694642,0.0716575424564223
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,23188,-0.0039712001035901,0.0022121225180533,-0.00830696023897457,0.000364560031794365,0.0726350268471427
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,28224,-0.00356189848568501,0.00198430984575694,-0.00745114578336862,0.000327348811998603,0.0726593973351304
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,28176,0.00512436025261806,0.0028559778983914,-0.000473356428229085,0.0107220769334652,0.072782772895458
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,23738,-0.0213010584532354,0.011916470887178,-0.0446573413921042,0.00205522448563352,0.0738645028801626
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,28187,-0.00543293205470125,0.00304237596267348,-0.0113959889415413,0.000530124832138763,0.0741500094000767
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,28553,-0.0030645686866786,0.00172613684220341,-0.00644779689739729,0.000318659524040088,0.0758439204116671
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",23071,-0.0076902181886248,0.00434178896105971,-0.0162001245523018,0.00081968817505224,0.0765390648455393
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,27682,-0.00744556442829123,0.00420765014471269,-0.0156925587119281,0.00080142985534564,0.0768164315602918
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,23056,0.0072183344523119,0.00408428189534589,-0.000786858062566053,0.0152235269671898,0.0771837318596156
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,23163,0.00581175707508107,0.00328991382493588,-0.000636474021793257,0.0122599881719554,0.0773188449307056
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",27702,-0.0144099931611699,0.00816381329842179,-0.0304110672260766,0.00159108090373677,0.0775570292503457
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,28091,-0.0230364949388312,0.0130568950227994,-0.0486280091835179,0.00255501930585562,0.0776895844615839
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,22594,0.0084874379129712,0.00482877968853818,-0.000976970276563642,0.017951846102506,0.0788159293341546
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,28187,-0.00514240396066759,0.00293018365704321,-0.0108855639284723,0.000600756007137092,0.0792741667530367
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,23071,0.00617660650122601,0.00352035014950641,-0.000723279791806562,0.0130764927942586,0.0793507522417651
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,27682,-0.00590415038748028,0.00337095301255769,-0.0125112182920934,0.000702917517132783,0.0798746692971891
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,23846,-0.00367653853622169,0.00210347344993515,-0.00779934649809458,0.000446269425651193,0.0805043260129299
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,27109,0.00578664630057801,0.00331449731163904,-0.000709768430234498,0.0122830610313905,0.0808467193236388
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,23725,-0.00947073165517441,0.0054830058821655,-0.0202174231842188,0.00127595987386996,0.0841289303122951
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,28224,-0.00383285206616804,0.00222156509110528,-0.00818711964473439,0.000521415512398312,0.0844855239519544
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",23071,0.0047224444410411,0.00274493031329607,-0.0006576189730192,0.0101025078551014,0.0853687849899165
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,27968,0.00694457481510754,0.0040394317715208,-0.000972711457073228,0.0148618610872883,0.0855897652872546
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,27544,0.00388211170298887,0.00225979467980464,-0.000547085869428232,0.00831130927540597,0.0858252603786294
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,27702,-0.0135004741683839,0.00786293379969433,-0.0289118244157848,0.00191087607901703,0.0859946118791602
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,23393,-0.00619273059755806,0.00361408575777877,-0.0132763386828045,0.000890877487688332,0.0866341222208308
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",27702,-0.00853667924249621,0.00498225373029192,-0.0183018965538684,0.00122853806887596,0.0866470079389557
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,22978,0.00493283406115662,0.00290292895854316,-0.000756906697587971,0.0106225748199012,0.0892835552797407
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,23056,0.00725727968241511,0.00427452805114305,-0.00112079529782527,0.0156353546626555,0.0895596391134036
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,28115,-0.0102553099330364,0.00605528139480471,-0.0221236614668536,0.00161304160078079,0.0903497201807189
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,23056,0.00627709605791603,0.00371182922244898,-0.000998089218083966,0.013552281333916,0.0908301145350005
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,23738,-0.00803902663586731,0.00475426062128558,-0.0173573774535871,0.00127932418185243,0.0908671362098618
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,27965,-0.00593057586719159,0.00350770498111665,-0.0128056776301802,0.00094452589579704,0.0908998676745114
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,28252,-0.00264285185657075,0.00156364263011145,-0.0057075914115892,0.000421887698447698,0.0910028049354289
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,23056,0.00729655103330862,0.00432056711509817,-0.00117176051228379,0.015764862578901,0.0912723020591244
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,23071,0.00536376255999849,0.00317716878328702,-0.000863488255244068,0.0115910133752411,0.0913823671574493
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,23738,-0.0114255322897793,0.00677434555588782,-0.0247032495793194,0.00185218499976083,0.0916956816345355
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,22978,-0.0066703347388568,0.00396263888137083,-0.0144371069463436,0.00109643746863002,0.0923294164594756
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",28091,-0.00804084206323463,0.00479397076665523,-0.0174370247658789,0.00135534063940962,0.0934984333669379
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23163,-0.00633561934605988,0.00378027047627796,-0.0137449494795647,0.00107371078744492,0.0937576024719213
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,28061,-0.00286068636826558,0.0017086460173295,-0.00620963256223139,0.000488259825700236,0.0940942619979173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,23795,-0.0114580892059743,0.0068611006120037,-0.0249058464055015,0.00198966799355298,0.0949310482454605
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,23071,0.00684008408499613,0.0040985893591273,-0.00119315105889337,0.0148733192288856,0.0951532764906818
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,27773,-0.00636360388870256,0.00381522026667979,-0.013841435611395,0.00111422783398983,0.0953365548111401
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,23188,0.00462091792158442,0.00277303573139502,-0.000814232111949832,0.0100560679551187,0.0956522252368542
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,23056,-0.00978964176891581,0.00587583487797715,-0.021306278129751,0.00172699459191941,0.0957100303474709
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,23056,0.0081706609230169,0.00490696073542462,-0.00144698211841535,0.0177883039644492,0.0959031252230157
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,23163,-0.00870806072835407,0.00523046400680198,-0.018959770181686,0.00154364872497781,0.0959515361774817
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,27544,-0.0037385202801614,0.0022495629073783,-0.00814766357862285,0.000670623018300063,0.0965467362741531
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,23795,0.00783481618616932,0.00472703401787567,-0.001430170488867,0.0170998028612056,0.0974419912924145
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,23846,0.00403438111367056,0.00244831203806831,-0.000764310480943317,0.00883307270828444,0.0994024968348299
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,28091,-0.00216899897544112,0.00131826379825285,-0.00475279602001671,0.000414798069134475,0.0999098431286176
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,28452,-0.00520305601972639,0.00316712365585246,-0.0114106183851972,0.00100450634574443,0.1004284963027
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,23725,-0.00461344845975342,0.00280826304022059,-0.0101176440185858,0.000890747099078945,0.1004350788714
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,28553,-0.00296698904889305,0.00181301947260419,-0.00652050721519726,0.000586529117411171,0.101748009642877
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,23163,-0.00336854056739416,0.00206048684017431,-0.0074070947741358,0.000670013639347477,0.102098809194604
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,23188,0.00246589171275711,0.00151003875048974,-0.000493784238202781,0.00542556766371701,0.102482800317282
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",23188,-0.00327384870783039,0.00200718584052388,-0.0072079329552572,0.000660235539596418,0.102890389741678
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,23393,0.00493578456535683,0.00302820647163154,-0.000999500119040986,0.0108710692497546,0.103128368456145
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,23163,-0.00378400248111268,0.00232447939278898,-0.00833998209097908,0.000771977128753719,0.103561298931166
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23188,-0.00668353029059159,0.00410927541404298,-0.0147377101021158,0.00137064952093265,0.103867594733767
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,27562,0.0155876219679383,0.00958514253543459,-0.00319925740151347,0.0343745013373901,0.103912715334123
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,23163,0.00742919934753306,0.00456984689311914,-0.00152770056298045,0.0163860992580466,0.104027137245356
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,27702,-0.00438303027782078,0.00269709228568942,-0.00966933115777205,0.000903270602130486,0.1041537717093
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,27562,-0.0138847083453446,0.00855391795729555,-0.0306503875416439,0.00288097085095466,0.104558381776872
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,28195,-0.00296262050238999,0.00182734466484142,-0.00654421604547917,0.000618975040699189,0.104970767147524
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,23872,-0.00480872222183732,0.00296838993515522,-0.0106267664947416,0.00100932205106691,0.105250520987485
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,23163,-0.00676691526411095,0.00418358618734221,-0.0149667441913017,0.00143291366307977,0.105785845264103
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,23600,-0.00333990314416654,0.00206738958260897,-0.00739198672608013,0.000712180437747044,0.106212143654833
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,23846,-0.0108736452418055,0.00675113006275942,-0.024105860164814,0.00235856968120297,0.107271288215725
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,22978,-0.00872351919860387,0.0054337818893213,-0.0193737317016736,0.00192669330446588,0.108414465034068
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,27431,0.00337012025722277,0.00210275917824668,-0.000751287732140721,0.00749152824658625,0.109009469100856
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,27500,0.0100101914422791,0.0062509269465163,-0.00224162537289289,0.022262008257451,0.109301366245346
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,27682,0.00362505195696655,0.00226956740395793,-0.000823300154791001,0.0080734040687241,0.110222842542938
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,28199,0.010686573421753,0.00669784804296624,-0.00244120874246084,0.0238143555859668,0.110606448650167
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,27562,-0.00815578615793959,0.00515594027770206,-0.0182614291022356,0.00194985678635645,0.113701408012905
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,23337,-0.0027246269840348,0.00172247458643293,-0.00610067717344335,0.000651423205373746,0.11370658294012
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,23071,-0.00550272468082067,0.00348646728617008,-0.012336200561714,0.00133075120007268,0.114508226789801
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,23163,-0.0038509036864289,0.00244476074453747,-0.00864263474572234,0.000940827372864534,0.115231828114762
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,27544,0.00415336758389234,0.00263851994095657,-0.00101813150038254,0.00932486666816722,0.11546939836218
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,23188,-0.0114966965448111,0.0073103979330359,-0.0258250764935615,0.00283168340393923,0.115813559252182
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",23795,-0.00453109588254518,0.00289365250167365,-0.0102026547858255,0.00114046302073518,0.11739136950995
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,22978,-0.00398041372930167,0.00254912793438078,-0.00897670448068799,0.00101587702208466,0.118424185683059
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,23393,0.00329293480179915,0.00211498645663017,-0.000852438653195976,0.00743830825679428,0.119495147612112
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,23071,0.00549361725766513,0.00353156269445719,-0.00142824562347095,0.0124154801388012,0.119822466335816
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,27528,0.00603506222090336,0.0038865902125255,-0.00158265459564662,0.0136527790374533,0.120484580261308
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,28091,0.00388328084203833,0.00251005204709954,-0.00103642117027676,0.00880298285435342,0.121852391007148
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,23738,-0.0125945277900798,0.00814454770542788,-0.0285578412927184,0.00336878571255888,0.122027282870138
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,23393,0.00560498226573439,0.00364508193408495,-0.0015393783250721,0.0127493428565409,0.124139558397451
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,23775,0.00389417463476725,0.00253750155566765,-0.00107932841434134,0.00886767768387585,0.124883344182692
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,23846,-0.00281886549940673,0.00183722345826315,-0.00641982347760251,0.000782092478789045,0.124967327038521
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,23056,-0.00613180464995974,0.00401795731602838,-0.0140070009893754,0.00174339168945589,0.126998687915354
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,22978,-0.00671868923006263,0.00440361190149841,-0.0153497685569995,0.00191239009687426,0.127092790119132
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,28176,-0.0157914528741886,0.0103539931349734,-0.0360852794187365,0.00450237367035926,0.127231466932054
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,27176,-0.00675550586749067,0.00443274716660311,-0.0154436903140328,0.00193267857905142,0.127520399266416
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,23071,-0.00597825858159291,0.00392875673682488,-0.0136786217857697,0.00172210462258385,0.128106310699075
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,23872,0.00272554935072194,0.00179282234429416,-0.000788382444094615,0.00623948114553849,0.128459840154692
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,23731,-0.00391751485331606,0.00257910713241483,-0.00897256483284914,0.00113753512621701,0.128790356457712
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,23393,0.00436674746023384,0.00288234295360884,-0.00128264472883948,0.0100161396493072,0.129786108955959
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,23163,0.00326903766728217,0.00216266718991358,-0.000969790024948444,0.00750786535951279,0.130655193826405
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,23795,0.00368049122024317,0.00243692739188588,-0.00109588646785316,0.00845686890833951,0.130980200993357
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,27448,0.00468012663614409,0.00310216870670017,-0.00140012402898825,0.0107603773012764,0.131396483373456
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,27562,-0.00371479152528789,0.00246544944272239,-0.00854707243302378,0.00111748938244799,0.131888756565731
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,23846,-0.00548832563216953,0.0036439178137069,-0.012630404547035,0.00165375328269598,0.132039191237063
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,23056,-0.00767315176620734,0.00509876195213381,-0.0176667251923896,0.00232042165997493,0.132362239040273
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,23766,0.00491140413335517,0.00326609953134128,-0.00149015094807374,0.0113129592147841,0.132658496275802
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],27702,-0.00578766561561222,0.00385146517479443,-0.0133365373582093,0.00176120612698486,0.132923212404986
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,23725,-0.011391906035816,0.00759028822809396,-0.0262688709628802,0.00348505889124813,0.133406930224825
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,28320,0.00279571625047769,0.00186387209023045,-0.00085747304637399,0.00644890554732937,0.133638325839527
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,23188,-0.0030401002704016,0.00202873930012095,-0.00701642929863867,0.000936228757835463,0.134012607806406
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,28091,-0.00970271766850242,0.00648493613600246,-0.0224131924950672,0.00300775715806241,0.134614543238652
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,23775,0.00378202326134906,0.00253094927260912,-0.00117863731296482,0.00874268383566294,0.13510784495959
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,28091,-0.00402869493804639,0.00269662285859828,-0.00931407574089903,0.00125668586480624,0.13519263492992
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,23872,-0.00270560816984889,0.00181103809405088,-0.00625524283418861,0.000844026494490838,0.135200785983088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,28253,0.00381267195074214,0.00256181065188696,-0.00120847692695629,0.00883382082844058,0.136690251030535
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,28276,-0.00323717773985684,0.00217543052598528,-0.00750102157078798,0.0010266660910743,0.136745429164369
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,28195,0.0036809779688654,0.00248361914836718,-0.00118691556193427,0.00854887149966507,0.138324224455601
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,28187,-0.00811627535274511,0.00549424591622973,-0.0188849973485554,0.00265244664306517,0.13962466249361
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",27544,-0.00282778828708566,0.00191705289291757,-0.0065852119572041,0.000929635383032782,0.140205009759719
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,28377,0.00414451629821969,0.00281610509154129,-0.00137504968120124,0.00966408227764062,0.141107780419165
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,27562,0.00543678502090625,0.00371295943610946,-0.00184061547386829,0.0127141855156808,0.143130872800607
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,27562,-0.0104696258223224,0.0071523308978051,-0.0244881943820204,0.0035489427373756,0.143258336775218
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,23071,0.00366073281752528,0.00250419429574264,-0.00124748800213029,0.00856895363718085,0.14379853209284
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,23188,-0.00425543820275028,0.00291558227994952,-0.00996997947145133,0.00145910306595077,0.144427336104689
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,27516,0.0120747108258831,0.00827620933686514,-0.00414665947437256,0.0282960811261388,0.144585793567988
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,23893,0.00195524248382984,0.00134161641893499,-0.000674325697282738,0.00458481066494241,0.145025169123415
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,28411,0.00348169808751834,0.0023929155694871,-0.00120841642867636,0.00817181260371305,0.14567962853238
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,23393,-0.00229585252350378,0.00159373484906561,-0.00541957282767237,0.000827867780664814,0.149725638801626
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,23188,-0.00331384920818753,0.00230568618718693,-0.00783299413507391,0.00120529571869885,0.150660257945514
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,23163,-0.00512814949659731,0.0035740040111652,-0.0121331973584811,0.00187689836528649,0.151344165941572
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,23056,0.0076906132476651,0.00536084342180966,-0.00281663985908184,0.018197866354412,0.151417490413439
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,27965,-0.00605028940389309,0.00421771703386634,-0.0143170147902711,0.00221643598248494,0.151442553202577
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,27682,-0.00481648277886041,0.00336001583444009,-0.011402113814363,0.00176914825664215,0.151734791345403
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,23056,0.00300067015650256,0.00209462989864069,-0.00110480444483318,0.00710614475783831,0.151998940169065
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,28307,-0.00786250584796859,0.00548930521923784,-0.0186215440776747,0.00289653238173757,0.152059964192017
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",28176,-0.00816010643566186,0.00570000952636618,-0.0193321251073396,0.00301191223601585,0.152270793621601
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,28224,0.00280857145621656,0.00196983918288931,-0.00105231334224648,0.00666945625467961,0.153940847130872
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,28521,-0.00765419152700262,0.00536882657051122,-0.0181770916052046,0.00286870855119937,0.1539736792006
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,27500,0.00529635629600146,0.00371643164196695,-0.00198784972225376,0.0125805623142567,0.154134241655529
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,23893,0.00254684893256447,0.00178734185500353,-0.000956341103242437,0.00605003896837139,0.154188580815065
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23163,-0.00531776216415557,0.00373206430032344,-0.0126326081927895,0.00199708386447838,0.154203949113071
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",23071,0.00489837950417803,0.00344393477816402,-0.00185173266102345,0.0116484916693795,0.154946718435269
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23198,0.00755771514068428,0.00532269776087562,-0.00287477247063193,0.0179902027520005,0.155649334612676
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,27562,-0.00800603987152019,0.00564409526319978,-0.0190684665873918,0.00305638684435139,0.156061798970021
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,23373,0.00375480540354185,0.00265056645037181,-0.00144030483918689,0.0089499156462706,0.156611812480986
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,28428,-0.00457538401039019,0.00323156645550142,-0.010909254263173,0.00175848624239258,0.15683304803501
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,23549,0.00629604768344431,0.00445890530956283,-0.00244340672329884,0.0150355020901875,0.157958336526533
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,23188,-0.00165252957505574,0.00117177398099507,-0.00394920657780607,0.000644147427694594,0.158470401780389
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,23725,-0.00363196845757469,0.00257734674055187,-0.00868356806905635,0.00141963115390698,0.158792428814861
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",23337,-0.00863960179549153,0.00614664965559009,-0.0206870351204481,0.00340783152946503,0.159862490250398
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,22978,0.00396804450303362,0.00283577642196236,-0.0015900772840126,0.00952616629007983,0.161742618686089
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,23687,-0.00499057903619135,0.00357203401352648,-0.0119917657027032,0.00201060763032054,0.162388994722522
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,27544,-0.00656217674884439,0.00469981745905003,-0.0157738189685824,0.00264946547089366,0.162646855885941
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,23029,-0.00330647603425962,0.00237728877300365,-0.00796596202934677,0.00135300996082753,0.164281309127487
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,23319,0.00312145583142552,0.00224875558018985,-0.00128610510574659,0.00752901676859763,0.165125523599104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,23071,-0.00447415352768018,0.00322608829459251,-0.0107972865850815,0.00184897952972115,0.165495905761261
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,28187,0.0049815279375004,0.00360222313904685,-0.00207882941503143,0.0120418852900322,0.166705336104515
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23056,0.0062291173009764,0.00450811869968453,-0.00260679535040528,0.0150650299523581,0.16706021753141
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,23163,-0.00481162133590488,0.00348353479767442,-0.0116393495393467,0.00201610686753698,0.167216417894655
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,28195,-0.00222562028839415,0.00161204016342987,-0.00538521900871669,0.000933978431928387,0.167405750133896
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,23725,-0.00502412613807458,0.00364032865086218,-0.0121591702937645,0.00211091801761531,0.16755968818381
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,28068,0.00344661228397423,0.00250180646782141,-0.00145692839295573,0.0083501529609042,0.168322537558974
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,27544,-0.00365562571918688,0.00265788485666725,-0.00886508003825469,0.00155382859988092,0.169022054018004
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,23841,-0.010397151777368,0.00756275877465626,-0.0252201589756942,0.0044258554209583,0.169211675150121
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23163,-0.00985722094995117,0.00718107225301274,-0.0239321225658561,0.00421768066595379,0.169869188661677
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,28187,0.00263107064223078,0.00191832421458186,-0.00112884481834965,0.00639098610281122,0.170215616923276
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,23393,-0.00506681398803258,0.00369812441019441,-0.0123151378320136,0.00218150985594847,0.17066768539476
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,23393,-0.00677068376869237,0.0049521545463281,-0.0164769066794954,0.00293553914211072,0.171569564386791
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",22978,-0.00540140660372325,0.0039626510655936,-0.0131682026922867,0.00236538948484021,0.172870966752217
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,27702,-0.00356082115611165,0.00261302877175309,-0.00868235754874771,0.00156071523652442,0.172982508150606
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,27702,0.0031157071668866,0.00228691875882754,-0.00136665360041537,0.00759806793418857,0.173081517467511
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,28218,0.00204671837374854,0.00150296272575338,-0.000899088568728094,0.00499252531622517,0.173275305055429
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,28470,-0.00435646191463137,0.00321396190034872,-0.0106558272393149,0.00194290341005211,0.175275351518543
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,23056,0.00322042198970777,0.00237942872064156,-0.00144325830274969,0.00788410228216523,0.175927311521123
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",23071,-0.00365680472623744,0.002706623759749,-0.00896178729534548,0.0016481778428706,0.176690224458965
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,23370,-0.00921255931506172,0.00683188181620624,-0.0226030476748259,0.00417792904470252,0.177521672640526
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,28330,0.010458599209031,0.00775768506531595,-0.00474646351898828,0.0256636619370502,0.177617772598833
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,23071,0.00779071414695614,0.00577907589653147,-0.00353627461024555,0.0191177029041578,0.177642696271491
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",23071,0.00523302194563605,0.00389982896486352,-0.00241064282549644,0.0128766867167685,0.179654819463769
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,22978,-0.0133286403373917,0.00993933724217573,-0.0328097413320562,0.00615246065727267,0.179934072227653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",27544,-0.00499666348767674,0.00374687503427667,-0.012340538554859,0.00234721157950553,0.182360811560619
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,23725,-0.00417184637575813,0.00313615188634889,-0.010318704073002,0.0019750113214857,0.18345077526868
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,23163,-0.00719207048342179,0.00540664388246036,-0.0177890924930441,0.00340495152620052,0.18345618051817
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,23725,-0.00437691294165488,0.00329111033624665,-0.0108274892006983,0.00207366331738855,0.183557475407772
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,23725,0.00408481110037596,0.00307480047320866,-0.00194179782711302,0.0101114200278649,0.184032353935971
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,23071,0.00365719075447241,0.00275766068106247,-0.00174782418041004,0.00906220568935487,0.184788858317634
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,28496,-0.00348964222285639,0.00263501581356442,-0.00865427321744264,0.00167498877172987,0.185402620171666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,28187,0.003279100842418,0.00248422278472608,-0.00158997581564513,0.00814817750048112,0.186855585291027
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",23795,0.00333007675621131,0.00252551630093758,-0.00161993519362635,0.00828008870604896,0.18732471587292
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,27682,-0.00710880780988621,0.00541217180987679,-0.0177166645572447,0.0034990489374723,0.189030381707147
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,28553,-0.00512159698610659,0.0039019210152699,-0.0127693621760356,0.00252616820382242,0.189333901469169
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,23393,-0.00351241358273304,0.00267825861458368,-0.00876180046731704,0.00173697330185096,0.189717227312291
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,23795,-0.00323674690914515,0.00247575762712821,-0.00808923185831645,0.00161573804002615,0.191097573441312
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,23725,-0.00875182404291639,0.00670887529541973,-0.0219012196219391,0.00439757153610629,0.192070934283408
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,27562,-0.00365522984366701,0.00282312156827229,-0.00918854811748069,0.00187808843014667,0.195418169152701
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23198,0.00186831168530997,0.00144400715379451,-0.000961942336127275,0.00469856570674722,0.195734187445497
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,23337,0.00250014886730079,0.0019355907118234,-0.00129360892787308,0.00629390666247466,0.196483461007776
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23163,0.00282618356123511,0.00219016848873884,-0.00146654667669302,0.00711891379916323,0.196926262503152
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,23188,0.00384593808478977,0.00298215988223559,-0.00199909528439199,0.00969097145397154,0.19718559082279
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",23071,0.00542019596051124,0.00421813247220073,-0.00284734368500218,0.0136877356060247,0.198813829972682
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,23188,0.00385268074075916,0.00300634090594329,-0.00203974743488969,0.00974510891640801,0.200024515564405
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,27863,0.00352981767387352,0.00275545761036824,-0.00187087924244822,0.00893051459019527,0.200194585079749
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,23071,-0.00578485010926981,0.00451798042012098,-0.0146400917327069,0.00307039151416732,0.200415197570082
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,27562,-0.00490323793818864,0.00383023931185439,-0.0124105069894233,0.00260403111304597,0.200507105975453
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,23738,-0.00484017642869238,0.00378138111624557,-0.0122516834165337,0.00257133055914893,0.200556852024317
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,23893,-0.00273188081604357,0.00213599179396688,-0.00691842473221866,0.00145466310013151,0.200918171073593
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,23862,0.0122195831156875,0.00956573510389068,-0.00652925768793826,0.0309684239193132,0.201461951172714
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,23163,0.00256810211687895,0.0020148552736006,-0.00138101421937823,0.00651721845313613,0.202469348537913
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,22978,-0.00433952499682678,0.00340477267596655,-0.0110128794417212,0.00233382944806766,0.202484375368817
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,22978,0.00360635009815697,0.00283266826421676,-0.00194567969970787,0.00915837989602182,0.202985410115674
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,27702,-0.00551186923768175,0.0043315258562758,-0.0140016599159823,0.00297792144061881,0.203205997836797
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,28105,0.00432253447243185,0.00341166346897117,-0.00236432592675164,0.0110093948716154,0.205170315579375
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,28488,-0.00456870081059756,0.0036220439410855,-0.0116679069351251,0.00253050531393001,0.207189559720452
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,23056,-0.00417143533043897,0.00331251948013424,-0.0106639735115021,0.00232110285062415,0.207936978646648
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,23163,-0.00484229984369754,0.0038554684584969,-0.0123990180223515,0.00271441833495639,0.209144495410126
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,23056,0.00487532311695909,0.0038846569253508,-0.00273860445672848,0.0124892506906467,0.209484136246282
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,23393,-0.00602211581040855,0.00480757930077953,-0.0154449712399364,0.00340073961911933,0.210353091397742
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,28260,0.00264632899203519,0.00211877447817784,-0.00150646898519337,0.00679912696926374,0.211678934253788
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,28521,-0.00386057069271457,0.00309172355309392,-0.00992034885677866,0.00219920747134952,0.211792709462935
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,23071,0.00575361487678656,0.00460830633090886,-0.00327866553179481,0.0147858952853679,0.211849215873523
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,23795,-0.00593674375064529,0.00476225012398727,-0.0152707539936603,0.00339726649236977,0.212547025031244
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,23337,0.00279381149966557,0.00224121708174976,-0.00159897398056395,0.00718659697989509,0.212571406299937
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,27562,-0.00747984465651985,0.00600870364412669,-0.0192569037990082,0.00429721448596846,0.213202993943334
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,23071,0.0032061435980698,0.00257992592822969,-0.00185051122126039,0.00826279841739999,0.213981090300169
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,23684,-0.0034310529098406,0.00276555459830785,-0.00885153992252398,0.00198943410284279,0.214751699375658
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",27682,0.0037214196268495,0.0030117333931664,-0.00218157782375665,0.00962441707745565,0.216602730367138
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,23795,-0.00508710184983807,0.00412000499297493,-0.0131623116360689,0.00298810793639278,0.216942475998982
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23198,-0.00280385848599109,0.00227254092531872,-0.00725803869961579,0.0016503217276336,0.217290358102447
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,23775,-0.00644521411035337,0.00522514587123894,-0.0166865000179817,0.00379607179727495,0.217401715389381
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,22978,0.00378834154892407,0.00307200572966013,-0.00223278968120977,0.00980947277905792,0.217520567678195
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,23188,0.00412131082154283,0.00335014925239259,-0.00244498171314665,0.0106876033562323,0.21863948914144
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,27682,0.00424472256183868,0.00345357559484544,-0.00252428560405839,0.0110137307277357,0.219052062782895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,28176,-0.00441308748646463,0.00361059374543537,-0.011489851227518,0.00266367625458869,0.221619217697149
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,23725,0.00732568273330916,0.00601233208023135,-0.00445848814394428,0.0191098536105626,0.223067872020872
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,22978,-0.00221715662582766,0.00183027455829549,-0.00580449476008682,0.00137018150843151,0.225762552667442
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,27702,-0.00412024962898267,0.00340285831664352,-0.010789851929604,0.00254935267163863,0.225974652100932
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,23188,0.00457164798354559,0.00377785543786098,-0.00283294867466193,0.0119762446417531,0.226246252994545
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,23725,-0.00399217742858493,0.00330006305721428,-0.0104603010207249,0.00247594616355505,0.226395488497748
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,27702,-0.00242464112202171,0.00200463218808559,-0.00635372021066946,0.00150443796662604,0.226473766058382
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,23071,-0.00338677569630996,0.0028022850235027,-0.00887925434237525,0.00210570294975533,0.226838001238565
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,28320,-0.00235530764494637,0.001951859533803,-0.00618095233120025,0.00147033704130751,0.227558031183805
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,28390,-0.00339806156586984,0.00281766902125044,-0.0089206928475207,0.00212456971578103,0.227834014833552
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,28452,0.00282718305734654,0.00235163939976612,-0.00178203016619505,0.00743639628088813,0.229289113598857
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,27682,-0.00403990104091771,0.00336629636543599,-0.0106378419171722,0.00255803983533683,0.230109769105069
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23071,-0.00278901012186152,0.00232829853002127,-0.0073524752407032,0.00177445499698016,0.23097807738847
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,23188,-0.00339230246187323,0.00283331195068656,-0.00894559388521888,0.00216098896147242,0.231204907996006
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,23056,0.0028322088864496,0.00237085749503286,-0.0018146718038148,0.00747908957671399,0.232258527046989
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,28159,0.0105788175217044,0.00886347240422341,-0.00679358839057348,0.0279512234339823,0.23267204943255
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,22978,-0.00660852405966783,0.00554021428293105,-0.0174673440542127,0.00425029593487702,0.232948971624118
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,27702,0.00399986928297094,0.0033586585282377,-0.00258310143237495,0.0105828399983168,0.233698045776926
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,23725,-0.00362679462307036,0.00304641575953173,-0.00959776951175255,0.00234418026561184,0.233857121524708
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,22978,0.00381901107219745,0.00322011589461857,-0.00249241608125494,0.0101304382256498,0.235640258244167
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,23198,0.00147391124329526,0.00124289010196514,-0.000962153356556418,0.00390997584314693,0.235684156518038
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,28378,0.00590764613949657,0.00500032976090274,-0.0038930001918728,0.0157082924708659,0.237433391153476
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,28452,-0.00240324051837558,0.00203953674605561,-0.00640073254064457,0.00159425150389341,0.238676263638333
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,28428,-0.0022359250274646,0.0019090600664605,-0.00597768275772718,0.00150583270279799,0.241521085558245
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23198,0.00211373442252658,0.00180615567420466,-0.00142633069891456,0.00565379954396772,0.241894421514925
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,22978,-0.00270381530854679,0.00233589367285613,-0.00728216690734481,0.00187453629025123,0.247076965169908
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,28176,-0.00232582792884123,0.00200964803551955,-0.00626473807845955,0.00161308222077709,0.247146977110585
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,23071,0.00321916022756172,0.00278594448398291,-0.00224129096104477,0.00867961141616822,0.247897504225271
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,23725,-0.0044329018917534,0.00385021533791511,-0.011979323954067,0.00311352017056022,0.249604534596541
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,27702,-0.00337274139506777,0.00293093510266594,-0.00911737419629301,0.00237189140615747,0.249849555288762
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,23071,-0.00534021853349245,0.00464339170800857,-0.0144412662811892,0.00376082921420434,0.250127587443564
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,23893,0.00120459652435068,0.00104800398212114,-0.000849491280606758,0.00325868432930813,0.250394432846971
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,23188,0.0034107626217786,0.00297109921027349,-0.00241259183035745,0.00923411707391465,0.250988649644415
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,28268,0.00453163904688261,0.00396121075510802,-0.00323233403312911,0.0122956121268943,0.252631869145257
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,27682,-0.00477776813692562,0.00417789121341675,-0.0129664349152225,0.00341089864137122,0.252806234302469
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,28553,-0.00274005028237413,0.00240594221757277,-0.00745569702881675,0.00197559646406849,0.254767829024162
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,28336,0.0023758675840561,0.00208699180964715,-0.00171463636285231,0.00646637153096451,0.254955902416228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,23071,0.00398462975847377,0.00350233821008962,-0.00287995313330188,0.0108492126502494,0.255255260749925
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,23056,0.00338305527119973,0.00297836135026484,-0.00245453297531937,0.00922064351771882,0.256019421502796
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,23056,-0.00740417119655926,0.00652021461979221,-0.020183791851352,0.00537544945823347,0.256147670000313
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,23188,-0.00211071691289424,0.00186280704969594,-0.00576181873029829,0.00154038490450981,0.257190690992796
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,28553,-0.00214711794220367,0.00189672258842297,-0.00586469421551269,0.00157045833110536,0.257637745526953
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,23163,-0.00394014717258216,0.00348788642838477,-0.0107764045722163,0.00289611022705199,0.258628638354863
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,22978,0.0032376509244672,0.0028665980283879,-0.00238088121117307,0.00885618306010747,0.258723998745895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,23872,0.00220298660278871,0.0019540158035949,-0.0016268843722573,0.00603285757783472,0.259578425151485
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,23188,0.00207652604573796,0.00184257522398748,-0.0015349213932775,0.00568797348475341,0.259767053213311
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,27639,0.00438312201552475,0.00389465937465758,-0.00325041035880411,0.0120166543898536,0.260421479626669
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,23163,0.00295276405625576,0.00262372618907509,-0.00218973927433142,0.00809526738684294,0.260427590018675
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,28033,0.00173769758130388,0.00154600880172925,-0.00129247967008546,0.00476787483269321,0.261027131507227
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,23188,-0.00323024934553242,0.00287843705001043,-0.00887198596355287,0.00241148727248803,0.26177910277256
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",28195,0.00729702999748536,0.0065055745767051,-0.00545389617285662,0.0200479561678274,0.262017422932226
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,23056,0.00447191924721822,0.00398855326232039,-0.00334564514692974,0.0122894836413662,0.262219403841618
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,23872,0.00245959434850103,0.0022001783503838,-0.00185275521825121,0.00677194391525327,0.263618055157199
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,22978,0.00270737095711877,0.00242378570087824,-0.00204324901660258,0.00745799093084011,0.264005600811228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,27682,0.00241935216088254,0.00217430010755235,-0.00184227604992007,0.00668098037168515,0.265845296948696
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,23393,-0.00461406162025526,0.00415244359316872,-0.0127528510628659,0.00352472782235542,0.266507554792977
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,27682,-0.00415348550018472,0.0037416973740131,-0.0114872123532504,0.00318024135288096,0.266985478320209
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,23872,-0.00172172775260076,0.0015567382042271,-0.00477293463288588,0.00132947912768437,0.268744539331166
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,23845,-0.00112153042008837,0.0010194115969849,-0.00311957715017877,0.000876516310002027,0.271267307449893
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,22978,0.00312775878858819,0.00284534199381241,-0.00244911151928414,0.00870462909646052,0.271668014663041
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,23393,-0.00343106501741799,0.0031354932499038,-0.00957663178722943,0.00271450175239346,0.273849415948499
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,23862,-0.00190886014463629,0.00174593134399461,-0.00533088557886573,0.00151316528959315,0.2742647483541
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,23188,0.00161801005628549,0.0014832290743994,-0.00128911892953733,0.00452513904210831,0.27534144442551
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,27702,0.00451826008514574,0.00414640277392777,-0.00360868935175268,0.0126452095220442,0.275862772026958
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,23393,-0.0042104807049637,0.00386684285217756,-0.0117894926952317,0.00336853128530432,0.276223407532016
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,22978,0.00370140339999714,0.00341089167780038,-0.00298394428849162,0.0103867510884859,0.277856971354296
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,23188,-0.00304444656461188,0.00280891874160173,-0.00854992729815128,0.00246103416892752,0.278442590065085
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,28091,0.00326875002276149,0.00302786270510329,-0.00266586087924097,0.00920336092476394,0.280348824214208
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,23163,-0.00773480437780504,0.00716711087296419,-0.0217823416888149,0.00631273293320477,0.280506197153082
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,27985,-0.00369328010955129,0.0034253329984714,-0.0104069327865552,0.00302037256745264,0.280942599025764
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,28176,-0.00901189975886207,0.00836461099570246,-0.0254065373104389,0.00738273779271475,0.281317886606652
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,28224,-0.0036522112600253,0.00339502755286262,-0.010306465263636,0.00300204274358544,0.282046912941554
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,28320,0.00200337212190096,0.00186666895032249,-0.00165529902073112,0.00566204326453303,0.283175399593461
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,28036,-0.00416629068724436,0.00388263818464683,-0.0117762615291521,0.00344368015466342,0.283254944171271
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,27346,0.00495426221946558,0.00462689132231528,-0.00411444477227237,0.0140229692112035,0.284289526987297
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,27702,-0.00373114458494233,0.0034848703313539,-0.010561490434396,0.00309920126451132,0.284327367170107
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,23642,0.00533052153210722,0.00498724085774893,-0.00444447054908069,0.0151055136132951,0.285156394774213
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,28091,-0.00239887255354828,0.00224493599316177,-0.00679894710014534,0.00200120199304878,0.285272398559886
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",28121,-0.00500456925259167,0.00468847860684818,-0.0141939873220141,0.00418484881683076,0.285792022688923
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,23725,0.00409831998258356,0.00384008323760499,-0.00342824316312223,0.0116248831282893,0.28587086649733
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,22978,0.0048647703657531,0.00457188827370395,-0.00409613065070665,0.0138256713822129,0.287312021613553
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,23337,-0.00618792927599817,0.00582403806154125,-0.017603043876619,0.00522718532462267,0.288028419534971
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,27918,-0.00182733413449286,0.00172492999943389,-0.00520819693338328,0.00155352866439756,0.289441785330675
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",23775,-0.0043914009570567,0.00414752292013769,-0.0125205458805266,0.00373774396641318,0.28970123172357
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,22978,-0.00389772974837724,0.00368375750123655,-0.0111178944508009,0.00332243495404641,0.290027674461241
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,28176,-0.00874133738289015,0.00828357633606359,-0.0249771470015748,0.00749447223579448,0.291314896405545
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,28082,-0.00190251574890067,0.00180512401284619,-0.0054405588140792,0.00163552731627786,0.291913538708307
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,23056,0.00239359011498326,0.00227393585273818,-0.00206332415638358,0.0068505043863501,0.292526274148308
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,22978,0.00607167831363606,0.00576846738161145,-0.00523451775432239,0.0173778743815945,0.292552160524363
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,23725,-0.00287876264251422,0.00273552970516832,-0.00824040086464413,0.00248287557961569,0.292645036646959
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,23766,-0.00227644925470887,0.00216376817517139,-0.00651743487804479,0.00196453636862705,0.292775239453175
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,23188,-0.0047644657924905,0.00453292875619608,-0.0136490061546348,0.00412007456965382,0.293233311982857
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,28176,0.0022692945294013,0.0021590317414192,-0.00196240768378033,0.00650099674258292,0.293235239601614
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,28224,-0.00628771496306516,0.00599173518388348,-0.0180315159234768,0.00545608599734646,0.294003964863894
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,23725,-0.00417306885011497,0.0039804791861419,-0.0119748080549531,0.00362867035472316,0.294472621135115
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,23393,-0.00622555770146718,0.00594294528367265,-0.0178737304574656,0.00542261505453122,0.294854846046843
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,28091,0.00621045602672135,0.00592871679844426,-0.00540982889822941,0.0178307409516721,0.294868316454834
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,23188,0.00191347209300066,0.00182701903532433,-0.00166748521623504,0.00549442940223635,0.294963312110946
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,22978,-0.00501622848241041,0.00479694623188583,-0.0144182430969066,0.00438578613208581,0.295704618968192
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,23188,0.00216689560405817,0.00207823023836628,-0.00190643566313973,0.00624022687125608,0.29711486897252
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,23056,-0.00455295280522676,0.00438785738400655,-0.0131531532778796,0.00404724766742608,0.299455319946396
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,27562,-0.00413812172285383,0.0039906088414233,-0.0119597150520435,0.00368347160633583,0.299761267903308
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,28261,-0.00192219870240723,0.00185973612440711,-0.00556728150624517,0.00172288410143071,0.301338223563814
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],28091,-0.00404217827278568,0.00392451854499851,-0.0117342346209828,0.0036498780754114,0.303027948208639
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,23862,-0.00649658736907148,0.00630989273979301,-0.0188639771390658,0.00587080240092282,0.303214076972343
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,28237,0.00169716607210352,0.00165376896573962,-0.00154422110074614,0.00493855324495318,0.304786637165893
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,23287,-0.00216343583122673,0.00211269439873205,-0.00630431685274155,0.0019774451902881,0.305837698662328
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,23188,-0.00257062028566294,0.00251983481535596,-0.00750949652376062,0.00236825595243475,0.307665944075547
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,23056,-0.00396621775991105,0.00389316463866867,-0.0115968204517016,0.00366438493187954,0.308325499668588
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",22978,0.00342551154100268,0.00336644908792015,-0.00317272867132081,0.0100237517533262,0.308905224306219
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",23071,-0.00276535675214652,0.00272089281260903,-0.00809830666486021,0.00256759316056718,0.309477375028494
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,28336,-0.00193684065825414,0.00191465812843369,-0.00568957058998417,0.00181588927347588,0.311744859123002
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,28278,0.00196703936133207,0.00194479795098229,-0.00184476462259321,0.00577884334525735,0.311816284120011
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,23725,-0.00271574223066444,0.00268622738945114,-0.00798074791398867,0.00254926345265979,0.312032743601124
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,22978,0.00385898703065473,0.00382239049842387,-0.00363289834625605,0.0113508724075655,0.312709947641003
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,23393,-0.00448093758860945,0.00445495347059569,-0.013212646390977,0.0042507712137581,0.314506495681622
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,23188,-0.00432687684116571,0.00430296879593735,-0.0127606956812029,0.00410694199887149,0.314639613825342
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,23163,0.00298901442689602,0.00298892478818808,-0.00286927815795261,0.00884730701174464,0.317306447489514
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,23163,-0.00285877630745236,0.00286470627611442,-0.00847360060863663,0.00275604799373191,0.318323738975395
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,23872,-0.00169135304911772,0.00169609883279933,-0.00501570676140442,0.00163300066316897,0.318676612342233
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,23846,-0.00238380294546192,0.00239504792748595,-0.00707809688333438,0.00231049099241054,0.31959809911075
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,23071,0.00223402577686834,0.00225119375000364,-0.00217831397313879,0.00664636552687547,0.32102561130626
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,23846,-0.00269109084710167,0.00271607235749389,-0.00801459266778969,0.00263241097358635,0.321792165794506
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,23725,0.00356130760257484,0.00359663451227023,-0.00348809604147482,0.0106107112466245,0.322097331908858
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,28288,-0.0020366029759468,0.0020581538972256,-0.00607058461450898,0.00199737866261538,0.322412854378784
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,28093,-0.00492221683880569,0.00498384972324983,-0.0146905622963753,0.00484612861876397,0.323340694216895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23188,-0.00331011643026643,0.00335799374748604,-0.00989178417533906,0.0032715513148062,0.324269885210729
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,23284,-0.00759616838792648,0.00772180534824557,-0.0227309068704878,0.00753857009463484,0.325258715937325
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,22978,0.00207283194221603,0.00211207821380578,-0.0020668413568433,0.00621250524127535,0.32639690719925
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,27702,-0.00446052698385836,0.00454737128936036,-0.0133733747110047,0.00445232074328795,0.326649490887647
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,23056,-0.00750679351278947,0.00765904772168716,-0.0225185270472963,0.00750494002171736,0.327036684655799
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,23056,0.00324979296928689,0.00332483100194081,-0.00326687579451711,0.00976646173309088,0.328366072006694
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,27638,-0.00258139382190275,0.00265043913891943,-0.00777625453418483,0.00261346689037933,0.330090152245481
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,23795,-0.00250625621757889,0.00257637485939083,-0.00755595094198491,0.00254343850682714,0.330670565255012
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,28237,-0.00227004193061398,0.00233403458684918,-0.00684474972083837,0.00230466585961042,0.330769021976218
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,28224,0.00181086054559646,0.00187594180610402,-0.00186598539436741,0.00548770648556034,0.334399131153334
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,23071,0.00343853200893817,0.0035756356714359,-0.00356971390707619,0.0104467779249525,0.336232444122178
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,27682,-0.00155303294956461,0.00161906652429206,-0.00472640333717705,0.00162033743804782,0.337458810653406
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,23261,-0.00556099456281198,0.00580916427659137,-0.0169469565449311,0.0058249674193071,0.338436094752871
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,27910,0.00209862892609948,0.00220349212808722,-0.00222021564495147,0.00641747349715044,0.34089711447104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,22978,-0.00416187022742233,0.00439732998162449,-0.0127806369914063,0.00445689653656166,0.343927069980351
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,23188,0.00322054381494459,0.00340786169997114,-0.00345886511699885,0.00989995274688803,0.344651574639314
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,28224,-0.00224621702858426,0.00238181355462897,-0.00691457159565705,0.00242213753848852,0.34565314996767
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,23071,-0.00312021308569546,0.00331795152606477,-0.00962339807678242,0.00338297190539149,0.347020501352415
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,27702,0.00228579894227276,0.00243345028281014,-0.00248376361203511,0.00705536149658063,0.347572468831626
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,23348,0.00329131461212317,0.00350427085969953,-0.00357705627288791,0.0101596854971342,0.347622641521124
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,28224,-0.00275853816261858,0.00295250759007808,-0.00854545303917161,0.00302837671393445,0.35015535864034
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,23056,-0.00476645015298671,0.00510418644230072,-0.0147706555798961,0.0052377552739227,0.350400596123421
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,28091,-0.00551798714137294,0.00591430095265124,-0.0171100170085694,0.00607404272582348,0.350832849314612
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,22978,0.00281007667175181,0.00301680451168556,-0.00310286017115188,0.0087230135146555,0.351617927712977
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,27544,-0.00257790698327528,0.00276782216163869,-0.00800283842008711,0.00284702445353655,0.351662812815341
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,23337,-0.00261167052829458,0.00282711658593216,-0.00815281903672162,0.00292947798013246,0.355603654474774
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,23071,-0.00379701621503046,0.00411320680434871,-0.0118589015515539,0.00426486912149302,0.355950184102979
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,23071,-0.00253354816021388,0.00276341098429902,-0.00794983368943996,0.0028827373690122,0.359246995607316
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,23188,-0.00572046442038399,0.00625029799279606,-0.0179710484862643,0.00653011964549628,0.360080069784324
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,23071,0.00369828057870132,0.00404112764852965,-0.0042223296124168,0.0116188907698194,0.360116925023311
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,23188,-0.00238110525531248,0.00260664181995734,-0.00749012322242887,0.00272791271180392,0.361001650534758
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,28521,-0.00180488798034186,0.00197603462759683,-0.00567791585043163,0.00206813988974792,0.361045796589044
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,23188,-0.00549387624872514,0.00603325652171423,-0.017319059031285,0.00633130653383475,0.362516265477762
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,23056,-0.00253292179437626,0.0027857851352407,-0.00799306065944803,0.00292721707069551,0.363237791559879
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,23393,0.00379387492437241,0.00417986684475093,-0.00439866409133941,0.0119864139400842,0.364070149054157
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,22978,-0.00261575479617291,0.0028877082834199,-0.00827566303167592,0.00304415343933009,0.365038642688081
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,23795,0.00184672059667737,0.00204917780203303,-0.00216966789530737,0.00586310908866211,0.367490712418216
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,23738,0.00706959100907468,0.0078842716820002,-0.00838358148764572,0.0225227635057951,0.369904056070731
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,28320,0.00410593067571797,0.00458788148576205,-0.00488631703637565,0.0130981783878116,0.370820711152988
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,23188,0.00270325845880045,0.00302711584293458,-0.00322988859335134,0.00863640551095223,0.371858659950183
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,23188,-0.00569600717861185,0.00637959261129707,-0.0182000086967541,0.0068079943395304,0.371947791927986
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",27544,0.00309927033795808,0.00347349920150629,-0.00370878809699424,0.00990732877291041,0.372260471119535
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,28553,-0.00196308239338182,0.00220086449354919,-0.00627677680073823,0.00235061201397458,0.372422063495195
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,23163,-0.004288128524255,0.00481467484870588,-0.0137248912277185,0.00514863417920852,0.373133091908957
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,28224,-0.00246757411999561,0.00278874944431399,-0.00793352303085103,0.00299837479085982,0.376254910720108
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,23071,-0.00367808688033231,0.00415724234303132,-0.0118262818726737,0.00447010811200909,0.376305026802859
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,23393,0.00206626216273715,0.00234297129255496,-0.00252596157067057,0.00665848589614487,0.377840927982099
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,23071,0.00203833022644767,0.00232019482979588,-0.00250925163995226,0.0065859120928476,0.379672458566695
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,28276,-0.00304986843601667,0.00348627613830408,-0.00988296966709267,0.00378323279505932,0.381678609136146
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,23693,-0.00355389013040165,0.00406326421208864,-0.0115178879860954,0.00441010772529209,0.381779126438192
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,28152,-0.00278873084768553,0.00319828207304596,-0.00905736371085562,0.00347990201548456,0.383245006354683
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,28176,-0.00353565837036774,0.00406391083400642,-0.0115009236050203,0.00442960686428484,0.384300296446005
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,23872,-0.00156972933649048,0.00180637614990733,-0.00511022659030885,0.00197076791732788,0.38485936603976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,23188,0.00342796614003932,0.00394507171038172,-0.00430437441230885,0.0111603066923875,0.384897887599434
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,23393,0.00501676089021195,0.00578254838942146,-0.00631703395305412,0.016350555733478,0.385639117311084
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,23775,-0.00308731720620108,0.00356111458527886,-0.0100671017933476,0.00389246738094549,0.385976788615282
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",22978,-0.00327617453964735,0.00378105282325128,-0.0106870380732198,0.00413468899392515,0.38624069761907
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,28198,-0.00380967486412777,0.00440628328245881,-0.0124459900977471,0.0048266403694915,0.387265439698431
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,28307,0.00248310333525667,0.00287728197756828,-0.00315636934077715,0.0081225760112905,0.388143064491067
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,27682,0.00190598678930253,0.00221083538135295,-0.00242725055814924,0.00623922413675431,0.388633590083575
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,27544,-0.00405274305032224,0.00470966740025661,-0.0132836911548252,0.00517820505418072,0.389512290398692
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",28091,-0.00205383310390633,0.00239325474007835,-0.0067446123944599,0.00263694618664724,0.390802767911119
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,23163,0.0035014933909085,0.00409250603033457,-0.00451981842854725,0.0115228052103643,0.392235330239449
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,23393,-0.00236589666363044,0.00276673317414499,-0.00778869368495462,0.00305690035769373,0.392491922561371
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,28553,-0.00131649457497338,0.0015396992120145,-0.00433430503052181,0.00170131588057504,0.392539719281732
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,23056,0.00290898425869542,0.00340838232936936,-0.00377144510686853,0.00958941362425937,0.393402353765687
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23056,0.00188620353288368,0.00221092342041058,-0.00244720637112106,0.00621961343688842,0.393596476953881
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,23862,0.00155502164837527,0.00182277793085887,-0.00201762309610812,0.00512766639285866,0.393609439561887
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,23163,-0.00236020261673968,0.00277257311393527,-0.00779444592005281,0.00307404068657346,0.39462933267322
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,23393,0.00169126854776745,0.00198694753451286,-0.00220314861987775,0.00558568571541264,0.394672905001917
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,28187,0.00187128706339741,0.00219933603220485,-0.0024394115597241,0.00618198568651892,0.394864460755287
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,28174,0.00131237427708025,0.0015429538113026,-0.00171181519307284,0.00433656374723334,0.395021235255435
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23188,-0.00207979628387901,0.00244802739808074,-0.00687792998411726,0.00271833741635923,0.395567146663766
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,28091,-0.00183072025335876,0.00216519291366023,-0.00607449836413281,0.00241305785741529,0.397826141759148
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,23188,-0.00263658415824224,0.00312473337126323,-0.00876106156591818,0.0034878932494337,0.398801665143526
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,28187,-0.00333940658382338,0.0039886017644931,-0.0111570660422299,0.00447825287458309,0.402466238895523
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,23738,-0.0149894411691242,0.0179093881107985,-0.0500918418662892,0.0201129595280407,0.402623492540898
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,28320,-0.00246374327604038,0.00295415940789929,-0.00825389571552298,0.00332640916344223,0.404292918225857
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,23163,-0.00219199044883561,0.00263631495164868,-0.00735916775406702,0.00297518685639581,0.405722388071885
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,23163,-0.00363799548604726,0.0043769766045343,-0.0122168696309345,0.00494087865883997,0.40588825776182
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,28091,-0.00422798487568612,0.00509088759424271,-0.0142061245604018,0.00575015480902959,0.40626290663681
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,23337,-0.00183961445732503,0.00222124843081386,-0.00619326138172019,0.00251403246707013,0.407571707100154
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,23393,0.00237588363404167,0.00287192871217222,-0.00325309664181589,0.00800486390989922,0.408087915912607
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",23071,0.00493810556715014,0.00597383475535894,-0.00677061055335339,0.0166468216876537,0.4084596762545
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,28187,-0.00166443257350051,0.00201421018879975,-0.00561228454354802,0.00228341939654701,0.408615395856414
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,28307,0.00216213997063316,0.00261740740733407,-0.00296797854774161,0.00729225848900793,0.408776067123917
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,23795,-0.00352588218153038,0.00427214572923809,-0.011899287810837,0.00484752344777627,0.409198900610039
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,23056,-0.00673495030301916,0.00818077295612295,-0.0227692652970201,0.00929936469098183,0.410365397961323
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,27881,-0.00385584721158264,0.00468600114661004,-0.0130404094589383,0.00532871503577305,0.41060383940274
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,27544,-0.00326500331314439,0.00397612632807505,-0.0110582109161715,0.00452820428988272,0.411566914984362
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,23795,-0.0028217330818634,0.0034506117663093,-0.00958493214382962,0.00394146598010283,0.413508922865516
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,22978,0.0044414715159711,0.00548517372152878,-0.00630946897822531,0.0151924120101675,0.41810776555288
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,27562,0.00262216731263009,0.00325121271293187,-0.00375020960471639,0.00899454422997656,0.419950178783556
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,23393,-0.00247386084978361,0.00310254264410408,-0.0085548444322276,0.00360712273266038,0.425246816087696
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,23893,0.00102747265726318,0.00129278005603751,-0.00150637625257033,0.0035613215670967,0.426750770086669
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,22978,0.00167692778096943,0.00211536864286829,-0.00246919475905242,0.00582305032099129,0.427940142632715
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,23355,0.00290239884397103,0.0036628299115086,-0.00427674778258582,0.0100815454705279,0.428139921525994
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,28521,-0.000486901546155637,0.000616184093669365,-0.00169462236974759,0.000720819277436319,0.429424300603992
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,28553,0.00172545733110802,0.00218553010768413,-0.00255818167995287,0.00600909634216891,0.429831384708973
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,28428,-0.00161771399186978,0.00206994841357211,-0.0056748128824711,0.00243938489873155,0.434500984116979
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,23056,0.00186227444169963,0.00240212353665998,-0.00284588769015393,0.00657043657355319,0.438192975969895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,23393,-0.00264411548669894,0.00341927691675325,-0.0093458982435353,0.00405766727013742,0.439354638751874
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,23163,-0.00259679721600735,0.00336412345168228,-0.00919047918130462,0.00399688474928992,0.440176198058817
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,23071,-0.00243336594462909,0.00316573231001439,-0.0086382012722573,0.00377146938299912,0.442104147304335
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,23862,-0.00228641150315037,0.00298921138535843,-0.00814526581845289,0.00357244281215214,0.444345891557866
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,23071,0.00194907158383855,0.00255350642803665,-0.00305580101511329,0.00695394418279039,0.445296951936453
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,27840,0.00612725687943559,0.00804428469607433,-0.0096395411248701,0.0218940548837413,0.446251079813808
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,22978,-0.00460421606277351,0.00605001108733748,-0.016462237793955,0.00725380566840795,0.446649320088632
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,22978,0.0027943723439875,0.00367895562940364,-0.00441638068964363,0.0100051253776186,0.447527902943014
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,23393,-0.00346091350384338,0.00456682838086063,-0.0124118971303302,0.00549007012264346,0.448555947534233
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,23862,0.00132910099298415,0.00175516787295667,-0.00211102803801092,0.00476923002397922,0.448907540202632
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",23775,0.00133941162725276,0.0017723311218972,-0.00213435737166575,0.00481318062617127,0.449815936163472
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,27489,-0.00181020788476127,0.00240044144356916,-0.00651507311415683,0.00289465734463429,0.450786887747936
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,28305,-0.00200205048377435,0.00266405128076473,-0.00722359099407321,0.00321949002652452,0.452354451124739
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,27562,0.00185529253216083,0.00247491257445637,-0.00299553611377365,0.00670612117809531,0.453478180881387
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,23188,-0.00386567822470783,0.00517030340785187,-0.0139994729040975,0.00626811645468184,0.454667111906466
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,23653,-0.00145212424070014,0.00194441435702777,-0.00526317638047456,0.00235892789907428,0.455180670180755
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,28320,-0.00611671936582976,0.00823374308285759,-0.0222548558082306,0.0100214170765711,0.457557830668949
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,27965,-0.00182843794904116,0.00246414944068671,-0.0066581708527871,0.00300129495470479,0.458083965575237
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23198,0.00205430331571501,0.00277877014453448,-0.00339208616757258,0.0075006927990026,0.459741390465321
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,23725,-0.00388489128567014,0.0053001188799259,-0.0142731242903249,0.00650334171898463,0.463576705930366
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,27544,-0.00150999144853782,0.00206815150793194,-0.00556356840408442,0.00254358550700879,0.465325216158216
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,23188,-0.00377708266287084,0.00519902207651053,-0.0139671659328315,0.0064130006070898,0.467540455756733
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,28276,-0.00287623619636621,0.00396311239196644,-0.0106439364846204,0.00489146409188801,0.467996911946285
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,28553,-0.00085927945200235,0.00119015740659406,-0.0031919879689267,0.001473429064922,0.470307726114381
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,27702,0.00143293256067288,0.0019964853100029,-0.0024801786469328,0.00534604376827856,0.47293133249602
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,28199,0.00251971948538718,0.00351712369706703,-0.00437384296086419,0.00941328193163856,0.473741192161275
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,23071,0.00259982734467483,0.00363748533498918,-0.00452964391190396,0.00972929860125361,0.47478186666618
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,27791,0.00848043918133938,0.0118694229521935,-0.0147836298049599,0.0317445081676387,0.474937783841347
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,27702,-0.00321349690518366,0.00451504196506574,-0.0120629791567125,0.00563598534634518,0.476637148069484
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,23198,-0.00357771285491519,0.0050449928053373,-0.0134658987533763,0.00631047304354592,0.478231615854747
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,23188,-0.00279887404538382,0.00397474873872267,-0.0105893815732803,0.00499163348251261,0.481337868009318
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,23071,0.0023754503495947,0.00337951513336932,-0.00424839931180917,0.00899930001099856,0.482127166399725
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,28072,-0.00288001188397254,0.00409893920801724,-0.0109139327316863,0.00515390896374124,0.482296109991096
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,27965,-0.00207005342778116,0.00295818066876589,-0.00786808753856229,0.00372798068299997,0.484075226427481
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,23725,-0.00193217738370468,0.00276139885929167,-0.00734451914791635,0.00348016438050699,0.484115523389899
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,23795,-0.0076323499233987,0.0109448729447394,-0.029084300895088,0.0138196010482906,0.485593872646207
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23163,0.00238296726623377,0.00341778294894004,-0.00431588731368871,0.00908182184615625,0.485668347806006
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,28176,-0.00270300184923175,0.00387864852537539,-0.0103051529589675,0.00489914926050402,0.485875697876636
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,27682,-0.00109775088196278,0.0015811717137843,-0.00419684744098002,0.00200134567705445,0.48752237993433
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,23071,0.00165198676978409,0.00238919911879848,-0.00303084350306093,0.00633481704262911,0.489296316955053
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23136,-0.00183560307631233,0.00266965400348764,-0.00706812492314811,0.00339691877052345,0.491723642438348
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23163,-0.00369417587534506,0.00538719314635708,-0.0142530744422049,0.00686472269151482,0.492888388565088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,27544,0.00242563827880359,0.00353783886079442,-0.00450852588835347,0.00935980244596066,0.492954046807018
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,23393,-0.00798889329519689,0.0116559431015931,-0.0308345417743194,0.0148567551839256,0.493103216544868
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,23795,-0.00361328966073643,0.00528418598198105,-0.0139702941854193,0.00674371486394642,0.494112517031812
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,23071,-0.00522799958505756,0.00765618372390043,-0.0202341196839024,0.00977812051378729,0.494710594302099
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,23056,0.00276992728907508,0.00407261090263763,-0.00521239008009467,0.0107522446582448,0.496425495702619
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",27489,-0.00220224010666156,0.00324065208503595,-0.00855391819333203,0.00414943798000891,0.49678441707559
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,27544,-0.00681860917092139,0.0100534183861374,-0.0265233092077506,0.0128860908659078,0.497626579157631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,23140,-0.00203314752507769,0.00300981623784916,-0.00793238735126205,0.00386609230110667,0.499361390779976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,23188,-0.00267572802914074,0.00396727061434422,-0.0104515784332554,0.00510012237497393,0.500031612958058
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,22978,0.00140386836093133,0.00209159003374188,-0.00269564810520276,0.00550338482706542,0.502101971808917
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,23071,0.00222235352407971,0.00332111467745002,-0.00428703124372232,0.00873173829188174,0.503400805474097
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,28031,0.00132751352312141,0.00198427161347659,-0.0025616588392927,0.00521668588553551,0.503489477148932
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,22978,0.00278052499427004,0.00418005950199298,-0.00541239162963619,0.0109734416181763,0.505937000266659
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,23056,0.00262710082944031,0.00395672310638147,-0.00512807645906737,0.010382278117948,0.506723371956465
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,22978,-0.00290920225238881,0.00438219697811039,-0.0114983083294852,0.00567990382470756,0.506781184833905
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,28452,-0.00286921423771381,0.00433452663451989,-0.0113648864413728,0.00562645796594518,0.508012425151067
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,23481,-0.00156361907236111,0.00236240228402791,-0.00619392754905581,0.00306668940433359,0.508056732386087
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,23188,-0.00352455051435658,0.00533909793046461,-0.0139891824580672,0.00694008142935406,0.509170744155283
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,23393,0.00327158844404416,0.00495777581735796,-0.00644565215797743,0.0129888290460658,0.509330694735548
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,28224,-0.00144558047223315,0.00220122355663787,-0.00575997864324338,0.00286881769877708,0.511368392332769
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,23163,-0.00302402783081141,0.0046365863646263,-0.012111737105479,0.00606368144385613,0.514272208108782
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",28452,-0.00329754162933761,0.00506793104702192,-0.0132306864815006,0.00663560322282536,0.515265944614354
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,23188,-0.00273860493556141,0.00422778084882586,-0.0110250553992601,0.00554784552813727,0.517143912692479
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,22978,0.00259286093114494,0.00400340294128654,-0.00525380883377667,0.0104395306960666,0.517208611425088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,27682,-0.00319585747459077,0.00493787453836636,-0.0128740915697888,0.00648237662060729,0.517499352866438
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",28521,-0.00301973952074411,0.00467448296191208,-0.0121817261260918,0.00614224708460356,0.518281295924761
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,27702,-0.00632355134915947,0.00980863227637347,-0.0255484706108515,0.0129013679125325,0.519131839517505
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,27702,0.0022281465960609,0.0034581948811101,-0.00454991537091489,0.0090062085630367,0.519380322415561
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,23198,0.0117182825022641,0.0182135069203763,-0.0239801910616735,0.0474167560662017,0.519981199428531
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,27702,0.00310105248166576,0.00485771229372126,-0.00642006361402791,0.0126221685773594,0.523233487931693
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,28428,-0.00159508314921067,0.00250506665232566,-0.00650501378776897,0.00331484748934763,0.524297520871509
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,23795,0.00104617221461186,0.00164422929325477,-0.00217651720016748,0.0042688616293912,0.524607195971548
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,23188,0.0044369329169432,0.00702893465852018,-0.00933977901375635,0.0182136448476428,0.527890934478069
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",23056,-0.00368039950641282,0.00583058625245135,-0.0151083485612175,0.00774754954839182,0.527901058349631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,23852,0.000849819581232071,0.00134786424491144,-0.00179199433879435,0.00349163350125849,0.528377829286723
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,27562,0.00212462294208675,0.00338052648776897,-0.00450120897394042,0.00875045485811393,0.529689010078684
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,23163,0.00251251785366491,0.00400956414239435,-0.00534622786542802,0.0103712635727578,0.530907213345844
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23188,-0.00266583845229366,0.00428065596977515,-0.011055924153053,0.00572424724846563,0.533445743905004
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,23393,0.00168412622959803,0.00271939740140026,-0.00364589267714648,0.00701414513634254,0.535723951137629
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23071,0.00296162697136416,0.00478431518671091,-0.00641563079458923,0.0123388847373175,0.535903766204073
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,23188,-0.00119340706515424,0.00192873232203444,-0.00497372241634173,0.00258690828603326,0.536085801162615
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,23393,-0.00334320636899141,0.0054098949472184,-0.0139466004655395,0.00726018772755666,0.536594604248373
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,23393,-0.00293058214562404,0.00476640324858065,-0.0122727325128421,0.00641156822159404,0.538665435714918
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,23393,-0.00149779584844338,0.00244059838733263,-0.00628136868761533,0.00328577699072856,0.539419391884516
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,23056,-0.00261499578111793,0.00426170866432673,-0.0109679447631983,0.00573795320096246,0.539483981140502
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,27702,-0.0019080942288612,0.00313088666072761,-0.00804463208388732,0.00422844362616492,0.542236422021934
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,23393,-0.002819767618523,0.00465261750554874,-0.0119388979293985,0.00629936269235254,0.544480473847161
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,27562,-0.00133442385627566,0.00221682303374286,-0.00567939700241166,0.00301054928986034,0.547210202958349
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,23795,-0.00139077786305255,0.00233528973123332,-0.00596794573626986,0.00318639001016477,0.55148268114048
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,27956,0.00524904882956058,0.0088312831298125,-0.0120602661048719,0.0225583637639931,0.552269551370222
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,28428,0.00117392874598748,0.00197964654699554,-0.00270617848612377,0.00505403597809874,0.553186431790784
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,22978,-0.00254349121182578,0.00431609949836066,-0.0110030462286127,0.00591606380496112,0.555663701073649
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,23071,0.00224747210528614,0.00382733294902178,-0.00525410047479655,0.00974904468536883,0.557064229325926
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,28187,-0.00173351481074581,0.00295693397442622,-0.0075291054006212,0.00406207577912959,0.557709434917453
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,22978,0.00125144270476811,0.00214827278057567,-0.00295917194516021,0.00546205735469642,0.560212525291695
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,28224,0.00309819601061602,0.00532739376398477,-0.00734349576679412,0.0135398877880262,0.560868132263916
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,27600,-0.00196125495861731,0.00338596749168116,-0.00859775124231239,0.00467524132507777,0.562438519579318
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,23071,-0.0020214465497901,0.00349129833125776,-0.0088643912790553,0.0048214981794751,0.562597763769719
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,23795,-0.00205753854367546,0.00355691942068359,-0.0090291006082153,0.00491402352086438,0.562958516422908
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,27965,-0.000483758384875446,0.000842618303298745,-0.00213529025934099,0.00116777348959009,0.56589574553412
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,22978,-0.00160750131873339,0.00280644577387137,-0.00710813503552128,0.00389313239805449,0.566793163761913
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,27411,0.00264688828618936,0.00463627980453127,-0.00644022013069192,0.0117339967030707,0.568066828458553
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,23056,-0.00207220065949809,0.00365766513101317,-0.00924122431628391,0.00509682299728773,0.571034672188459
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,23163,-0.00135188310474101,0.00239731836015328,-0.00605062709064143,0.00334686088115941,0.572817636568471
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,23071,-0.00297090316538941,0.00527214946812661,-0.0133043161229176,0.00736250979213875,0.573093879164423
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,28224,0.00123215241714864,0.00220459069240912,-0.00308884533997323,0.00555315017427051,0.576232338112314
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,23056,-0.00194531697468574,0.00348854334437901,-0.0087828619296686,0.00489222798029712,0.577102375956292
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,28307,-0.00142293827968324,0.00255603409843061,-0.00643276511260723,0.00358688855324075,0.577738398209175
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,23071,0.00271130422078194,0.00490902566318955,-0.00691038607906959,0.0123329945206335,0.580741298177372
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,23738,-0.000815668376360122,0.00148131682204387,-0.00371904934756611,0.00208771259484587,0.581887481204847
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,23775,0.00907439800338349,0.0165275718501661,-0.023319642822942,0.041468438829709,0.582979008562037
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,28415,-0.00103280251085773,0.00188206204507706,-0.00472164411920878,0.00265603909749331,0.583173696485678
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,23163,0.0019301474845702,0.00352850982975889,-0.00498573178175722,0.00884602675089763,0.58437376213802
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,23163,-0.002694416689438,0.00494412408270912,-0.0123848998915479,0.00699606651267188,0.585776982049039
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,27702,-0.00168854988922694,0.00309954668316199,-0.00776366138822443,0.00438656160977056,0.585913917413289
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,22882,-0.00130388829382622,0.00239467249978544,-0.00599744639340568,0.00338966980575323,0.586105883934446
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,28022,-0.00103631183508811,0.00190343749771426,-0.00476704933060807,0.00269442566043184,0.586141497961454
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,28452,-0.000796286480325495,0.00146696856288608,-0.00367154486358222,0.00207897190293123,0.587264282982865
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,23163,0.00158533108870514,0.00294330565862359,-0.00418354800219708,0.00735421017960737,0.590152435927987
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23198,-0.00167982563117657,0.00312127761460835,-0.00779752975580894,0.00443787849345579,0.590454315791531
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,27682,0.0019797931173644,0.0036819856335245,-0.00523689872434361,0.00919648495907241,0.590790483810615
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,22978,-0.00207016250420134,0.00385691194861733,-0.00962970992349131,0.00548938491508863,0.591451779479053
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,23071,-0.0014781324603877,0.00276447087385648,-0.0068964953731464,0.00394023045237099,0.592870011611285
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23163,-0.0019000042474068,0.00355974566735237,-0.00887710575541744,0.00507709726060384,0.593521580206598
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,23188,-0.00111455195683992,0.00209330137783509,-0.00521742265739669,0.00298831874371685,0.59442818795535
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,27544,0.0017699472864197,0.00333303580126413,-0.00476280288405799,0.00830269745689739,0.595401175485095
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,23370,0.00358669264287797,0.00694542691429226,-0.0100263441091349,0.0171997293948908,0.605572496519184
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,27562,-0.00106691647543487,0.00207795403024138,-0.00513970637470798,0.00300587342383824,0.607643731652773
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,23071,0.00234086216910111,0.00456873934754742,-0.00661386695209183,0.0112955912902941,0.608400484268343
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,28187,0.00268231917534324,0.00524389134823161,-0.00759570786719073,0.0129603462178772,0.608995819261085
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,28553,0.00185643111789193,0.00363929042491649,-0.00527657811494439,0.00898944035072826,0.609979753890323
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,28520,-0.000968946415432676,0.0019038231807056,-0.00470043984961566,0.00276254701875031,0.610792827963027
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,27562,-0.00579960136249064,0.0114551976727737,-0.0282517888011271,0.0166525860761459,0.612660238228427
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,27562,0.00270098248454376,0.00536004411219624,-0.00780470397536086,0.0132066689444484,0.614328304539665
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,23071,-0.00395110650963739,0.00784647992551527,-0.0193302071636473,0.0114279941443725,0.614581412648242
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,23071,-0.00116463172546968,0.00231625995495691,-0.00570450123718523,0.00337523778624587,0.615104772213508
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,22978,-0.00161419532393738,0.0032183455406305,-0.00792215258357315,0.00469376193569839,0.615981447597088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,28553,-0.00154421031008859,0.00307940724874744,-0.00757984851763357,0.0044914278974564,0.616048833721324
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,22978,-0.00128113290455168,0.00255677345749291,-0.00629240888123778,0.00373014307213443,0.616323791734339
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,23393,-0.00142096461120337,0.00283600428614498,-0.00697953301204753,0.00413760378964078,0.61634445743129
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",23393,-0.00243398368566496,0.00486369212884634,-0.0119668202582038,0.00709885288687387,0.616770352584076
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,22978,0.00089751620238674,0.00179682511515378,-0.00262426102331467,0.00441929342808815,0.617431165810736
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,28224,-0.00279492449472262,0.00559802005736474,-0.0137670438071575,0.00817719481771226,0.617592951655807
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,23198,0.00165591337609518,0.00332388867536576,-0.00485890842762172,0.00817073517981207,0.618357977571562
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,28322,0.00523708252889465,0.0105351794799799,-0.0154118692518659,0.0258860343096552,0.619119396078289
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,23056,0.00167164646089629,0.00342053498519237,-0.00503260211008076,0.00837589503187334,0.625052334897587
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,27702,0.0016342279303838,0.00335086191443353,-0.00493346142190592,0.00820191728267351,0.625763554846472
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,27702,0.00219226635694751,0.00450620297277324,-0.00663989146968804,0.0110244241835831,0.626616774509869
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",23795,-0.00229473691431362,0.00472505938193345,-0.0115558533029032,0.00696637947427594,0.627218039184087
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,28331,0.000813048885680046,0.00167643847543884,-0.00247277052618009,0.00409886829754018,0.627690157104666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,23056,-0.00164036103195284,0.00340239712191385,-0.008309059390904,0.00502833732699831,0.62972583943234
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,22978,-0.0017926759443605,0.00372606458925801,-0.0090957625393062,0.00551041065058521,0.63043737204678
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,23056,-0.00199094376262403,0.00414417968073658,-0.0101135359368677,0.00613164841161966,0.630933858122756
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",23795,-0.00235904946575936,0.00491471343434851,-0.0119918877970824,0.00727378886556372,0.631233686086999
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,23188,-0.00154966639199285,0.00324478662344863,-0.00790944817395217,0.00481011538996646,0.632949022557871
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,23056,0.0020817973742597,0.00435928404201272,-0.00646239934808524,0.0106259940966046,0.632971580061275
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,23163,0.00138300911004678,0.00290030934532474,-0.00430159720678972,0.00706761542688328,0.633474274803284
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,23725,0.00186481881678463,0.00394284107256961,-0.0058631496854518,0.00959278731902106,0.636243772110162
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,22978,-0.00144094838293875,0.00305985588759911,-0.007438265922633,0.0045563691567555,0.6377020935779
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,23393,-0.00205344617950923,0.00437102062779724,-0.0106206466099918,0.00651375425097337,0.638511991540638
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,23056,0.00173513881928159,0.00369677123014653,-0.00551053279180561,0.00898081043036879,0.638812469734699
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,27918,0.00109226158941539,0.0023273075688551,-0.00346926124554061,0.00565378442437139,0.638841640220036
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,27544,-0.00126861968921976,0.00271529537045486,-0.00659059861531129,0.00405335923687176,0.640351614663762
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23198,0.00224574915743384,0.00481678533447101,-0.00719515009812934,0.011686648412997,0.641052385907838
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,23775,-0.000900991490432753,0.00193891305629505,-0.00470126108077104,0.00289927809990554,0.642158473839319
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,23480,0.00104815653617055,0.00226057138678416,-0.0033825633819264,0.0054788764542675,0.642889318404299
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,28452,0.00191237107517279,0.00413161700833368,-0.00618559826116123,0.0100103404115068,0.643466383898057
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,23071,0.00119863305358151,0.00260524029931125,-0.00390763793306855,0.00630490404023156,0.645459253878516
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,23163,-0.00130616213244358,0.00286825616133748,-0.00692794420866504,0.00431561994377787,0.648836229656202
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,23862,-0.00276429844253255,0.006071742802499,-0.0146649143354306,0.00913631745036549,0.64891724385588
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",23056,-0.00177648830401414,0.00392476045943266,-0.00946901880450215,0.00591604219647387,0.650815054305168
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,23056,0.00229348867694269,0.00507773119880993,-0.00765886447272478,0.0122458418266102,0.651506752408213
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,27965,-0.00129961094901411,0.00289223315822383,-0.00696838793913281,0.00436916604110458,0.653186174695575
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,28091,0.00142512957155492,0.00317248872061036,-0.00479294832084137,0.00764320746395122,0.653280023564097
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,23056,0.0021824722632157,0.00486109174982953,-0.00734526756645017,0.0117102120928816,0.65345931605143
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,28553,-0.00217331145096952,0.00484703585275026,-0.01167350172236,0.00732687882042099,0.653882747181938
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,23056,-0.00107865292495923,0.00241233364729404,-0.00580682687365555,0.00364952102373709,0.654777566536346
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",28109,-0.00204531801897639,0.00460364312837358,-0.0110684585505886,0.00697782251263582,0.656841783239047
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,23188,-0.000716101413281448,0.00162267602111805,-0.00389654641467282,0.00246434358810992,0.658993481740888
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,28553,0.000483147221176482,0.0010967975848243,-0.00166657604507915,0.00263287048743211,0.65957314293246
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,28111,0.00103068268832788,0.00234338584796055,-0.0035623535736748,0.00562371895033056,0.660066312684724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,22978,-0.00284733749388387,0.00647930043853673,-0.0155467663534159,0.00985209136564811,0.660338642094157
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,28224,-0.00231723230481162,0.00527698499049338,-0.0126601228861786,0.00802565827655541,0.660577586678558
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,27682,-0.000826629621286233,0.00188730067424414,-0.00452573894280475,0.00287247970023229,0.661392803887005
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,23278,0.00147020047686474,0.00335836424408465,-0.00511219344154118,0.00805259439527066,0.661555063438981
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,23188,-0.00183184021426888,0.00420107646868828,-0.0100659500928979,0.00640226966436015,0.662811281077634
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,22978,0.00144518805228137,0.00331991072575834,-0.00506183697020498,0.00795221307476771,0.663342018101781
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,23725,-0.00151875272460641,0.00353822955244537,-0.00845368264739933,0.00541617719818651,0.667751844452855
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,27544,-0.00253190047677122,0.00589935236427677,-0.0140946311107537,0.00903083015721126,0.667793568541242
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,22981,-0.00185824762589457,0.00433070094739507,-0.0103464214827889,0.00662992623099977,0.667863912256928
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",23071,-0.00120504681408974,0.00281054954356397,-0.00671372391947512,0.00430363029129564,0.668103038269207
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,23725,-0.00179912867996868,0.00420321467439873,-0.0100374294417902,0.00643917208185283,0.668628541409174
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,28176,-0.000980752631967682,0.00229655919634577,-0.00548200865680539,0.00352050339287002,0.669343946035154
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,28144,-0.00259016135302016,0.00607446459919537,-0.0144961119674431,0.00931578926140275,0.66981850710699
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,23071,-0.00126297125806495,0.00296198508749461,-0.00706846202955438,0.00454251951342447,0.669825100488763
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,23056,0.00135134104522473,0.00320003459827831,-0.00492072676740076,0.00762340885785021,0.672817653474531
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,23071,-0.00146815619737335,0.00349322720870312,-0.00831488152643147,0.00537856913168477,0.67428009569631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,27702,-0.00172025650613437,0.00410564960726977,-0.00976732973638311,0.00632681672411437,0.675221283611165
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,22978,0.00175031628649714,0.0041847946465231,-0.00645188122068815,0.00995251379368242,0.675763724383982
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,27682,-0.000792764820780922,0.00190120520899334,-0.00451912703040786,0.00293359738884601,0.676696166754122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,28428,0.00204756637325588,0.00492124034574729,-0.0075980647044088,0.0116931974509206,0.677364020093995
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,23163,-0.00104437949798996,0.00251316600008465,-0.00597018485815587,0.00388142586217595,0.677733455349914
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,28202,-0.00150846260942511,0.00366932165189656,-0.00870033304714237,0.00568340782829215,0.68100144030184
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,23056,0.00271828607965058,0.00662859695991255,-0.010273763961778,0.0157103361210792,0.681747641235974
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",23795,-0.00258813500525554,0.00631123530584759,-0.0149581562047168,0.00978188619420573,0.68174821096189
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",23725,0.00122154864377666,0.00298173249137056,-0.00462264703930964,0.00706574432686296,0.682046255212318
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,23795,-0.00106018708129657,0.00259331455085084,-0.00614308360096422,0.00402270943837109,0.682678774712606
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,28091,0.000738704980068374,0.00180774296736258,-0.00280447123596227,0.00428188119609902,0.682811497306686
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,27500,0.00171446471913999,0.00423530733100918,-0.006586737649638,0.010015667087918,0.685625542029858
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,28390,-0.00177654686706914,0.00440150255495572,-0.0104034918747823,0.00685039814064408,0.686493144676881
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,23775,-0.00109146636647682,0.00270616565633998,-0.00639555105290317,0.00421261831994954,0.686712210193513
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,23862,0.000871835063937706,0.00216219385490412,-0.00336606489167436,0.00510973501954978,0.686791616001122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,23056,0.00202757799606017,0.00505654229099992,-0.00788324489429967,0.01193840088642,0.688437741645793
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,27544,0.00135912839871484,0.00341700771526338,-0.00533820672320138,0.00805646352063106,0.690814631205112
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,23188,0.000810436240418637,0.00203862987548016,-0.00318527831552248,0.00480615079635975,0.690973203329545
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,22936,-0.00218302086879101,0.00550241237223846,-0.0129677491183784,0.00860170738079636,0.691563726627474
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,23393,0.00100034038817318,0.002523866496656,-0.00394643794527258,0.00594711872161894,0.691848738682875
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,28087,-0.000786337041412884,0.00198458295151831,-0.00467611962638877,0.003103445543563,0.691943674010935
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,23071,0.00197622982572108,0.00502070627708528,-0.00786435447736607,0.0118168141288082,0.693868279294482
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,23775,-0.00184084846018483,0.00476263605888086,-0.0111756151355913,0.00749391821522166,0.699115929726423
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,23163,-0.00221525313720126,0.00573768474253952,-0.0134611152325787,0.0090306089581762,0.699434798392066
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,23163,-0.00182084353551201,0.00474849776615917,-0.011127899157184,0.00748621208615996,0.701384651524078
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,28320,-0.000557593176886944,0.00145478141243428,-0.00340896474525812,0.00229377839148424,0.701512722771158
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,22978,0.000840512691630248,0.00220708665493236,-0.00348537715203718,0.00516640253529767,0.703336994403322
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,23725,-0.00163519164128404,0.0043016208728684,-0.0100663685521061,0.00679598526953801,0.703849475430848
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,23393,0.00163741248545662,0.00433510051855646,-0.00685938453091404,0.0101342095018273,0.705649181165228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,23355,-0.00141548814755568,0.00377164571822292,-0.00880791375527261,0.00597693746016125,0.707442844655279
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,23365,-0.000571507961468783,0.00153336759090328,-0.00357690843963921,0.00243389251670165,0.709364507501776
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,22978,0.00239259082985105,0.00644573051629781,-0.0102410409820927,0.0150262226417948,0.710499431226699
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,23056,0.00189094983761261,0.00512626057880394,-0.0081565208968431,0.0119384205720683,0.712224219750411
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,23163,-0.000927359214284129,0.00253076800007603,-0.00588766449443315,0.00403294606586489,0.714044668837968
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,27544,0.00121021633854226,0.00330440839497937,-0.0052664241156173,0.00768685679270181,0.714186596558988
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",23056,0.00135790211351004,0.00377322063088105,-0.00603761032301681,0.0087534145500369,0.718941069559666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,22479,0.00124572860946344,0.00346796686963349,-0.00555148645501821,0.00804294367394509,0.719441322650774
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,28187,0.000838297856710656,0.00234609205423304,-0.00376004256958611,0.00543663828300742,0.720857410221137
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,23188,0.00251938344689168,0.00714140686122613,-0.0114777740011115,0.0165165408948949,0.724252604619314
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,27702,-0.00135061855234047,0.00385260729546903,-0.00890172885145978,0.00620049174677883,0.725911683236132
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,23056,-0.00221469183008254,0.00632083239312566,-0.0146035233206088,0.0101741396604438,0.726056905766675
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,23393,-0.000997555335691887,0.00286970838476702,-0.00662218376983526,0.00462707309845148,0.728132035709948
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23163,-0.00116167196149091,0.00341090388616726,-0.00784704357837873,0.00552369965539691,0.733425899071767
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,23738,0.00266870984341513,0.00784560212757654,-0.0127086703266349,0.0180460900134651,0.73374386686276
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,23393,0.00185739180651878,0.00551789862633728,-0.00895768950110228,0.0126724731141398,0.736412305318016
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,26744,-0.000924525689859756,0.00277140050016933,-0.00635647067019165,0.00450741929047214,0.73868771589673
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,22978,0.00146926752075007,0.0044109646533606,-0.0071762231998367,0.0101147582413368,0.739066085067681
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",22940,0.000595166687964528,0.00178966157599611,-0.00291257000098784,0.0041029033769169,0.739470817644208
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,28430,0.000741723637544529,0.00223230287505335,-0.00363358999756003,0.00511703727264909,0.739689072347104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,23071,-0.00107853005216136,0.00326532740343608,-0.00747857176289608,0.00532151165857337,0.741178049868852
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,23163,0.00155131912922306,0.00476334717680752,-0.00778484133731967,0.0108874795957658,0.744670657026432
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,23862,0.00200342739857862,0.00615245710860717,-0.0100553885342914,0.0140622433314487,0.744706825265606
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,28176,0.00105151122588239,0.00323655230488967,-0.00529213129170137,0.00739515374346615,0.74526960404031
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,27702,-0.00201749681762517,0.00636804250783996,-0.0144988601329915,0.0104638664977412,0.751385723184208
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,28176,0.00101509605207101,0.00324778264418078,-0.00535055793052332,0.00738075003466534,0.754624513288313
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",27544,0.000919926530344225,0.00294369466168931,-0.00484971500656681,0.00668956806725526,0.754657264417433
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,27965,0.0022321074170861,0.00724304527452314,-0.0119642613209793,0.0164284761551515,0.757953368115746
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,23872,-0.00126961855094873,0.00412285528567393,-0.00935041491086963,0.00681117780897217,0.758125786478456
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,23188,0.000973822444401037,0.00322351264297744,-0.00534426233583475,0.00729190722463683,0.762578714961385
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,23163,-0.00125665445971709,0.00419348133865913,-0.00947587788348899,0.00696256896405481,0.764432682947001
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,23843,0.000509425229680098,0.00172806510701192,-0.00287758238006326,0.00389643283942346,0.768152932101481
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,27702,0.000599996170016006,0.00207770558286689,-0.00347230677240309,0.0046722991124351,0.772753243688313
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,27544,0.000898966286841017,0.00312609050268484,-0.00522817109842126,0.0070261036721033,0.773678947879497
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,27562,-0.00249213117138166,0.00867364775276837,-0.0194924807668077,0.0145082184240443,0.773867820754834
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,23862,-0.000591617454763139,0.00205992772319594,-0.00462907579222717,0.00344584088270089,0.773959372470151
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,23056,-0.00209364536733412,0.00749611705245085,-0.0167860347901378,0.0125987440554695,0.780019173213047
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,27544,0.00121471970235455,0.00438101562521232,-0.00737207092306159,0.00980151032777069,0.781575663848393
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,23846,-0.00063723670385274,0.00233189024550803,-0.00520774158504848,0.003933268177343,0.784647694218631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,23775,-0.00042541262200474,0.00155685712210348,-0.00347685258132755,0.00262602733731807,0.784662724420031
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",23331,-0.0012086863436774,0.00442618015721537,-0.00988399945181952,0.00746662676446473,0.784796732234948
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,27082,0.000423046697129986,0.00159982709522371,-0.00271261440950848,0.00355870780376845,0.791448482729949
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",23738,-0.0016010050083321,0.00605671191761725,-0.0134721603668619,0.0102701503501977,0.791523572218234
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,22978,-0.00101348145086913,0.0038952570732974,-0.00864818531453204,0.00662122241279377,0.794724597107884
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,27544,0.000938692129044601,0.00366682125884423,-0.00624827753829009,0.00812566179637929,0.797955721972082
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,28224,-0.000495803166361878,0.00196119488519455,-0.00433974514134319,0.00334813880861943,0.80041944800937
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,22978,-0.00203379465814318,0.00806225966388666,-0.017835823599361,0.0137682342830747,0.800841495336396
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,23056,0.00107198407353548,0.00428889061081277,-0.00733424152365755,0.00947820967072851,0.802632595689661
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,23795,0.000445036233766587,0.00180968230379022,-0.00310194108166225,0.00399201354919543,0.805746642354943
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,28307,-0.000703929861146052,0.00292858377228976,-0.00644395405483399,0.00503609433254189,0.810048832589817
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,28307,0.000454848790844697,0.00189382804523076,-0.00325705417780759,0.00416675175949699,0.810196890319431
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,28125,-0.000423989238079078,0.00176631296284095,-0.00388596264524734,0.00303798416908918,0.810299472769576
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,23757,-0.000394052239077906,0.00165002655327849,-0.00362810428350374,0.00283999980534793,0.811250560154301
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,27879,-0.00172195694499839,0.00721227482398543,-0.0158580156000098,0.0124141017100131,0.811298367940437
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,22978,-0.00101105995932076,0.00438104107035792,-0.00959790045722228,0.00757578053858077,0.817487190033613
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,23188,-0.00104292903170022,0.00455070229713528,-0.00996230553408536,0.00787644747068492,0.818731196326426
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,28037,-0.00111120050875451,0.00490098168304044,-0.0107171246075138,0.00849472359000475,0.820635203856238
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,27544,0.000857494701558729,0.00379906424367624,-0.00658867121604671,0.00830366061916417,0.821427035689662
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,23872,0.000821627955339782,0.00364996775045581,-0.00633230883555361,0.00797556474623317,0.821899100527032
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,23393,0.00130868538795153,0.00582904661865919,-0.0101162459846205,0.0127336167605235,0.822361630232656
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,23337,0.000430280527272023,0.00196852379408324,-0.00342802610913112,0.00428858716367517,0.826978910242781
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,23071,0.000704688166773561,0.00328635534400137,-0.00573656830746913,0.00714594464101625,0.830214833963709
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",26796,0.00042882758510086,0.00201324407556701,-0.00351713080301049,0.00437478597321221,0.831326028024208
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,27702,0.000462924736051846,0.00217991835136458,-0.00380971523262273,0.00473556470472642,0.831828727831869
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,23071,-0.000699699487649942,0.00338949216138402,-0.00734310412396262,0.00594370514866274,0.836455335891903
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,22978,0.000479133942145894,0.00232413216847636,-0.00407616510806777,0.00503443299235955,0.836670833334342
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,28224,-0.000537242500898471,0.00265741739924765,-0.00574578060342387,0.00467129560162693,0.839787511502443
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,27448,0.000660655724131926,0.00328078422356248,-0.00576968135405053,0.00709099280231438,0.840409762062209
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23188,0.000390468402716207,0.00194557896005156,-0.00342286635898486,0.00420380316441727,0.84093865666391
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,23163,0.00108352946566694,0.00543077361581251,-0.00956078682132558,0.0117278457526595,0.841860414960142
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,27702,0.000500370099921429,0.00251291659810497,-0.00442494643236432,0.00542568663220718,0.842170915673777
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,23071,0.000699115586488254,0.00351161717011205,-0.00618365406693136,0.00758188523990787,0.84219683346645
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,23393,0.00077419584141392,0.0039293806668257,-0.00692739026556445,0.00847578194839229,0.843807771819409
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",23056,-0.000613814894802682,0.00316371099513754,-0.00681468844527227,0.0055870586556669,0.846163989333441
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23188,-0.000593405698009819,0.00307044149762427,-0.00661147103335338,0.00542465963733374,0.846753939784649
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,23725,0.000659353385997072,0.00341478478110369,-0.00603362478496615,0.0073523315569603,0.846891836749309
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,23862,0.000624872426148078,0.00326971167581485,-0.00578376245844902,0.00703350731074517,0.848441560527273
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,23846,0.000382429698956684,0.0020619024007049,-0.00365889900642493,0.0044237584043383,0.852858692729996
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,27562,0.00110216046294084,0.00600433755323491,-0.0106663411413996,0.0128706620672813,0.854359439321975
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,28195,0.000482829491521952,0.00267849245787053,-0.00476701572590428,0.00573267470894818,0.856948451149625
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,23071,-0.000474803445015107,0.00266424950002955,-0.00569673246507303,0.00474712557504281,0.858557399256339
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,23071,0.00119962848645,0.0068087719015138,-0.012145564440517,0.014544821413417,0.860147266532766
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,23775,0.000318513767842444,0.00183034106562537,-0.00326895472078329,0.00390598225646818,0.861852164714173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,27702,-0.000384254595358651,0.00220871863753333,-0.00471334312492399,0.00394483393420669,0.861888953991502
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,27544,-0.000584493049478676,0.00340886935326214,-0.00726587698187248,0.00609689088291512,0.863861423511956
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,23023,0.00101113500183752,0.0059019105741947,-0.0105566097235841,0.0125788797272591,0.863971039680453
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,23198,0.000490108312466718,0.00289077502821005,-0.00517581074282498,0.00615602736775842,0.865371673582638
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,23393,0.000874406846590372,0.00516172293140516,-0.00924257009896374,0.0109913837921445,0.865481815757997
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,23872,0.000679462809633872,0.00414613809576382,-0.00744696785806322,0.00880589347733096,0.869828196573543
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,23188,-0.000525409742192094,0.00320917896361238,-0.00681540051087236,0.00576458102648817,0.869952273315924
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,22978,0.000578767827371056,0.00353890989802612,-0.00635749557276014,0.00751503122750226,0.870091494476041
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,23188,-0.000612588272177261,0.00377072558305541,-0.00800321041496587,0.00677803387061135,0.870945836403202
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,23163,-0.000734046026577347,0.00453695671759807,-0.00962648119306957,0.00815838913991487,0.871470592087282
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,28187,0.000334143103661755,0.00206724249166686,-0.00371765218000529,0.0043859383873288,0.871592790466611
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,22978,-0.000807873489086902,0.00500323186303433,-0.0106142079406342,0.00899846096246039,0.871724400136552
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,22978,-0.000958618049876482,0.00599067053616553,-0.0127003323007609,0.010783096201008,0.872867916844576
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,22978,0.000521632775379411,0.00326757410032792,-0.0058828124612633,0.00692607801202213,0.87316673555464
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,23337,0.000487069388915778,0.00305500880607418,-0.00550074787098962,0.00647488664882118,0.873329077907153
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,28176,0.000930722918050401,0.00587887488735588,-0.0105918718611671,0.0124533176972679,0.874208539184559
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,23393,-0.000386948080086606,0.00245603932016525,-0.00520078514761049,0.00442688898743728,0.874813059692843
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,23188,-0.000303857350396609,0.00195781877381297,-0.00414118214707003,0.00353346744627681,0.876663439001748
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,23056,0.000579839584998501,0.00376500250128636,-0.00679956531752276,0.00795924448751976,0.877604969217303
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,27562,0.000490534122690124,0.00320194234133373,-0.00578527286632399,0.00676634111170424,0.878242527939171
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,22978,0.000414082455139318,0.00279891025930304,-0.00507178165309465,0.00589994656337329,0.882388128043992
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,28237,0.000344351137695683,0.00235114309291742,-0.00426388932442246,0.00495259159981382,0.883558397481526
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,27544,-0.000478649486489209,0.00327384799474339,-0.00689539155618626,0.00593809258320784,0.883761463205978
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,23872,-0.000226194473712233,0.0015919854668421,-0.00334648598872275,0.00289409704129828,0.88701544593765
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,23862,-0.000388976185177391,0.00303076488767527,-0.00632927536502092,0.00555132299466614,0.897878951934199
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,22978,0.000217505209336328,0.0017495501136438,-0.00321161301340552,0.00364662343207818,0.901062485018247
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,28281,0.000438795658548334,0.00355298441377074,-0.00652505379244232,0.00740264510953899,0.901711588042181
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,23393,-0.000443306711244627,0.00372173318128302,-0.00773790374655934,0.00685129032407009,0.905186874800357
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,22978,-0.000654788913375112,0.00553193749636227,-0.0114973864062452,0.0101878085794949,0.905779329934845
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,22978,0.000278359724361024,0.00235621181512246,-0.00433981543327899,0.00489653488200104,0.905958818934843
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,23188,-0.000235714067510586,0.0020332646968152,-0.00422091287326837,0.0037494847382472,0.907709923862757
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,27682,-0.000249091507130188,0.00230545922910408,-0.00476779159617418,0.00426960858191381,0.913961411187881
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,23056,-0.000445432204613744,0.00448684322520477,-0.0092396449260151,0.00834878051678761,0.920920641816024
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,23056,0.000257457976510199,0.00260664956598861,-0.00485157517282748,0.00536649112584788,0.921321991720871
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",28320,0.000187794136099464,0.001908183873446,-0.00355224625585469,0.00392783452805362,0.921603369454517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",23071,0.000265301389544344,0.00276202699817012,-0.00514827152686909,0.00567887430595778,0.923479196005113
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,23163,0.000241241957377426,0.00252231750155728,-0.00470250034567484,0.0051849842604297,0.923804957990599
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",27562,-0.000523532408321421,0.00550943851260907,-0.0113220318930352,0.0102749670763924,0.924295947150587
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",23071,-0.000439283012730759,0.00462407630577377,-0.00950247257204735,0.00862390654658583,0.924316380144235
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,27544,0.000310664492374161,0.0032862960693626,-0.00613047580357654,0.00675180478832486,0.924686199915526
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,23795,-0.000491114351874119,0.0052348378674051,-0.0107513965719881,0.00976916786823988,0.925255686657143
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,28521,0.000461243948409758,0.00505909148135165,-0.00945457535503947,0.010377063251859,0.927357119625599
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,28187,-0.000313500997000058,0.00351248891037992,-0.0071979792613447,0.00657097726734458,0.928881293432899
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,23056,-0.000449000146762975,0.00515372343814865,-0.0105502980855343,0.00965229779200837,0.930575688207193
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,23188,-0.000547365687648903,0.0062834743778827,-0.012862975468299,0.0117682440930012,0.930583281714807
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,23846,-0.000292734718230271,0.00339643664237212,-0.00694975053727962,0.00636428110081908,0.931317076715445
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,23725,-0.000222207073667966,0.00262177646595918,-0.00536088894694795,0.00491647479961202,0.932457367461717
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,27562,0.000303585487496713,0.00383005777623078,-0.00720332775391561,0.00781049872890904,0.936823259788001
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,23071,-0.000188499880789755,0.00244115127614965,-0.00497315638204307,0.00459615662046356,0.93845109829309
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,27544,-0.000401918272136584,0.00541965971371707,-0.011024451311022,0.0102206147667489,0.940884154422392
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,23056,0.000392289737078643,0.00533290423112155,-0.0100602025559196,0.0108447820300769,0.941360944508525
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,27682,0.000536016354821572,0.00740056793048084,-0.0139690967889209,0.015041129498564,0.942260963579041
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23198,-0.000438557637386132,0.00631087237231511,-0.0128078674871237,0.0119307522123515,0.944598285053708
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,23188,-0.000327115069603316,0.00478460670655666,-0.00970494421445437,0.00905071407524773,0.945493104961278
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,27544,-0.000300053368064728,0.00452485016120562,-0.00916875968402774,0.00856865294789829,0.947129646504257
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,23795,-0.00013851001200481,0.0020946816749252,-0.00424408609485821,0.00396706607084859,0.947279172420819
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,28414,0.000195560426636036,0.0029981228358924,-0.00568076033171307,0.00607188118498514,0.947993226929757
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,28187,-0.000147878514310271,0.00233321100314345,-0.00472097208047144,0.0044252150518509,0.94946449875008
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,27702,-0.00032551870884225,0.00528235642159366,-0.0106789372951658,0.0100278998774813,0.950862893239847
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,23725,0.000142930101288567,0.00236755058720356,-0.0044974690496304,0.00478332925220754,0.951861099658475
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,27702,0.000204952920788331,0.00361171842993444,-0.00687401520188318,0.00728392104345984,0.954747422194736
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,27562,0.000345620879078944,0.00631759850797703,-0.012036872196556,0.0127281139547139,0.956371782608753
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,28238,0.000325851196348655,0.00644517817170312,-0.0123066980201895,0.0129584004128868,0.959678598497119
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,23163,0.000240124846164511,0.00482100558168233,-0.00920904609393286,0.00968929578626188,0.960275788152091
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,23163,-0.0001415582749009,0.00288171980755818,-0.00578972909771493,0.00550661254791313,0.96082182164504
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,23188,6.12339403807279e-05,0.00140600290330059,-0.00269453175008843,0.00281699963084989,0.965262058026424
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,23393,-0.000121174504955611,0.00303042711402107,-0.0060608116484369,0.00581846263852568,0.968104669597814
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,23725,-0.000263042393224189,0.0077128187941191,-0.0153801672296976,0.0148540824432492,0.972794048786651
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,23071,0.000136903379879877,0.00421270018667849,-0.00811998898600997,0.00839379574576973,0.974075372233437
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,27562,-8.07108946725862e-05,0.00272549012206592,-0.00542267153392179,0.00526124974457661,0.976375632225441
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,28176,-0.000131971055406616,0.00451484005787147,-0.0089810575688347,0.00871711545802147,0.976680959186171
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,23056,8.90337409741371e-05,0.00305239769322163,-0.00589366573774027,0.00607173321968854,0.976730488162653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,22936,7.12818462771222e-05,0.00245882960603502,-0.00474802418155151,0.00489058787410575,0.976872696510266
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,23056,8.05375751158753e-05,0.00285974076868551,-0.00552455433150773,0.00568562948173948,0.977532754849608
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,22978,0.000124090350009644,0.00468060994832627,-0.00904990514870984,0.00929808584872913,0.978849530278363
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,23056,-0.000173844049031054,0.00670587261634784,-0.0133173543770728,0.0129696662790107,0.97931806192726
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,23775,6.60023584866473e-05,0.00277078187393463,-0.00536473011442523,0.00549673483139852,0.980995714922605
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",27544,-4.82046258471574e-05,0.00209051612034762,-0.0041456162217285,0.00404920697003418,0.981603600719143
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,23198,8.15450579847896e-05,0.00394769898712916,-0.00765594495678836,0.00781903507275794,0.983519965782469
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,26907,-3.42313291785216e-05,0.00194019900357364,-0.00383702137618286,0.00376855871782582,0.985923620138319
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",23071,5.59834704389942e-05,0.00355238731833457,-0.00690669567349677,0.00701866261437476,0.987426479872134
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,22936,-4.40516766480766e-05,0.00282702988914061,-0.00558503025936368,0.00549692690606752,0.987567748366174
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,27910,3.74186421173218e-05,0.00241547387693147,-0.00469691015666836,0.00477174744090301,0.987640398248495
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,28129,2.7846649255466e-05,0.0020006920977658,-0.0038935098623655,0.00394920316087643,0.988895094555171
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,23071,4.58101368646069e-05,0.00335271458020759,-0.00652551044034226,0.00661713071407148,0.989098485293754
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,23071,-5.22430163289806e-05,0.00430726065082201,-0.00849447389194013,0.00838998785928217,0.990322753718452
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,22940,-3.66762474529e-05,0.00336552563034399,-0.00663310648292712,0.00655975398802132,0.99130521752659
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,28224,-3.43104432525439e-05,0.00320357894217165,-0.00631332516990897,0.00624470428340388,0.991454867361423
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,23071,5.23286580207812e-05,0.00497217369048189,-0.00969313177532371,0.00979778909136528,0.991603067903049
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,27871,-2.71916323371775e-05,0.00298822033808386,-0.00588410349498155,0.00582972023030719,0.992739728986514
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,23393,4.54596342732329e-05,0.00507380357740912,-0.00989919537744865,0.00999011464599511,0.992851385235345
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,23056,-4.38302271299871e-05,0.00518641085994393,-0.0102091955126201,0.0101215350583601,0.993257251159204
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,23393,3.19853551232857e-05,0.00409383688589243,-0.00799193494122587,0.00805590565147244,0.993766217564452
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,23071,2.00182923755543e-05,0.0034561868146485,-0.0067541078643355,0.00679414444908661,0.995378715102053
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,28553,5.8796070556546e-06,0.0013521157764028,-0.00264426731469383,0.00265602652880514,0.996530480676683
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,28452,5.98916908995011e-06,0.00417121038017787,-0.00816958317605868,0.00818156151423858,0.998854380033123
